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The work presented in this thesis aims to develop analytical methods and apply 
them for the quality control of botanicals and botanical health products. Firstly, for the 
quality control of botanical health products used for sexual performance enhancement 
and slimming, targeted adulterant screening was carried out using high performance 
liquid chromatography-diode array detector (HPLC-DAD), liquid chromatography-
mass spectrometry (LC-MS) and gas chromatography-mass spectrometry (GC-MS). 
Secondly, for the quality assessment of adaptogenic botanicals together with raw and 
steamed Panax notoginseng, non-targeted metabolite profiling using liquid 
chromatography-linear ion trap-Orbitrap XL fourier transform mass spectrometry (LC-
LTQ-Orbitrap XL FT MS) coupled with multivariate data analysis was applied to 
commercial samples in Singapore and China. 
Undeclared western drugs such as Phosphodiesterase-type 5 (PDE-5) inhibitors 
as well as their analogues found in the botanical health product samples have resulted in 
severe adverse reactions. Screening for the presence of synthetic drugs illegally added 
into botanical health products is important to ensure the quality of botanical health 
products and to safeguard the interests and safety of consumers. A new and simple 
HPLC-DAD method was developed, optimized and validated for the simultaneous 
detection and determination the presence of 19 PDE-5 inhibitors and their analogues in 
botanical health products used for sexual performance enhancement. This method was 
applied to screen two hundred and seventy-one botanical health products purchased on-
line. Out of the one hundred and ninety-eight sexual performance enhancement 
products, one hundred and four (52.5%) were found to be adulterated with unapproved 
or undeclared components, in which 21 samples (10.6%) were detected to contain PDE-
 X 
5 inhibitors and their analogues. Out of the seventy-three slimming products, twenty-six 
(35.6%) were found to contain compounds such as caffeine, sibutramine and 
glibenclamide. The concentrations of the adulterated PDE-5 inhibitors and/or their 
analogues in five commercial products were quantified using the HPLC-DAD method. 
In this study, three new synthetic adulterants were detected and isolated for the 
first time from three botanical health products used for sexual performance 
enhancement. They were sildenafil analogues (hydroxythiohomosildenafil and 
descarbonsildenafil) and dapoxetine, isolated from LFW, Maccino coffee and MHD1 
respectively. The structures of these three synthetic adulterants were identified using 
high-resolution MS, LC-MS/MS, NMR and IR. 
In addition, a metabolomic investigation platform, in which non-targeted 
metabolite profiling was coupled with multivariate data analysis, was developed to 
assess the quality of 5 commonly used adaptogenic botanicals (Panax ginseng, Panax 
quinquefolium, Eleutherococcus senticosus, Gynostemma pentaphyllum and Rhodiola 
rosea) and Panax notoginseng purchased in Singapore and China. In the first part of the 
study, a pressurized liquid extraction (PLE) method and a LC-LTQ-Orbitrap XL FT MS 
method were developed and optimized. In the second part of the study, the 5 
adaptogenic botanicals together with raw and steamed P. notoginseng were extracted 
using the optimized PLE method. The extract of each sample was profiled using the 
developed LC-LTQ-Orbitrap XL FT MS method. The acquired raw chromatographic 
data was pre-processed and subjected to multivariate data analysis. This metabolomic 
investigation platform has been demonstrated to be a useful tool for the quality 
evaluation of these 5 adaptogenic botanicals and P. notoginseng. 
In conclusion, the work presented in this thesis has provided a new screening 
method for adulterants and a new metabolomic platform for evaluating the quality of 
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botanicals and botanical health products. The methodologies developed and applied are 
important to ensure the quality of health products and hence the safety of consumers. 
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Chapter 1 Introduction 
 
The World Health Organization (WHO) estimates that 80% of the population 
depend on traditional medicine for primary health care in some Asian and African 
countries (WHO, 2008). The use of botanicals or herbal medicines constitutes a large 
part of traditional medicine. According to WHO, botanicals refer to various types of 
plants or plant extracts used alone or in combination to treat, diagnose and prevent 
illnesses or to maintain well-being while botanical health products are products derived 
from botanicals and are usually sold over the counter as dietary supplements used for 
the pursuit of health and well-being (Bast et al., 2002; WHO, 1996; Liu, 2011; 
NCCAM, 2010). The 2007 National Health Interview Survey (NHIS) has found that 25-
35% of population in US uses botanicals and/or botanical health products (Barnes et al., 
2008). This number could be even larger in some Asian countries, such as China, Japan 
and Singapore. The reasons individuals take botanicals and/or botanical health products 
probably vary as much as people do. For some person, using botanicals is part of a 
pattern of returning to nature, combined with eating organically grown foods and 
following a generally healthy diet and physically active lifestyle. For others, botanicals 
represent a mild alternative to prescription antianxiety agents or sleep aids for dealing 
with the stress and pressure of daily life (Cardellina, 2002). 
The popularity of botanicals and botanical health products is accompanied by 
questions regarding the quality, safety and efficacy of commercially available botanical 
products. Quality, safety and efficacy are three interrelated issues. Quality is the basic 
starting point and is the paramount issue because it can affect the efficacy and safety of 
the botanicals and botanical health products being used. Although quality control of 
  2 
botanicals and botanical health products is challenging because of their complex nature, 
various methods have been developed to control their quality.  
 
1.1 Quality of botanicals and botanical health products 
Ensuring that botanicals and botanical health products are of suitable quality is 
important for several reasons. Firstly, botanicals are natural products and thus the 
composition may be affected by many factors. Secondly, botanicals contain numerous 
chemical constituents, including flavonoids, alkaloids, glycosides, fatty acids and 
terpenes (Barnes, 2003). Thirdly, different parts of the plant (e.g. roots and leaves) may 
contain different chemical constituents or constituents in different concentrations. 
However, many manufacturers entered this industry with little investment and easy 
access to a growing market and may not be careful in processing or labeling their 
products (Low et al., 2009). As a result, some commercial botanical products produced 
by different manufacturers were of different quality. A study on selected commercial 
ginseng products prepared from Panax ginseng CA Meyer and Panax quinquefolius L. 
(Araliaceae) and Eleutherococcus senticosus Maxim (Araliaceae), marketed as 
botanical supplements in North America highlighted the lack of quality control (Fitzloff 
et al., 1998). The results showed that the contents of ginsenosides of 232 Panax ginseng 
and 81 Panax quinquefolius products ranged from not detectable to 13.54% and 0.009% 
to 8.00%, respectively. Hence, in order to guarantee a good and consistent quality of 
botanicals and botanical health products, the quality control process is very important. 
 
1.1.1 Factors affecting the quality 
In order to control the quality of botanicals and botanical health products, it is 
necessary to understand the different factors which could affect the quality of botanicals 
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and botanical health products before actual quality assessment is carried out. It is well 
established that botanicals and botanical health products quality and quality variations 
are due to both intrinsic and extrinsic factors (Fong, 2002; Khan, 2006). These factors 
are reviewed below. 
 
1.1.1.1 Intrinsic factors 
Intrinsic factors, including species differences, organ specificity, diurnal and 
seasonal variation, are factors arising from the plants. This is easy to understand as 
botanicals are derived from dynamic living organisms, each of which is capable of 
being slightly different in its physical and chemical characters due to genetic influence. 
For example, narrow leafed and broad leafed Hypericum perforatum (St. John’s wort) 
have different hypericin concentrations (Campbell et al., 1997; Southwell et al., 1991). 
In addition, both qualitative and quantitative variations of phytochemicals are greater in 
the wild than in domesticated populations of the same species. Thus, to ensure chemical 
uniformity, it is necessary that the starting plant material for the manufacture of 
botanicals be accurately identified and authenticated. 
Moreover, with regards to organ specificity, the site of biosynthesis and the site 
of accumulation and storage are normally different (Fong, 2002). Chemical biosynthesis 
usually happens in the leaves, and the synthesized phytochemical constituents are then 
transported to other parts of the botanicals. Diurnal and seasonal variations are other 
intrinsic factors affecting chemical accumulation in both wild and cultivated botanicals 
(Khan, 2006). Depending on the botanicals, the accumulation of chemical constituents 
can occur at any time during the various stages of their growth. In a majority of cases, 
maximum chemical accumulation occurs at the time of flowering, followed by a decline 
beginning at the fruiting stage. The time of harvest can thus influence the quality of the 
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final botanical product (James, 1981). 
 
1.1.1.2 Extrinsic factors 
Extrinsic factors affecting qualities of botanicals include soil, light, water, 
temperature and nutrients. These factors can affect phytochemical accumulation in 
botanicals. There are many scientific reports investigating the influence of these 
extrinsic factors on the quality of botanicals. For example, Atropa belladonna L. 
(Solanaceae) has different alkaloid concentrations when it is cultivated in Caucasus 
(1.3%) and Sweden (0.3%) (McChesney, 1999) and the concentrations of ginsenosides 
in Panax notoginseng (Burk) F. H. Chen are different between samples cultivated in 
Yunnan Province, China and Shaanxi Province, China (Mahady et al., 2001). 
The methods employed in the field collection, harvest, post-harvest processing, 
shipping and storage can also influence the physical appearance and chemical quality of 
the botanical source materials (Fong, 2002). Contamination is usually caused by human 
error or unscrupulous operator (Newall et al., 2002). Contamination by microbial and 
chemicals agents such as pesticides, herbicides and heavy metals, as well as by insect, 
animal, animal parts and animal excreta during any of the stages of botanical materials 
production can lead to lower quality and unsafe materials (Busse, 1999; McChesney, 
1999; Simon, 1999). Accidental or intentional contamination of botanical material with 
conventional drugs or poisonous substances (e.g. heavy metals, pesticide residues) and 
microorganisms can also occur. Contamination with toxic heavy metals can occur at the 
cultivation, post-harvest processing and product manufacturing stages. For example, 




Accidental botanical substitution (misidentification of plant species) or 
intentional botanical substitution (exchange with other plant species) can affect the 
safety and efficacy profiles of the resultant botanical products (Barnes, 2003). A classic 
example of fatal toxicity caused by botanical substitution was renal failure and renal 
cancer following the use of slimming products in which the nontoxic botanicals 
including Stephania tetrandra and Clematis armandii were substituted with 
Aristolochia species in Belgium in 1990s  (Newall et al., 2002). 
In recent years, adulteration of botanical health products with synthetic drugs or 
chemicals represents another problem in product quality. US FDA, Hong Kong, Korea, 
Japan and Singapore have reported several cases of adulteration of synthetic 
phosphodiesterase type-5 (PDE-5) inhibitors and their analogues in botanical health 
products (Blok-Tip et al., 2004; Hasegawa et al., 2009; Hou et al., 2006; Lam et al., 
2008; Li et al., 2009a; Lin et al., 2008; Reepmeyer et al., 2009a; Reepmeyer et al., 
2007a; Shin et al., 2003; Zou et al., 2006a). Synthetic PDE-5 inhibitors, including 
sildenafil, vardenafil and tadalafil are FDA approved drugs used for the treatment of 
erectile dysfunction. The adulteration of these PDE-5 inhibitors as well as their 
analogues is a safety concern. This subject will be reviewed in Section 1.2. 
 
1.1.2 Methods and techniques used for quality control 
Even under the best conditions, quality control of botanicals and botanical 
health products is challenging because the constituent concentrations may vary from 
batch to batch. Unlike regulated pharmaceuticals, the active ingredients for botanical 
products are not well-characterized or in some cases, are even unknown (Taylor, 2004). 
The therapeutic effects are usually caused by multiple constituents. These constituents 
may work “synergistically” and could hardly be separated into active parts (Liang et al., 
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2004). Hence, instead of targeting one or several marker compounds or 
pharmacologically active components in botanicals and botanical health products, the 
whole botanicals and botanical health products could be employed for evaluating their 
quality. 
 
1.1.2.1 Morphological, microscopic and chemical methods 
Conventionally, the quality control of botanicals is largely based on routine 
morphological identification method and microscopic identification method. Physical 
and chemical identification are also employed (Zhong et al., 2009). Morphological 
identification is based on the appearance of the botanicals to determine its quality 
standards. The shape, color, smell, the surface texture, cross section and water entity are 
the main features used for morphological identification (Lombard et al., 2007). 
Microscopic identification includes the observations of transverse or longitudinal 
section, the powder, the surface, the dissociated tissue and the polarized light 
microscopy (Zhong et al., 2009). Physical and chemical identification is the method 
which certain chemical reactions or physical properties of chemical constituents in 
botanical products are introduced to carry out qualitative and/or quantitative analysis 
(Cheng et al., 2007). They generally apply to botanicals with different chemical 
composition, or similar traits, but without a clear characteristic of microscopic 
identification. 
All of these conventional methods have their own disadvantages. For example, 
morphological identification method and microscopic identification method can be 
affected by human factors. Different identifiers may have different results when 
identifying a same botanical sample. With regards to the physical and chemical 
identification method, usually only one or two active ingredients are considered. 
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1.1.2.2 Chromatographic methods 
Several chromatographic techniques, such as thin layer chromatography (TLC), 
high performance liquid chromatography (HPLC), gas chromatography (GC), capillary 
electrophoresis (CE) as well as hyphenated techniques, can be applied for the quality 
control of botanicals. Chromatographic method emphasizes the integrated 
chromatographic or spectroscopic characteristic, which is represented by the relatively 
stable proportion and the peak sequence of the multiple constituents (Liang et al., 2009).  
 
1.1.2.2.1 TLC 
TLC is a simple, low-cost, versatile and specific method for the identification of 
botanical products (Jiang et al., 2010) and it is the common method of choice for 
botanical product analysis before instrumental chromatographic methods like GC and 
HPLC are established. It is possible to get useful qualitative information from the 
developed TLC plate. For example, based on different fingerprint pattern of TLC, P. 
ginseng, P. quinquefolium and P. notoginseng are successfully differentiated and 
identified separately (Xie et al., 2006). These fingerprint patterns could be applied for 
further authentication of P. ginseng, P. quinquefolium and P. notoginseng samples from 
different sources. At the same time, with the help of image analysis and digitized 
technique developed in computer science, using TLC for the evaluation of similarity 
between different samples is also possible. In addition, it is also possible to get 
quantitative information with the introduction of high performance TLC (HPTLC) 
technique. For example, a validated HPTLC method to quantify betulinic acid in 
Nelumbo nucifera (Nymphaeaceae) Rhizome extract (Mukherjee et al., 2010) and a 
HPTLC method to simultaneous determine three steroidal glycoalkaloids in Solanum 
xanthocarpum (Shanker et al., 2011) have been reported. 
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1.1.2.2.2 HPLC and hyphenated techniques 
HPLC is a popular method for the analysis of botanical products because of its 
easy operation, wide suitability and high reproducibility for both qualitative and 
quantitative analysis (Jiang et al., 2010). Reverse-phase columns may be the most 
popular columns used in the analytical separation of botanical products. One of the 
main advantages of HPLC is that it can be coupled with multiple detectors, such as UV 
or diode array detector (DAD), evaporative light scattering detector (ELSD), 
fluorescence detector (FD), MS and Nuclear Magnetic Resonance (NMR) (Jiang et al., 
2010). With the additional UV spectral information provided, HPLC chromatograms 
can be applied for documentation of complete botanical extracts. This makes the 
qualitative analysis of complex botanical samples become much easier than before. 
DAD is very convenient and sensitive for determining components with chromophore 
groups, but compounds like saponins, which have very few chromophoric groups, have 
a poor response with DAD. ELSD is an alternative detector for determination of non-
chromophore compounds in botanical products. However, the general implementation 
of ELSD for quantitative analysis is hampered by its poor reproducibility. 
The column efficiency of HPLC system is increased by using stationary phase 
(column) with a particle size less than 2 µm (Wilson et al., 2005). However, the column 
back pressure is inversely proportional to the square of the particle size and this results 
in a 8-fold increase in back pressure when moving from a 3.5 to 1.7 µm stationary 
phase. Thus, the use of sub 2 µm particle stationary phases, while being attractive as a 
means of improving chromatographic performance, requires the use of higher back 
pressures than those conventionally applied in HPLC. Ultra-high performance liquid 
chromatography (UHPLC) is designed to undertake the high pressure result from 
smaller particle size. The combination of very high pressures and a sub 2 µm stationary 
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phases provided significantly increased resolution and rapid analysis times as the result 
of the superior efficiency of the chromatographic process compared to conventional 
HPLC. This increased resolution proves to be extremely advantageous for the 
chromatographic analysis of very complex mixtures such as botanical products (Wilson 
et al., 2005). For example, the high throughout qualitative analysis of polyphenols in 
tea samples using UHPLC system has been reported (Guillarme et al., 2010). 
In addition, with the introduction of MS, the coupling of LC and MS has opened 
a new way to widely and routinely applied to the analysis of botanical products. In most 
cases, one could identify the chromatographic peaks directly on-line by comparison 
with literature data or with commercial standards, allowing avoid the time-consuming 
isolation of all compounds to be identified (He, 2000). The mass spectra data can help 
to identify and/or confirm the structures of target and unknown chemical compounds. 
Compared to LC-DAD, LC-MS also provides higher selectivity and sensitivity for 
analyzing minor components, isomeric compounds or compounds without 
chromophoric groups. There are various types of mass spectrometers available in 
commercial market worldwide. These include single quadrupole, triple quadrupole 
(QqQ), linear ion trap, time-of-flight (TOF) and Orbitrap (Fourier transform mass 
spectrometry, FT MS) (Rousu et al., 2010). 
The QqQ mass spectrometers can provide rich MSn fragments information 
useful for structural elucidation of unknown components in botanicals. It is also a 
suitable instrument for quantitative work due to the high detection sensitivity and 
reproducibility of multiple-reaction monitoring (MRM) mode. The hybrid triple 
quadrupole-linear ion trap (Q-Trap) in which the last quadrupole is replaced by a linear 
ion trap is a major advancement of QqQ technology (Hager et al., 2003). The ion trap is 
used for MSn experiment with high sensitivity scanning. A study on the characterization 
  10 
of coumarins in Radix glehniae was carried out using the Q-Trap system (Yang et al., 
2010). A total of 41 coumarins were successfully identified on the basis of their MS 
fragmentation patterns. 
The TOF or quadrupole TOF (Q-TOF) mass spectrometer is well-known for its 
high full scan sensitivity and mass accuracy (Rousu et al., 2010). Hence, the use of TOF 
or Q-TOF mass spectrometers coupled with very high data acquisition rate 
chromatography, such as UHPLC, is in many cases preferred in plant metabolite 
analysis. The detection of all metabolites in a single run, without the need for 
preadjustment of detection for certain metabolites and with the possibility of various 
post-acquisition data filtering and processing options, makes the screening of plant 
metabolites both straightforward and cost effective (Tiller et al., 2008). Our group has 
reported the analysis of raw and steamed P. notoginseng using UHPLC-Q-TOF (Toh et 
al., 2010). Each metabolite profile of P. notoginseng samples was successfully acquired 
within 10 min. 
In an Orbitrap mass spectrometer, the high-resolution mass analyzer is usually 
combined with a linear ion trap (LTQ) to allow accurate mass measurements, high 
trapping capacity and MSn scan function (Hu et al., 2005). Therefore, the LTQ-Orbitrap 
is capable of MS/MS and produces very high accuracy mass data which makes it a 
useful instrument in identification of both human and plant metabolites. For example, 
the LTQ-Orbitrap system was evaluated for accurate measurement of human liver 
metabolites at a resolving power of 60000 (Lim et al., 2007), providing < 2 ppm mass 
accuracy in external calibration mode. The wide dynamic range of high mass accuracy 
together with an insignificant trade-off in sensitivity for resolving power shows that 
LTQ-Orbitrap is an invaluable analytical tool in automated metabolite identification. 
The higher resolving power of LTQ-Orbitrap can be utilized to remove interference 
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from isobaric endogenous components or metabolites to improve accuracy of mass 
measurement. The high mass accuracy of the resultant exact masses provides chemical 
formulae which can be used to assign with greater confidence the structures of the 
metabolites in botanicals. The identification of chemical constituents in a complex 
Traditional Chinese Medicine (TCM) formula containing seven herbal medicines using 
the LTQ-Orbitrap system has been reported (Su et al., 2010). Thirty three chemical 
constituents in the TCM formula were finally identified by comparing their TICs to 
these of the standard compounds in the seven herbs. 
Finally, the hyphenation between HPLC and NMR is also available. Although it 
is mostly used in the analysis of drugs in biological fluids (Durand et al., 2010; Pham et 
al., 2005; Stulten et al., 2008), it is also a vital and an attractive analytical tool for the 
analysis of botanical products (Kang et al., 2010; Kang et al., 2008; Wolfender et al., 
2001; Yang, 2006). It is used for structural identification of natural products as well as 
for the qualitative and quantitative analysis of herbal medicine, especially for plants 
metabolomic studies (Jiang et al., 2010). Jiang et al. used metabolic profiling and 
phytogenetic analysis for the authentication of Ginger species. The discrimination of 
chamomile flowers from different geographical regions, ginseng roots from different 
ages and Cannabis sativa from different cultivars were also successfully carried out by 
employing 1H NMR and PCA (Choi et al., 2004; Shin et al., 2007; Wang et al., 2004). 
Furthermore, a LC-NMR method was developed to quantify α- andγ-linolenic acids 
in mixtures (Sykora et al., 2007). 
 
1.1.2.2.3 GC and hyphenated techniques 
Some active components in botanical products are volatile chemical compounds. 
Thus, the analysis of volatile compounds by GC and GC-MS is very important in the 
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quality control of such botanical products. The high selectivity of capillary columns 
enables separation of many volatile compounds simultaneously with comparatively 
short times. Furthermore, the hyphenation with MS provides reliable information for 
the qualitative analysis of the complex constituents (Liang et al., 2004). The sensitivity 
and specificity of GC-MS have been increased by GC–MS/MS techniques in which the 
molecular ion after the first MS separation is exposed to a second fragmentation with a 
collision gas. These secondary fragmentations can then be separated and detected 
(daughter ion spectrum) (Pragst et al., 2006). 
In addition, new sample extraction and pretreatment methods for GC-MS have 
been developed, e.g. solid-phase microextraction (SPME) (Cao et al., 2006), headspace 
single-drop microextraction (HSDME) (Jain et al., 2010; Jeannot et al., 2010), 
headspace solid-phase microextraction (HS-SPME) (Schulz et al., 2009) and 
microextraction-assisted extraction (MAE) (Prieto-Blanco et al., 2008). Compared to 
the regular steam distillation, these new established methods are simple, rapid, low-cost, 
and sometimes, only a small quantity of sample (50 mg) is needed, even without 
organic solvent (Prieto-Blanco et al., 2008). 
Two-dimensional gas chromatography (GC × GC) is a novel technique which 
can be used for the analysis of complex mixtures. It is considered to be the most 
powerful and versatile separation tool in GC. It has the advantages of enhanced 
sensitivity and resolution with two capillary columns of different separation 
mechanisms via a modulator (Dalluge et al., 2003). The development and application of 
the comparative GC × GC is summarized in a review article (Adahchour et al., 2008). It 
has been used for the detection of some micro-constituents or contaminants (Dasgupta 
et al., 2010; Hilton et al., 2010), establishment of the comprehensive fingerprint 
(Purcaro et al., 2010; Wang et al., 2010), and exploration of the unknown volatile 
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compounds in botanical products and other drugs (Baharum et al., 2010). 
 
1.1.2.2.4 CE 
CE, with high resolution, minimal sample and solvents consumption, short 
analysis time and high separation efficiency, is an effective tool for the quality control 
of botanical products (Ganzera, 2008). The majority of commercially available CE 
instruments employ UV or DAD as detector because of their simplicity, convenience 
and availability. In order to improve the detection sensitivity, more sensitive detection 
methods, like laser-induced fluorescence, electrochemical, MS, fluorescence and 
chemiluminescence detectors, have been applied (De Andres et al., 2010; Jacksen et al., 
2010; Zhou et al., 2006).  
Several separation modes are used in the CE technique: capillary zone 
electrophoresis (CZE), micellar electrokinetic chromatography (MEKC), non-aqueous 
CE (NACE) and capillary electrochromatography (CEC). Multiple separation modes in 
CE make it suitable for many samples. For example, CZE is suitable for the separation 
of both anionic and cationic compounds. MEKC is suitable for neutral compounds. 
NACE, based on electrolyte solutions prepared from pure organic solvents, is suitable 
for compounds with poor water solubility (Li et al., 2008). NACE also offers other 
attractive features, such as alteration of selectivity, reduced electrophoretic currents and 
improved mass spectrometric compatibility (Liu Q et al., 2006). In the process of the 
application of CE in the analysis of botanical products, the chromatographic conditions, 
including buffer concentrations, pH, additives and voltage can be optimized in order to 
obtain better separation results (Ganzera, 2008). A recent review has summarized the 
applications of CE in the analysis of TCMs (Feng et al., 2010). 
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1.1.2.3 FT-IR and NMR spectroscopic methods 
In addition to the above-mentioned chromatographic methods, a variety of 
spectroscopic methods, such as Fourier transform infrared spectroscopy (FT-IR), near-
infrared spectroscopy (NIR) and NMR, can also be used in the quality control of 
botanicals and/or botanical products. In comparison with chromatographic methods, 
spectroscopic methods emphasize much more on the integrative and holistic 
characteristics of botanical products. Moreover, spectroscopic methods are simple, rapid 
and no pre-preparation of sample is required (Jiang et al., 2010). 
FT-IR is originally a spectroscopic technique to identify the functional groups of 
the chemical constituents, but it has been widely used for the identification, quality 
control and manufacturing process supervision of botanical products in recent years. 
Based on this technique, the discrimination of botanicals from different habitats, 
different manufacturers and different species have been performed (Li et al., 2006; Liu 
HX et al., 2006; Wu et al., 2008). 
Compared with FT-IR, NIR has a higher precision and an easier sample 
preparation. Sometimes even no sample preparation is needed. As a result, there is an 
increasing trend on the use of NIR for the qualitative and quantitative analysis of 
botanical products in recent years (Lu et al., 2008). Moreover, like other spectroscopic 
techniques, the appearance of two-dimensional NIR (2D-NIR) can enhance spectral 
resolution, simplify the spectrum with overlapped bands or even provide information 
about temperature-induced spectral intensity variations that is hard to obtain from one-
dimensional NIR spectroscopy (Lu et al., 2008). Although FT-IR and NIR is not as 
powerful as the conventional LC method, the major component(s) (> 0.1%) in botanical 
products can be analyzed quickly and simultaneously by NIR. The rapidity, availability, 
practicability and integrity of FT-IR and NIR make these research methods very 
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effective for the analysis of botanical products (Lau CC et al., 2009). 
High-resolution NMR spectroscopy is an effective tool for structural elucidation 
traditionally, but in recent years, it has been developed into an important tool for the 
qualitative and quantitative analysis of botanical products, especially for the 
metabolomic studies of plants (Kim et al., 2010a; Liu et al., 2010; Schripsema, 2010). 
In comparison with other analytical methods for studying metabolomics, such as LC-
MS and GC-MS, NMR has the advantage of simple sample preparation and 
reproducibility. Among different NMR techniques, 1H NMR is most frequently used for 
metabolomic study assisted by computer-based data analysis methods, such as 
multivariate data analysis. The multivariate data analysis, including principal 
component analysis (PCA) and partial least square-discriminant analysis (PLS-DA), are 
often used to reduce the complexity of NMR data and to analyze the metabolic profiling 
of botanical products for authentication, quality control, determination geographic 
source and detecting adulteration of drugs (Eisenreich et al., 2007). PCA and PLS-DA 
will be discussed in Section 1.3.5. 
In addition to the qualitative analysis of the chemical constituents of botanical 
products, NMR spectroscopy can also be used for the quantitative analysis of chemical 
components in botanical products. Compared with conventional chromatographic 
methods, quantitative NMR (qNMR) analysis is more accurate and precise, less time-
consuming, easy to perform, more specific and highly reproducible (Pauli, 2001). In a 
report regarding the quantitative determination of phlorotannins in algal extract, qNMR 
is compared with three other methods (Parys et al., 2007). The results show that qNMR 




1.1.2.4 DNA methods 
Authentication and identification is one of the most important steps in ensuring 
the quality of botanical products. Since genetic composition is unique for each 
individual, DNA methods for botanical identification are less affected by age, 
physiological conditions, environmental factors, harvest, storage and processing 
methods (Yip et al., 2007). There are two general approaches used for DNA-based 
authentication of medicinal botanicals: the first one covers determination of the 
nucleotide sequence of one or more genetic loci in the botanicals of interest and 
identification of the nucleotide sequence that is characteristic of a given species; the 
second one, rather than focusing on specific genetic loci, makes use of species-specific 
variations of the nucleotide sequence that are spread randomly over the entire genome, 
resulting in characteristic fingerprint of genomic DNA (Sucher et al., 2008). At present, 
genomic fingerprint has been widely used for the authentication of single herb, species 
and population, homogeneity analysis and detection of adulterants (Jiang et al., 2006; 
Sun et al., 2007; Wang et al., 2007; Yang et al., 2007). 
 
1.2 Targeted adulterant screening in botanical health products 
Undeclared synthetic drugs added into botanical health products is one 
important factor affecting their quality. Because of the unknown safety profile of those 
synthetic drugs, the adulteration may lead to health hazards. The resulting clinical 
consequences may be serious and sometimes life threatening. In the following section, 
an overview of adulteration of botanical health products used for sexual performance 
enhancement and slimming with synthetic compounds is presented. The reported cases 




1.2.1 Sexual performance enhancement products 
Erectile dysfunction is a highly prevalent problem as well as the major men’s 
sexual concern affecting 5-20% of population (Feldman et al., 1994; Hatzimouratidis et 
al., 2008). Synthetic phosphodiesterase type-5 (PDE-5) inhibitors are widely used for 
the treatment of erectile dysfunction. To date, three PDE-5 inhibitors have been 
approved by the United States Food and Drug Administration (US FDA) for the 
treatment of erectile dysfunction. They contain sildenafil, tadalafil and vardenafil. 
Sildenafil (Viagra®) from PfizerTM is the first PDE-5 inhibitor licensed for the treatment 
of erectile dysfunction in 1998. Two other PDE-5 inhibitors, vardenafil (Levitra®) and 
tadalafil (Cialis®) are approved as drugs for the treatment of erectile dysfunction by US 
FDA in 2003 (Gratz et al., 2004). Udenafil (Zydena®), a novel long-acting PDE-5 
inhibitor, was approved by the Korean Food and Drug Administration (KFDA) in 2005 
(Salem et al., 2006). 
The popularity of these synthetic compounds has expanded the market for 
erectile dysfunction treatments. Many kinds of botanical health products appear in the 
market as an alternative treatment for sexual performance enhancement. Being natural, 
these botanical health products are generally believed to be safer than synthetic 
compounds. The use of botanical health products for the treatment for erectile 
dysfunction has greatly increased. However, some botanical health products advertised 
as “100% natural” were found to be adulterated with PDE-5 inhibitors and their 
analogues in recent years. These analogues are not US FDA approved drugs and limited 
or no reports on their pharmacological activities can be found. Based on their structural 
similarities with sildenafil, vardenafil, tadalafil and udenafil, similar pharmacological 
activity may or may not be expected. More importantly, the safety profiles of these 
analogues are largely unknown. It is important to note that these four synthetic 
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compounds are prescription drugs and must be used under medical supervision. Adverse 
effects such as headache, facial flushing, nasal congestion, dyspepsia, visual 
disturbances and muscle aches have been reported (Wespes et al., 2002). 
Moreover, fatal cases caused by those adulterated botanical health products had 
also been reported.  For example, one case of liver function impairment in Japan might 
be due to the use of a product containing hydroxyhomosildenafil (Pharmaceutical and 
Food Safety Bureau-Health Labor and Welfare Ministry (Japan), 2004). In Hong Kong, 
a 28-year-old, previously healthy man presented with unsteady gait and frequent falls 
due to the use of a health product adulterated with acetildenafil (Poon et al., 2007). In 
Singapore, four illegal sexual performance enhancement products had been found to be 
adulterated with sildenafil and a very high dose of glibenclamide (Health Sciences 
Authority of Singapore (HSA), 2008a). They had caused serious adverse reactions, e.g. 
coma and extensive neurological damage, leading to at least ten deaths to date (Health 
Sciences Authority of Singapore (HSA), 2008b; 2008c; Low et al., 2009). In the United 
States, a case of sensorineural hearing loss of a 57-year-old man after ingesting 
vardenafil was reported (Snodgrass et al., 2010). Hence, it is important to determine the 
presence of those PDE-5 inhibitors and their analogues in botanical health products. 
The reports on adulterations of botanical health products with PDE-5 inhibitors 
as well as their analogues are presented in Table 1.1. The number of reported cases of 
adulterated botanical health products used for sexual performance enhancement had 
doubled from year 2006 to present. The structures of the adulterated PDE-5 inhibitors 





A                                                   B 
Structure A 
X1 = O X2 = N R1 = CH3 R2 = H R3 = H Sildenafil 
X1 = O X2 = N R1 = CH2CH3 R2 = H R3 = H Homosildenafil 
X1 = O X2 = N R1 = CH2CH2OH R2 = H R3 = H Hydroxyhomosildenafil 
X1 = O X2 = N R1 = Cyclopentyl R2 = H R3 = H Cyclopentynafil 
X1 = O X2 = N R1 = H R2 = CH3 R3 = CH3 Methisosildenafil 
X1 = O X2 = N R1 = CH3 R2 = H R3 = CH3 Dimethylsildenafil 
X1 = O X2 = N R1 = H R2 = H R3 = H Desmethylsildenafil 
X1 = O X2 = CH R1 = H R2 = H R3 = H Norneosildenafil 
X1 = S X2 = N R1 = CH3 R2 = H R3 = H Thiosildenafil 
X1 = S X2 = N R1 = CH2CH3 R2 = H R3 = H Thiohomosildenafil 
X1 = S X2 = N R1 = CH2CH2OH R2 = H R3 = H Hydroxythiohomosildenafil
X1 = S X2 = N R1 = H R2 = CH3 R3 = CH3 Thiomethisosildenafil 
Structure B 
X = N R = CH2CH3 Acetildenafil 
X = N R = CH3 Desmethylacetildenafil 
X = N R = H Desethylacetildenafil 
X = N R = CH2CH2OH Hydroxyacetildenafil 
X = CH R = H Piperiacetildenafil 
 






Figure 1.1 Chemical structures of PDE-5 inhibitors and their analogues. 
R = CH3 Tadalafil 
R = NH2 Aminotadalafil 










Xanthoanthrafil (Benzamidenafil)                                          Avanafil 
 
                         
Udenafil                                                    Thioquinapiperifil 
 
Figure 1.1 (Continued) Chemical structures of PDE-5 inhibitors and their identified 
analogues. 
X = N R = CH2CH3 Vardenafil 
X = N R = CH2CH2OH Hydroxyvardenafil
X = N R = H Desethylvardenafil
X = CH R = H Pseudovardenafil 
R = H Imidazosagatriazinone 
R = COOH Acetil-acid 
R = COCH3 Gendenafil 
Tadalafil analogue condensed from 
aminotadalafil and hydroxymethyl-




Table 1.1 Synthetic PDE-5 inhibitors and their analogues found in sexual performance enhancement botanical health products (in chronological 
order). 
 
No. Year PDE-5 inhibitors & analogues detected Type of botanical health products Uses References 
1 2002 Sildenafil Herbal medicine capsules from China Male tonic, sexual 
dysfunction 
(Ku et al., 2002) 
2 2002 Sildenafil A soft drink collected from Nagoya City 
(Japan) markets by Aichi prefecture drugs 
inspectors in 2001 
Roborant nutrition (Mikami et al., 2002) 
3 2002 Sildenafil Pink and cream capsule with dark brown 
powder dietary supplement in Taiwan 
Male tonic, sexual 
dysfunction 
(Tseng et al., 2002) 
4 2002 Sildenafil Thirteen herbal medicine samples collected 
by State Food and Drug Administration 
(SFDA) of China 
Male tonic, sexual 
dysfunction 
(Zhang et al., 2002) 
5 2003 Homosildenafil An imported miscellaneous beverage 
submitted for inspection in Korea 
Male tonic, sexual 
dysfunction 
(Shin et al., 2003) 
6 2004 Acetildenafil (hongdenafil) A commercial herbal drink submitted to 
Korea Food and Drug Administration 
(KFDA) for testing 
Male tonic, sexual 
dysfunction 
(Shin et al., 2004) 
7 2004 Acetildenafil, homosildenafil and 
hydroxyhomosildenafil 
Three traditional Chinese medicine samples 
submitted by the Dutch Food and Consumer 
Product safety Authority and Dutch Health 
Care Inspectorate 
Male tonic, sexual 
dysfunction 
(Blok-Tip et al., 
2004) 
8 2004 Sildenafil, tadalafil and 
homosildenafil 
Nineteen herbal samples collected in US 
market by US FDA 
Sexual Performance 
enhancement 
(Gratz et al., 2004) 
9 2005 Homosildenafil and acetildenafil Two dietary supplements in Japan Male tonic effects (Takako et al., 2005) 
10 2005 Sildenafil Two dietary supplements Actra-Rx and 
YiliShen sold on websites 
Enhancing sexual 
performance 





11 2005 Sildenafil and tadalafil Two herbal products purchased via the 
internet or at Canadian health food stores 
Male tonic, sexual 
dysfunction 
(Fleshner et al., 
2005) 
12 2005 Vardenafil One herbal medicine in oral liquid 
formulation purchased in a supermarket 
Male tonic, sexual 
dysfunction 
(Zhu et al., 2005) 
13 2006 Acetildenafil A dietary supplement in Taiwan market For erectile 
dysfunction 
(Lai et al., 2006) 
14 2006 Hydroxyacetildenafil One dietary supplement submitted to HSA 
of Singapore for testing 
Enhancing sexual 
performance 
(Hou et al., 2006) 
15 2006 Aminotadalafil and 
hydroxyhomosildenafil 
One herbal medicine submitted to HSA of 
Singapore for testing 
Enhancing sexual 
performance 
(Zou et al., 2006a) 
16 2006 Sildenafil, tadalafil, vardenafil, 
acetildenafil, homosildenafil and 
hydroxyhomosildenafil 
Pre-mixed bulk powder submitted to HSA 
of Singapore for testing 
Enhancing sexual 
performance 
(Zou et al., 2006b) 
17 2006 Piperidenafil (Pseudovardenafil) An herbal dietary supplement purchased on 
the internet. 
For the enhancement of 
sexual function 
(Reepmeyer et al., 
2006) 
18 2006 Acetildenafil, homosildenafil and 
hydroxyhomosildenafil 
Two herbal supplements submitted to HSA 
of Singapore for testing 
Enhancing sexual 
performance 
(Oh et al., 2006) 
19 2006 Sildenafil Herbal supplements purchased by SFDA of 
China 
Improving both male 
and female sexual 
function 
(Liang et al., 2006) 
20 2006 Sildenafil asnd tadalafil Three marketed herbal products Sexual enhancement (Abdel-Hamid, 2006) 
21 2006 Sildenafil and tadalafil Four herbal products in the market of Saudi 
Arabia 
To nourish the body 
andfortify the male 
sexual function 
(Bogusz et al., 2006) 





Several “all-natural” herbal products To enhance sexual 
function or efficacy 




23 2006 Sildenafil, hydroxyhomosildenafil 
and yohimbine 
Two herbal food supplements in Taiwan 
market 
For the enhancement of 
sexual function 
(Lin et al., 2006) 
24 2007 Pseudovardenafil and 
hydroxyacetildenafil 




(Park et al., 2007) 
25 2007 Acetildenafil, piperidenafil, 
hydroxyhomosildenafil, 
hydroxyacetildenafil 
Twenty-six dietary supplements bought in 
Hong Kong market 
Male tonic, sexual 
dysfunction 
(Poon et al., 2007) 
26 2007 Noracetildenafil An herbal dietary supplement submitted to 
US FDA for testing 
Male tonic, sexual 
dysfunction 
(Reepmeyer et al., 
2007a) 
27 2007 Methisosildenafil (Aidenafil) An herbal dietary supplement submitted to 
US FDA for testing 
For the enhancement of 
sexual peroformence 
(Reepmeyer et al., 
2007b) 
28 2007 Imidazosagatriazinone A dietary supplement in Taiwan market For erectile 
dysfunction 
(Lai et al., 2007a) 
29 2007 Piperidenafil (Pseudovardenafil) A dietary supplement in Taiwan market For erectile 
dysfunction 
(Lai et al., 2007b) 
30 2007 Sildenafil Chinese herbal/patent medicines  collected 
from New York City's Chinatown 
Male tonic effects (Miller et al., 2007) 
31 2007 Desmethylacetildenafil A herbal product Male tonic effects (Zou et al., 2007b) 
32 2007 Thiosildenafil, piperidenafil “True Man Sexual Energy”, “Energy Max”  For sexual 
enhancement 
(US FDA, 2007) 
33 2008 Thioquinapiperifil, thiosildenafil One dietary supplement in Japan For sexual 
enhancement 
(Uchiyama et al., 
2008) 
34 2008 Aminotadalafil and 
hydroxyhomosildenafil 
One dietary supplement purchased on the 
internet 
Male tonic effects, 
sexual dysfunction 
(Hasegawa et al., 
2008) 
35 2008 Aminotadalafil and its 
stereoisomers 
A health food in Japan Male tonic effects (Kurita et al., 2008) 
36 2008 Imidazosagatriazinone A new herbal health product purchased in 
Hong Kong market 
For enhancing erectile 
function 
(Lam et al., 2008) 
37 2008 Thiosildenafil and 
thiohomosildenafil 
Two health supplements submitted to HSA 
for analysis 
For the enhancement of 
sexual function 
(Zou et al., 2008a) 
  
24 
38 2008 Xanthoanthrafil (Benzamidenafil) A natural herbal supplement sent to HSA of 
Singapore for testing 
For the enhancement of 
sexual function 
(Zou et al., 2008b) 
39 2008 Thioquinapiperifil (KF31327) A health supplement submitted to HSA of 
Singapore for testing 
Promote and support 
healthy sexual function 
and endurance 
(Ge et al., 2008) 
40 2008 Gendeafil Dietary supplements in Taiwan For energy 
enforcement 
(Lin et al., 2008) 
41 2008 Hydroxyvardenafil and 
methisosildenafil 
A health food seized by KFDA Male tonic effects (Choi et al., 2008) 
42 2008 Homosildenafil and 
thiohomosildenafil 
Marihuana sample in the Netherlands Male tonic effects (Venhuis et al., 
2008b) 
43 2008 Acetildenafil, piperidenafil and 
hydroxyacetildenafil 
Three herbal aphrodisiacs For sexual 
enhancement 
(Venhuis et al., 
2008a) 
44 2008 Thiohomosildenafil A herbal aphrodisiac For sexual 
enhancement 
(Venhuis et al., 
2008c) 
45 2008 Xanthoanthrafil A dietary supplement in Japanese market Male tonic effects (Kumasaka et al., 
2008) 
46 2008 Hydroxyhomosildenafil A dietary supplement tested by US FDA For erectile 
dysfunction 
(US FDA, 2008) 




(Man et al., 2009) 
48 2009 Sildenafil Eighty-five aphrodisiac herbal formulations 
sold in Indian market 
Male tonic effects (Savaliya et al., 
2009) 




Twenty-six herbal products For sexual 
enhancement 
(Gryniewicz et al., 
2009) 
50 2009 Hydroxythiohomosildenafil 
(thiohydroxyhomosildenafil) 








51 2009 Dapoxetine A health supplement submitted to HSA of 
Singapore for testing 
For sexual 
enhancement 
(Li et al., 2009b) 
52 2009 Sulfoaildenafil 
(thiomethisosildenafil) 
A bulk material, labeled as an ingredient for 
a dietary supplement, submitted to US FDA 
for testing 
For sexual performance 
enhancement 
(Gratz et al., 2009) 
53 2009 Sildenafil, tadalafil, vardenafil, 
hydroxyhomosildenafil and 
thiomethisosildenafil 
Seventeen commercial formulations of 
herbal drugs or dietary supplements 
For sexual dysfunction (Balayssac et al., 
2009) 
54 2009 Sildenafil and vardenafil Five different cosmetic creams obtained 
from Internet websites 
For male and female 
genitals stimulation 
(De Orsi et al., 2009) 
55 2009 Thiohydroxyhomosildenafil and 
hydroxyhomosildenafil 




(Reepmeyer et al., 
2009b) 
56 2009 Thiosildenafil and 
thiomethisosildenafil 
Herbal aphrodisiacs appropriated from 
distributors’ warehouses 
Male tonic, sexual 
dysfunction 
(Reepmeyer et al., 
2009a) 
57 2009 Cyclopentynafil and N-Octyl-
nortadalafil 
A dietary supplement in Japanese market For erectile 
dysfunction 
(Hasegawa et al., 
2009) 
58 2010 A tadalafil analogue A health food product submitted to HSA of 
Singapore for testing 
Male tonic (Haberli et al., 2010) 
59 2010 Sildenafil, tadalafil, vardenafil and 
yohimbine 
Twenty-six natural dietary supplements 
bought at Changsha, China 
For male sexual health (Zhang et al., 2010) 




(Ng et al., 2010) 
61 2010 Hydroxythiohomosildenafil “Magic Power coffee” tested by US FDA Male tonic (US FDA, 2010b) 
62 2010 Aminotadalafil E-cigarette samples purchased by US FDA via the internet Male tonic 
(Hadwiger et al., 
2010) 
63 2011 Nitroso-prodenafil A herbal dietary supplement Libido enhancing (Venhuis et al., 2011) 
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1.2.2 Slimming products 
The presence of synthetic drugs as illicit adulterants in slimming botanical 
health products also poses a serious health risk to consumers. One notable example is 
the adulteration of a slimming product known as Slim 10 by N-nitrosofenfluramine, a 
hepatotoxic agent, possibly leading to a fatal case of hepatic failure in Singapore (Lau 
G et al., 2004; Nakagawa et al., 2005). From 2001 to 2002, more than 800 cases of liver 
damage in Japan were reported among people taking Chinese weight loss aids 
containing nitrosofenfluramine (Nakadai et al., 2003). Another article reported that 
there were 12 cases of acute liver injury associated with the use of weight-reducing 
herbal products “Chaso” and “Onshido”, which were also found to be adulterated with 
nitrosofenfluramine. Two patients developed fulminant hepatic failure. One died and 
the other underwent a liver transplant (Adachi et al., 2003). More recently, the US FDA 
reported a weight loss capsule “Que She”, which was advertised as “an all-natural blend 
of Chinese herbs”. It was found to be adulterated with fenfluramine, propranolol, 
sibutramine and ephedrine (US FDA, 2010a). Fenfluramine was known to cause serious 
heart valve damage and had been withdrawn from the US market since 1997. 
Propranolol is a beta blocker and can pose a risk to people with bronchial asthma and 
certain heart conditions (US FDA, 2010a). Sibutramine is an appetite suppressant and is 
known to increase the risk of heart attack and stroke in patients who have a history of 
heart disease (Eroglu et al., 2009). It has been withdrawn from sale in Singapore and 
US (Health Science Authority of Singapore, 2010; US FDA, 2010c). Ephedrine can 
pose a risk to people with certain cardiovascular conditions. The adulteration of these 
synthetic drugs into so-called “all-natural product” may cause serious safety problems. 
The reports on the adulterations of undeclared synthetic drugs found in botanical health 




Table 1.2 Undeclared synthetic drugs found in botanical health products for slimming (in chronological order). 
No. Year Drug detected Type of botanical health products References 
1 2002 Fenfluramine Herbal products sold in UK (Corns et al., 2002) 
2 2003 Fenfluramine, 
nitrosofenfluramine 
A Chinese dietary supplement for weight reduction sold in Japan (Kawata et al., 2003) 
3 2003 Nitrosofenfluramine “Chaso” and “Onshido” in Japan (Adachi et al., 2003) 
4 2004 Aspirin, ephedra alkaloids, 
phenylpropanolamine, caffeine
Three imported dietary supplements in Japan (Takashi et al., 2004) 
5 2004 Diethylpropion, fenfluramine, 
mazindol 
Slimming dietary supplement in China (Feng et al., 2004) 
6 2004 Fenfluramine Two dietary supplements purchased in China (Wang et al., 2004) 
7 2004 Nicotinamide, 
nitrosofenfluramine, thyroxine 
fenfluramine 
“Slim 10” capsule in Singapore (Lau G et al., 2004) 
8 2004 Nitrosofenfluramine A weight loss products “Sen-no-moto-ko-no” in Japan (Kawaguchi et al., 2004) 
9 2005 Fenfluramine, mazindol, 
nitrosofenfluramine, thyroxine 
Four dietary supplements imported by individuals from China (Mikami et al., 2005) 
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10 2005 Fenfluramine A Chinese herbal weight loss medicine (Bryant et al., 2005) 
11 2006 Fenfluramine and phentermine A herbal slimming remedy sold in Saudi Arabia (Bogusz et al., 2006) 
12 2006 Sibutramine A Chinese herbal medicine, called "Li Da Dai Dai Hua Jiao Nang" (Jung et al., 2006) 
13 2006 Sibutramine A Chinese slimming product (Vidal et al., 2006) 




A herbal product for weight loss in Singapore (Zou et al., 2007a) 
15 2007 N-desmethylsibutramine, 
nitrosofenfluramine 
Three slimming products in Hong Kong (Yuen et al., 2007) 
16 2007 Sibutramine A Chinese herbal medicine for slimming "Meizitanc" in Poland (Wiergowski et al., 2007) 
17 2009 Sibutramine A dietary supplement “Venom HYPERDRIVE 3.0” (US FDA, 2009b) 
18 2009 Fenproporex, fluoxetine, 
furosemide, cetilistat 
72 slimming botanical health products in US market (US FDA, 2009a) 
19 2010 Fenfluramine, propranolol, 
sibutramine, ephedrine 





1.3 Metabolomic investigations for the quality control of botanicals 
In the field of botanical science, metabolomics, associated with innovative 
methodology and techniques, proves to be an effective approach for analysis of various 
chemical compounds contained in plant cells (Pichersky et al., 2000). The methodology 
of metabolomic investigation typically employs two principal analysis techniques (Fig. 
1.2). The first technique is non-targeted sample profiling technique including LC-MS, 
GC-MS, etc. It is mainly used for comprehensive, simultaneous, high-throughput and 
accurate metabolite analysis. The second technique is computational multivariate data 
analysis which is used to process the massive amount of raw chromatographic data. In 
particular, PCA and PLS-DA are the most commonly used multivariate data analysis 
methods. More detailed information regarding these two techniques will be introduced 
in section 1.3.4 and 1.3.5. 
Plant metabolomics is usually considered as comprehensively elucidating the 
biosynthetic flow of “gene-to-metabolite” on the molecular level and the correlations 
among gene expression, proteins and metabolites in system biology and functional 
genomics (Pichersky et al., 2000). In this thesis, however, metabolomic investigation 
has been independently applied to authenticate botanicals and to evaluate and 
discriminate the quality of botanicals based on their metabolite fingerprints as well as 
on marker metabolites. As introduced in previous section of this chapter, botanical 
medicine, including herbs and their derived products, contain various chemical 
components. Through metabolomic investigation, the detectable chemical constituent 
signals (including signals of both major and minor constituents) in metabolite 
fingerprinting are simultaneously and comprehensively processed by multivariate data 
analysis. Hence, the correlation between chemical constituents in botanicals and their 
quality can be visualized from statistical results. 
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Figure 1.2 Correlation between metabolite analysis and multivariate analysis in 




Furthermore, new or unknown commercial botanical derived products can be predicted 
by the developed regression models. Therefore, metabolomic investigation could serve 
as a reasonable and suitable analytical platform for authentication and quality control of 
botanicals. In the following section, detailed information of botanical samples 
investigated as well as each analytical step of the metabolomic investigation are 
introduced. 
 
1.3.1 Selected botanicals for investigation 
Adaptogenic botanicals are the main targeted samples for quality investigation 
in this study. The term “adaptogen” is used to categorize botanicals which improve the 
nonspecific response to and promote recovery from stress (Kelly, 2001). An adaptogen 
has a normalizing influence on physiology, irrespective of the direction of change from 
physiological norms caused by the stressor and is incapable of influencing normal body 
functions more than required to gain nonspecific resistance (Kelly, 2001). In the 1950s, 
Russian researchers determined that many botanicals, especially those belonging to the 
Araliaceae family, have adaptogenic properties. Panax ginseng (Chinese or Korean 
ginseng) and Eleutherococcus senticosus (Siberian ginseng) are two well-known 
adaptogenic plants. Other adaptogenic botanicals include Panax quinquefolium 
(American ginseng), Gynostemma pentaphyllum (Jiaogulan) and Rhodiola rosea 
(Hongjintian) (Kelly, 1999). 
The general term “Ginseng” is often noted to refer to the root of the perennial 
herbs of Panax ginseng C.A. Meyer (Araliaceae) and Panax quinquefolim L. which 
contain a series of tetracyclic triterpenoid saponins (ginsenosides) as active ingredients 
(Nocerino et al., 2000). P. ginseng is indigenous to the mountainous forests of eastern 
Asia. Traditionally, the usage of P. ginseng has been divided into (a) short-term use: to 
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improve stamina, concentration, healing process, stress resistance, vigilance and work 
efficiency in healthy individuals and (b) long-term use: to improve well-being in 
debilitated and degenerative conditions especially those associated with old age (SFDA 
of China, 2005). For the long-term use, an interval is needed every three months 
(Blumental et al., 2000). Two varieties of P. ginseng are commercially available: white 
and red P. ginseng. White P. ginseng is produced by air-drying the root, while red P. 
ginseng is produced by steaming the root followed by drying (Shibata et al., 1985). 
These two forms have some different compositions of the active chemical constituents. 
P. quinquefolium, also known as American ginseng, mainly grows in North America. 
Although in the same genus as P. ginseng, P. quinquefolium is considered a “yin” tonic 
rather than a “yang” tonic (Court, 2000). As such, P. quinquefolium is indicated for a 
hotter, more aggressive constitution. It contains many of the same ginsenosides as P. 
ginseng and has similar effects on the body (SFDA of China, 2005). Eleutherococcus 
senticosus Maxim (Araliaceae), also known as Siberian ginseng or Ciwujia, is often 
confused with P. ginseng. It was called as Siberian ginseng because of its similar 
adaptogenic properties as P. ginseng (SFDA of China, 2005). E. senticosus is used to 
help fatigue and stress and to improve endurance (Wong et al., 1998). However, the 
secondary compounds isolated from E. senticosus are different from those of P. ginseng 
and other adaptogens and mainly include phenylpropanoids, lignans, saponins, 
coumarins, vitamins, provitamins and eleutherosides A-M (Tang et al., 1992). Of these 
eleutherosides, the major compound eleutherosides E and B usually serve as marker 
compounds in the identification and analysis of E. senticosus.  
In addition to botanicals from Araliaceae family, Rhodiola rosea and 
Gynostemma pentaphyllum are two typical adaptogenic botanicals from other families. 
R. rosea (Hongjintian), which belongs to Crassulaceae family, has been categorized as 
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an adaptogen due to its observed ability to increase resistance to a variety of chemical, 
biological and physical stressors (Kelly, 2001). The biologically active constituents of R. 
rosea include organic acids, flavonoids, tannins and phenolic glycosides. The 
stimulating and adaptogenic properties of R. rosea are originally attributed to two 
compounds isolated from its roots, p-tyrosol and the phenolic glycoside rhodioloside 
(Linh et al., 2000). Gynostemma pentaphyllum (Thunb.) Makino (Cucurbitaceae), 
commonly known as Jiaogulan or Southern ginseng, is relatively new to the list of 
adaptogens (Hu et al., 2010). According to a study in 1995, G. pentaphyllum contains 
nearly four times as many saponins as P. ginseng does. These saponins, known as 
gypenosides, are similar to the ginsenosides and panaxosides found in P. ginseng (Liao 
et al., 1995). Specifically, gypenosides III, IV, VIII, XII and malonyl gypenosides III 
and VIII are identical to ginsenosides Rb1, Rb3, Rd, F2 and malonyl ginsenosides Rb1 
and Rd (Cui et al., 1999). Furthermore, gypenoside XVII was also isolated from P. 
quinquefolium, P. notoginseng and P. japonicas (Morita et al., 1985). Because of this 
similarity to P. ginseng, G. pentaphyllum has attracted much interest as a potential new 
botanical drug and is sometimes used as an alternative to P. ginseng. Preliminary 
pharmacological studies show that G. pentaphyllum has powerful regulatory effects, e.g. 
hepatoprotective effects (Chen MH et al., 2009; Circosta et al., 2005b; Li et al., 1993). 
In addition, G. pentaphyllum has demonstrated antibacterial and anti-inflammatory 
activity and a beneficial effect on blood pressure regulation. It also has been shown to 
bolster the immune system, improve fat metabolism, moderate cholesterol levels and 
enhance strength and physical endurance (Circosta et al., 2005a; Li et al., 1993; Lin et 
al., 1993; Razmovski-Naumovski et al., 2005; Suntararuks et al., 2008). Compared to P. 
ginseng, G. pentaphyllum is cheaper and easily available and is already widely used as a 
general tonic. The need for reliable analytical platform that can be used for the quality 
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control of commercial products derived from G. pentaphyllum, such as herbal teas and 
extracts is obvious. 
Besides these adaptogenic botanicals, Panax notoginseng (Burk.) F. H. Chen is 
also investigated in this work. It is commonly known as Tianqi or Sanqi, is mainly 
cultivated in Yunnan Province of China. Together with P. quinquefolium and P. ginseng, 
P. notoginseng is regarded as highly prized medicinal botanical (SFDA of China, 2005). 
Although P. notoginseng is not adaptogenic, it has antihypertensive, antithrombotic, 
antiatherosclerotic and neuroprotective effects, etc (Ng, 2006). The chemical 
constituents of P. notoginseng consist of various saponins, amino acid, polysaccharides 
and flavonoids (Lau et al., 2003). Like P. ginseng, P. quinquefolium and P. vietnamensis, 
the major pharmacological active constituents of P. notoginseng are saponins. To date, a 
total of 56 dammarane-type saponins have been isolated and characterized (Dan et al., 
2008). P. notoginseng is divided into two forms in commercial market: the raw and 
steamed forms. Raw P. notoginseng is traditionally used to arrest various internal or 
external hemorrhage, to eliminate blood stasis, to improve blood circulation, to disperse 
bruises and to reduce swelling and pain (Tang et al., 1992; The State Pharmacopoeia 
Commission of PR China, 2005; Zhu, 1998). Steamed P. notoginseng is claimed to be a 
tonic to nourish blood and increase production of various blood cells in anaemic 
conditions (State Administration of Traditional Chinese Medicine (PRC), 1996). In 
addition, steamed P. notoginseng was reported to have more potent in vitro and ex vivo 
antiplatelet and anticoagulant effects compared to raw P. notoginseng (Lau AJ et al., 
2009). Steaming resulted in changes in chemical compositions between raw and 
steamed P. notoginseng and hence their different pharmacological activities (Lau et al., 
2003). Metabolite fingerprints of both raw and steamed P. notoginseng revealed these 
differences (Chan et al., 2007; Lau AJ et al., 2004; Lau et al., 2003). 
  
  35
1.3.2 Sample extraction techniques 
In order to obtain an informative and consistent fingerprint, a good sample 
extracting method is needed. Thus, the selection and optimization of the extraction 
technique and operation procedure is an important task. Several conventional extraction 
methods, including maceration (soaking), Soxhlet extraction (distillation), ultra-
sonication, decoction and supercritical fluid extraction, are usually used for the 
extraction of botanicals. However, such methods can be time consuming, requiring the 
use of large amount of organic solvent and may have lower extraction efficiencies (Ong 
et al., 2006). Another extraction technique, namely pressurized liquid extraction (PLE) 
is increasingly being used. Compared with conventional extraction methods, by using 
high extraction temperature and pressure, PLE has the advantages of short extraction 
time, less solvent consumption, high extraction efficiency with good batch-to-batch 
reproducibility and automatic operating capabilities (Dabrowski et al., 2002; Wan et al., 
2006a). It has been applied for the extraction of samples from different fields, such as 
environmental samples (Garcia-Lopez et al., 2009; Martinez Vidal et al., 2009), food 
samples (Delgado-Zamarreno et al., 2009; Llorca et al., 2009; Milagros Delgado-
Zamarreno et al., 2009) and Traditional Chinese Medicines (Chen XJ et al., 2009; Qian 
et al., 2009). It has also been applied to extract P. notoginseng for its chemical 
characteristic study (Wan et al., 2005; Wan et al., 2006a; Wan et al., 2006b; Wan et al., 
2007; Wan et al., 2006c). PLE technique will be further discussed and compared with 
ultra-sonication extraction technique in Chapter 5. 
 
1.3.3 Metabolite fingerprinting 
Metabolite fingerprinting is a key step in plant metabolomics. It is well known 
that the holistic system of botanicals is featured by the integrity of the ingredients 
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contained in the botanicals and the quality of botanicals can be affected by various 
factors as introduced in Section 1.1.1. This creates a challenge in establishing quality 
control standards for raw materials and the standardization of finished botanical 
products because no single component can contribute to the total efficacy (Jiang, 2005; 
Zhao et al., 2003). Hence, it is necessary to develop a type of quality assessment system 
that adequately meets the complex characteristics of botanicals. Metabolomics, in 
which the non-targeted metabolite fingerprinting is coupled with multivariate data 
analysis, represents a rational approach for the quality assessment of botanicals and 
botanical derived products. 
Specific chromatographic patterns caused by the multiple chemical components 
in botanicals could be constructed using a variety of chromatographic techniques as 
introduced in Section 1.1.2.2. The entire pattern of each botanical sample can then be 
evaluated to determine not only the absence or presence of desired markers but also the 
complete set of raios of all detectable analytes (Liang et al., 2004). Futhermore, with 
the help of hyphenated techniques, such as GC-MS, LC-MS/MS, LC-NMR, CE-MS, 
LC-Q-TOF. combined with resolution methods recently developed in chemometrics, 
database searching and structural elucidation techniques, metabolite fingerprinting 
analysis based metabolomic investigation represents a comprehensive qualitative and 
quantitative approach for the purpose of quality evaluation of botanicals and their 
derived products (Gong et al., 2006; Liang et al., 2010). Liquid Chromatography-Linear 
Ion Trap-Orbitrap XL Fourier Transform Mass Spectrometry (LC-LTQ-Orbitrap XL FT 
MS) has very high resolution and sensitivity (Makarov, 2000). Although it is primarily 
oriented towards proteomics in the life sciences, its high mass resolution is useful for 
botanical chromatographic profiling due to the presence of several compounds with 
closely related structures and the possibility to avoid ion suppression (Metz et al., 2008). 
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1.3.4 Data pre-processing 
One of the main issues in chromatographic fingerprint based botanical 
metabolomic investigation is the small retention time shift between chromatographic 
run. Almost all chromatographic instruments exhibit small retention time shift over time. 
It could be caused by various factors, such as minor changes of stationary phase (i.e. 
temperature and pressure) and minor changes of mobile phases (i.e. ratios, pH and flow 
rate) (Gong et al., 2004). It is of great importance to correct this small retention time 
shift before conducting chromatographic data processing, e.g. similarity comparison 
and pattern recognition based on principal component analysis (PCA). Hence, peak 
alignment becomes an essential step in botanical metabolomic investigation. Previously, 
chromatographic peaks with retention times and peak areas are manually selected out 
from different chromatograms to construct a “retention time-peak area” matrice. 
However, it could be very difficult to select an optimal set integration parameters for 
chromatograms obtained from complex botanical samples. In addition, the selection and 
extraction of peaks to include in data analysis is difficult, partly subjective and a large 
amount of the data in the original chromatograms are discarded (Nielsen et al., 1998).  
In recent years, a number of softwares are developed for automatic data pre-
processing, peak alignment and identification (Lommen, 2009). MetAlignTM software 
package (http://www.metalign.nl) is chosen in the present study for peak alignment. The 
advantages of metAlignTM with regards to other peak alignment softwares lie in a 
combination of aspects, i.e. (A) compatibility with Masslynx, Xcalibur, Chemstation, 
Agilent, Bruker and ANDI/netCDF formats and output in any of these formats as well 
as excel, (B) an easy interface for filling in parameters, (C) compatible with GC-MS as 
well as LC-MS, (D) automated baseline corrections of mass traces and peak finding and 
(E) capability to compare (align) hundreds of data sets (Lommen, 2009). Baseline 
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correction, noise elimination and peak smoothing of raw total ion chromatograms (TICs) 
data are carried out before peak alignment. 
 
1.3.5 Multivariate data analysis 
Compared with univariate analysis, multivariate data analysis becomes 
increasingly used in the analysis of botanical chromatographic data matrix with the 
entire chromatographic data containing the complete qualitative and quantitative 
information being selected. PCA and PLS-DA are two widely used multivariate data 
analysis methods that analyze data based on projection methods. Projection methods 
convert the multi-dimensional data matrice to a low-dimensional model plane, usually 
consisting of two to five dimensions. Score plots and loading plots summarized from a 
huge number of chromatographic data are generated (Okada et al., 2010). Each 
chromatographic data is statistically processed and then represented as a vector on the 
score plot. This vector is regarded as the reduced form of the chromatographic data. In 
addition, the loading plot shows the contribution of each signal (variable) contained in 
chromatographic data. 
PCA is an unsupervised analysis and is guided by the variance and covariance 
(correlation) in the data sets. It assumes no prior knowledge of class structure and 
transforms the variables in a data set into a smaller number of latent variables (t1, t2, etc.) 
called principal components (PCs). The PCs are computed as linear combinations of a 
set of manifest input variables and reflect the largest eigenvalues of the covariances in 
the data. Thereby, the first few PCs usually give an adequate description of the whole 
data table. All redundancy (repeated information in the variables and the samples) is 
thereby summarized. Hence, it simplifies the graphical interpretion of the data as well 
as their quantitative use. The resulting PC model is more compact and statistically 
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stable than the individual input data. Therefore, PCA can be used for sample similarity 
comparison and pattern recognition. The similarity of individual observations 
(individual botanical samples) is visualized by the score plot (Martens et al., 2001). 
Furthermore, PLS-DA is a typical kind of supervised analysis which needs pre-
existing knowledge provided by the researcher. It relates to a data matrix containing 
independent variable X to a matrice containing dependent variable Y. PLS-DA is used 
to maximize the correlation between the independent variable X to the dependent 
variable Y so that the dependent variable Y can be predicted from X. Hence, PLS-DA 
represents the regression analogy of PCA working with two matrices, X and Y (Okada 
et al., 2010). 
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Chapter 2 Hypotheses and objectives 
 
2.1 Hypotheses 
Botanicals and botanical health products are becoming increasingly popular and 
easily available from pharmacies, health shops and supermarkets etc. With the 
advancement in technology, purchase of commonly used botanical health products can 
also be easily done through the internet. Many of these products are offered on-line 
without providing sufficient information and advice for consumers on their safety and 
direction for appropriate use. Hence, it is hypothesized that botanical health products 
available from the internet are of poor quality and are adulterated with undeclared 
components, such as PDE-5 inhibitors and their analogues. At the same time, it is 
hypothesized that a HPLC-DAD method could be developed and used as a suitable tool 
for the preliminary screening for PDE-5 inhibitors and their analogues.. 
In addition, adaptogenic botanicals and P. notoginseng (both raw and steamed 
forms) are widely used and sold in Singapore and China. The sources, cultivation, 
processing techniques and storage are important factors and not regulated. The 
differences in these factors can result in botanical materials with different quality. 
Hence, with these concerns, we hypothesize that the quality of some commonly used 
adaptogenic botanicals and P. notoginseng can be studied using non-targeted metabolite 
profiling, and such metabolomic multivariate data analysis will be useful tools to 
explore the quality of commercial botanical products. 
 
2.2 Objectives 
The overall objective of this study is to develop analytical methods/platform to 
investigate the quality of botanicals and botanical health products. The specific 
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objectives of this research were: 
1. to develop a simple HPLC-DAD method for the simultaneous detection and 
determination of 19 PDE-5 inhibitors and their analogues 
2. to screen for adulterants/synthetic components in botanical health products sold 
on-line using HPLC-DAD, LC-MS and GC-MS 
3. to develop and optimize a PLE method for the extraction of adaptogenic 
botanicals as well as raw and steamed P. notoginseng 
4. to develop, optimize and validate a LC-LTQ-Orbitrap XL FT MS method for the 
non-targeted metabolite profiling of adaptogenic botanicals as well as raw and 
steamed P. notoginseng 
5. to investigate the quality of five commonly used adaptogenic botanicals and P. 
notoginseng in Singapore and China using the developed LC-LTQ-Orbitrap XL 
FT MS method coupled with multivariate data analysis 
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Chapter 3 Targeted adulterant screening in botanical health 
products used for sexual performance enhancement and 
slimming 
 
In Section 3.1, a simple HPLC-DAD method was developed, optimized and 
validated for the simultaneous detection and determination of 19 PDE-5 inhibitors and 
their analogues adulterated in botanical health products. An in-house UV spectra library 
containing information of retention times and UV profiles of these compounds was 
created by analyzing the standards. In Section 3.2, targeted adulterant screening was 
applied to botanical health products bought on-line to investigate the prevalence of 
adulteration. The extracts of botanical products were screened using the method 
developed. The retention time and UV spectrum of the suspected compound were 
compared with the in-house library. 
 
3.1 HPLC-DAD method development 
3.1.1 Introduction 
As introduced in Section 1.2, PDE-5 inhibitors, namely sildenafil citrate, 
vardenafil hydrochloride, tadalafil and udenafil are licensed prescription drugs used for 
the treatment of erectile dysfunction. Sildenafil, vardenafil and tadalafil are approved 
by US FDA while udenafil is approved by the Korea Food and Drug Administration 
(KFDA). Adverse effects of these drugs include headache, facial flushing, rhinitis and 
dyspepsia. Other reported adverse effects are visual disturbances, myalgia, nausea, 
diarrhea, vomiting, dizziness and chest pain (Tsertsvadze et al., 2009). These four 
prescription drugs must be used under medical supervision. 
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Structural modifications of these PDE-5 inhibitors result in a series of PDE-5 
inhibitor analogues and are reviewed in Chapter 1 (Fig. 1.1). Based on their structural 
similarity with these PDE-5 inhibitors (mainly sildenafil), it is reasonable to suspect 
that these analogues may have similar activity as the approved PDE-5 inhibitors. On the 
other hand, none of these analogues has been approved by any regulatory authority 
worldwide. Hence, it is illegal for these analogues to be sold in the market as drugs for 
sexual performance enhancement. However, some botanical health products used for 
sexual performance enhancement were found to be adulterated with these analogues 
(Blok-Tip et al., 2004; Hou et al., 2006; Li et al., 2009a; Park et al., 2007; Reepmeyer 
et al., 2006; Shin et al., 2003; Shin et al., 2004; Zou et al., 2006a; Zou et al., 2008a). 
The adulteration of these products is extremely dangerous for consumers who 
unknowingly consume these products. Therefore, it is necessary to develop analytical 
methods to detect these PDE-5 inhibitors as well as their analogues. 
Different analytical methods, namely HPLC-DAD and LC-MS, have been 
developed to determine the presence of PDE-5 inhibitors and their analogues in 
commercial botanical health products (Gratz et al., 2006; Zhu et al., 2005; Zou et al., 
2006b). One HPLC-DAD and LC-MS method was developed for the simultaneous 
detection and quantification of 5 PDE-5 inhibitors and related analogues by our group 
previously (Zou et al., 2006b). However, as the number of new PDE-5 inhibitor 
analogues keep increasing, an improved method is needed for the simultaneous 
determination of more PDE-5 inhibitor and their analogues. As the most commonly 
used and easily available analytical instrument, HPLC-DAD system serves as a suitable 
tool for preliminary targeted adulterant screening. In this section, a HPLC-DAD 
screening method is developed, optimized and validated for the simultaneous 
determination of 19 PDE-5 inhibitors and their analogues. 
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3.1.2 Objective 
The objective of the study presented in this section is to develop, optimize and 
validate a HPLC-DAD screening method for the simultaneous determination of 19 




Sildenafil citrate was supplied by Pfizer (New York, NY, USA). Vardenafil 
hydrochloride was supplied by Bayer (West Haven, CT, USA). Commercial standards 
of homosildenafil, hydroxyhomosildenafil, dimethylsildenafil, norneosildenafil, 
thiosildenafil, thiohomosildenafil, hydroxythiohomosildenafil, acetildenafil, hydroxyl-
acetildenafil, piperiacetildenafil, desethylvardenafil, pseudovardenafil, carbodenafil, 
acetil-acid, imidazosagatriazinone, chloropretadalafil and aminotadalafil were 
purchased from TLC PharmaChem (Concord Ontario, Canada). The chemical structures 
of these 19 analytes are shown in Fig. 3.1. 
Methanol (HPLC grade) was supplied by J. T. Baker (Phillipsburg, NJ, USA). 
Acetonitrile (HPLC grade) was supplied by Tedia (Fairfield, OH, USA). Ammonium 
formate (97%) was purchased from Sigma-Aldrich (Steinheim, Germany). Formic acid 
(98%) was purchased from Fluka analytical (Steinheim, Germany). 0.45 µm nylon 
membrane filters were purchased from Whatman International Ltd. (Maidstone, UK). 





A                                                 B 
 
Structure No. Analyte X1 X2 R1 R2 
1 Sildenafil O N CH3 H 
2 Homosildenafil O N CH2CH3 H 
3 Hydroxyhomosildenafil O N CH2CH2OH H 
4 Thiosildenafil S N CH3 H 
5 Thiohomosildenafil S N CH2CH3 H 
6 Hydroxythiohomosildenafil S N CH2CH2OH H 
7 Dimethylsildenafil O N CH3 CH3
A 
8 Norneosildenafil O CH H H 
   X R 
9 Acetildenafil N CH2CH3 
10 Hydroxyacetildenafil N CH2CH2OH B 
11 Piperiacetildenafil CH H 
 
  





Figure 3.1 Chemical structures of 19 analytes investigated in this study. 
R = H           Imidazosagatriazinone (12) 
R = COOH  Acetil-acid (13) 
X = N R = CH2CH3 Vardenafil (17) 
X = N R = H Desethylvardenafil (18)
X = CH R = H Pseudovardenafil (19) Carbodenafil (16) 
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3.1.3.2 Samples 
Samples of commercial botanical health products 1 to 4 were purchased on-line. 
The detailed information of these 4 samples was shown in Table 3.1. 
 
Table 3.1 Detailed information of 4 commercial botanical health products used in this 
section. 
 




Package Website of purchase 
1 LFW Capsule 20 https://www.biogulfstore.com/orders/Affiliate/products.php 
2 Maxidus Capsule 20 https://www.biogulfstore.com/orders/Affiliate/products.php 
3 Cockstar Capsule 14 http://www.vitadigest.com/cockstar.html 




3.1.3.3 Standard preparation 
Stock solutions of sildenafil, homosildenafil, hydroxyhomosildenafil, 
dimethylsildenafil, norneosildenafil, thiosildenafil, thiohomosildenafil, hydroxythio-
homosildenafil, acetildenafil, hydroxyacetildenafil, piperiacetildenafil, vardenafil, 
desethylvardenafil, pseudovardenafil, carbodenafil, imidazosagatriazinone, acetil-acid, 
chloropretadalafil and aminotadalafil were prepared at concentrations between 1.1 and 
1.6 mg/ml in methanol (HPLC grade), respectively. 80 µl of acetil-acid, carbodenafil, 
sildenafil, homosildenafil, dimethylsildenafil, hydroxyacetildenafil, desethylvardenafil, 
pseudovardenafil, aminotadalafil and chloropretadalafil stock solutions, 120 µl of 
vardenafil, thiosildenafil, thiohomosildenafil, hydroxythiohomosildenafil, 
piperiacetildenafil and norneosildenafil stock solutions, 160 µl of acetildenafil, 
imidazosagatriazinone and hydroxyhomosildenafil stock solutions were mixed together 
to yield a standard solution mixture. It was further diluted 2, 4, 8, 20 and 40 times with 
methanol (HPLC grade) to yield a series of working solutions for the calibration curves. 
Stock solutions and the mixed standard solution were stored at 4 oC until ready for use. 
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The mixed standard solution was prepared weekly. Working solutions were prepared 
daily from the mixed standard solution and filtered through a 0.45 µl nylon membrane 
filter prior to injection into the HPLC system. 
 
3.1.3.4 Sample preparation 
The capsule contents were emptied and mixed. Approximately 0.5 g of sample 
powder was ultrasonically extracted with 10 ml methanol (HPLC grade) for 30 min. 
The extract was filtered through a 0.45 µm nylon membrane filter and diluted for 
analysis. 
 
3.1.3.5 HPLC-DAD analysis 
An Agilent 1100 series HPLC chromatograph with diode array detector (Palo 
Alto, CA, USA) was used for the qualitative and quantitative analyses. System control, 
data acquisition and process were performed using HP ChemStation software (Palo Alto, 
CA, USA). An Agilent ZORBAX Eclipse Plus C18 column (250 mm × 4.6 mm i.d., 5 
µm) was used. The mobile phases were (A) 0.01 M ammonium formate aqueous 
solution (pH 3.3) and (B) acetonitrile (HPLC grade). The pH of mobile phase (A) was 
adjusted using formic acid. The gradient elution profile was as follows: 0–22 minutes, 
(B) rose from 10% to 30% (v/v); 22–40 minutes, (B) rose from 30% to 60% (v/v); 40–
45 minutes, (B) rose from 60% to 90% (v/v); 45–50 minutes, (B) decreased from 90% 
to 10% (v/v). The flow rate of mobile phases was 1 ml/min. The injection volume was 
10 µL. The UV detection wavelength was set at 225, 254 and 280 nm and absorption 
spectra from 200 to 400 nm were recorded on-line during the chromatographic run. The 
compounds were identified by comparing their retention times and UV spectra with an 
in-house library containing those profiles of standards. 
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3.1.3.6 In-house library of PDE-5 inhibitors and their analogues 
Reference standard solutions of the 19 analytes investigated in this study were 
prepared by diluting the stock solutions of each compound five times. The reference 
standard solutions were then filtered and injected into the HPLC system. The retention 
times and UV spectra of the standards were obtained and compiled into an in-house UV 
library. 
 
3.1.3.7 Method validation 
Working solutions as prepared in Section 3.1.3.3 were analyzed in triplicate. The 
calibration curves were constructed by plotting the peak areas of the analytes against 
the corresponding concentrations. Peak areas were integrated using HP ChemStation 
software (Palo Alto, CA, USA). The limits of detection (LOD) and quantitation (LOQ) 
for each analyte were determined as the analyte signal having a peak area equal to three 
times (S/N = 3) and ten times (S/N = 10) of that of noise, respectively. The intra- and 
inter-day variations were determined by analyzing known concentrations of the 19 
analytes in 5 replicates during a single day and by duplicating the experiments on 3 
successive days. Four commercial health products (Table 3.1) were known to be 
adulterated sildenafil, hydroxyhomosildenafil, hydroxythiohomosildenafil and 
aminotadalafil and were selected to calculate the recoveries of these compounds. The 
recoveries were determined by adding known concentrations of standards into the four 
samples respectively. The spiked samples were then extracted as described in Section 
3.1.3.4. The unspiked samples were concurrently prepared and analyzed. 
 
3.1.4 Results and discussion 
3.1.4.1 Optimization of chromatographic conditions 
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Various compositions of the mobile phase were attempted to optimize the 
chromatographic separation. At first, Milli-Q water was used without adding any 
modifiers, the analytes could not be well separated and the peak shapes were broad. 
Different modifiers were then added and compared for aqueous solution. Acidified 
aqueous solution was reported to improve the peak resolution of PDE-5 inhibitors and 
their analogues (Zou et al., 2006b). 0.01%, 0.05% and 0.1% (v/v) formic acid aqueous 
solutions were investigated in this study. However, no significant difference of the peak 
resolution was found by using these three different concentrations of formic acid. The 
problem encountered using formic acid as the modifier was that sildenafil and 
homosildenafil co-eluted under current chromatographic conditions. Ammonium 
formate at the concentration of 0.01 M was then tried. However, the analytes cannot be 
separated with heavy peak tailing because of the relatively high pH value of ammonium 
formate aqueous solution. This was solved by acidifying the ammonium formate 
aqueous solution using formic acid. The desired separation and acceptable tailing factor 
were achieved finally using the acidified ammonium formate aqueous solution. 
Therefore, 0.01 M acidified ammonium formate aqueous solution and acetonitrile were 
selected as the mobile phases. 
In addition, a gradient elution profile of the mobile phases was developed and 
optimized. Good chromatographic separation of the 19 analytes was achieved and the 
chromatogram of the 19 mixed standards is shown in Fig. 3.2. In the first 22 minutes of 
the chromatographic run, the mobile phase (B) was increased from 10% to 30%. This 
was useful for the chromatographic separation although no analyte eluted out during 
this period. Any shortening of this time range would result in the co-elution of 
acetildenafil and desethylvardenafil peaks with retention times of 25.1 and 25.6 minutes 
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respectively. The identities of the two small peaks, one next to peak 15 and the other 




Figure 3.2 Typical HPLC-DAD chromatogram of the standards of 19 PDE-5 inhibitors 
and their analogues (UV detection wavelength 254 nm): (1) sildenafil, (2) 
homosildenafil, (3) hydroxyhomosildenafil, (4) thiosildenafil, (5) 
thiohomosildenafil, (6) hydroxythiohomosildenafil, (7) dimethylsildenafil, 
(8) norneosildenafil, (9) acetildenafil, (10) hydroxyacetildenafil, (11) 
piperiacetildenafil, (12) imidazosagatriaz, (13) acetil-acid, (14) 
aminotadalafil, (15) chloropretadalafil, (16) carbodenafil, (17) vardenafil, 
(18) desethylvardenafil, (19) pseudovardenafil. 
 
3.1.4.2 In-house library of PDE-5 inhibitors and their analogues 
An in-house UV spectra library of 19 PDE-5 inhibitors and their analogues is 
created. Fig. 3.3 shows the UV profiles of these 19 analytes. The UV spectra of acetil- 
acid, carbodenafil and imidazosagatriazinone are significantly different from both each 
other and from the other 16 analytes [Fig. 3.3 (A)]. Therefore, these three analytes can 
be identified using UV spectra. However, as shown in Fig. 3.3 (B-F), the UV spectra of 
the other 16 analytes can be divided into five groups (each figure is one group) with 






Figure 3.3 Overlaid UV spectra of standards of the 19 selected analytes: (A) acetil-acid, 
carbodenafil and imidazosagatriazinone; (B) dimethlysildenafil, 
norneosildenafil, hydroxyhomosildenafil, homosildenafil and sildenafil; (C) 
thiosildenafil, thiohomosildenafil and hydroxythiohomosildenafil; (D) 
vardenafil, desethylvardenafil and pseudovardenafil; (E) acetildenafil, 




The differentiation of the analytes in each group can be achieved by comparing 
the retention times of the analytes. Hence, from Fig. 3.2, it is clear that the developed 
HPLC-DAD method can be used for the simultaneous determination of the 19 analytes. 
 
3.1.4.3 Method validation 
The linear regression data of 19 analytes were shown in Table 3.2. All the 
analytes show good linearity (R2 > 0.998) in a relatively wide concentration range. The 
LOD and LOQ of sildenafil, homosildenafil, hydroxyhomosildenafil, acetildenafil and 
vardenafil are higher than previously reported results (Zou et al., 2006b). It was 
probably caused by the different aqueous buffer. These relatively higher LOD and LOQ 
are still acceptable because the contaminants of PDE-5 inhibitors and their analogues 
found to be present in health products are usually large in an apparent attempt to 
generate pharmacological activity. 
The intra- and inter-day variations are evaluated by analyzing the mixed 
standard solution of the 19 analytes. The R.S.D. values of the peak areas of the 19 
analytes are all less than 4.1% indicating good precision of the developed method. The 
four products were chosen based on the type of adulterants present. The average 
percentage recoveries of sildenafil, hydroxyhomosildenafil, hydroxythiohomosildenafil 
and aminotadalafil are in the range of 96.8 – 104.3% as shown in Table 3.3. The high 
recoveries of the tested analytes proved that the developed HPLC-DAD method is 
robust. This method is the first elaborated and validated method that enables the 
simultaneous determination of 19 PDE-5 inhibitors and their analogues without using 
the MS detector. It can be used for the preliminary detection and determination of 




Table 3.2 Retention time, linear regression data and precision of 19 PDE-5 inhibitors and their analogues. 









(µg/ml) Intra-day Inter-day 
1 Sildenafil 28.3 y = 16.48x + 0.559 0.9991 0.7 – 58.8 0.25 0.66 0.50 2.91 
2 Homosildenafil 28.9 y = 15.55x – 1.029 0.9989 0.8 – 60.8 0.27 0.71 0.78 2.55 
3 Hydroxyhomosildenafil 27.9 y = 11.56x + 3.954 0.9990 0.9 – 86.4 0.29 0.84 0.86 2.38 
4 Thiosildenafil 36.2 y = 10.06x + 6.020 0.9988 1.1 – 64.8 0.42 1.05 0.87 3.21 
5 Thiohomosildenafil 37.0 y = 13.34x + 6.893 0.9991 0.9 – 67.8 0.36 0.84 0.57 2.87 
6 Hydroxythiohomosildenafil 35.5 y = 13.78x + 2.113 0.9984 0.9 – 72.6 0.33 0.81 0.79 3.11 
7 Dimethylsildenafil 29.5 y = 14.81x + 1.716 0.9991 0.8 – 63.6 0.26 0.71 0.61 4.07 
8 Norneosildenafil 46.2 y = 14.42x + 9.782 0.9987 0.6 – 69.0 0.14 0.57 0.65 3.83 
9 Acetildenafil 25.1 y = 15.50x – 2.621 0.9989 0.9 – 84.8 0.43 0.87 1.16 2.45 
10 Hydroxyacetildenafil 23.6 y = 9.00x + 0.709 0.9991 1.3 – 59.6 0.56 1.29 0.73 2.94 
11 Piperiacetildenafil 27.0 y = 15.78x – 0.061 0.9988 0.8 – 75.6 0.30 0.73 0.75 2.91 
12 Imidazosagatriazinone 45.1 y = 10.56x + 6.672 0.9989 1.0 – 86.4 0.32 0.94 0.76 3.57 
13 Acetil-acid 33.9 y = 26.54x + 1.738 0.9990 0.4 – 60.8 0.14 0.39 0.58 2.79 
14 Aminotadalafil 31.7 y = 8.88x + 2.585 0.9991 1.1 – 62.0 0.33 1.08 0.49 2.20 
15 Chloropretadalafil 43.9 y = 9.39x + 14.100 0.9993 0.6 – 58.8 0.42 0.60 0.93 1.89 
16 Carbodenafil 22.5 y = 17.99x – 2.432 0.9992 0.7– 61.6 0.31 0.69 0.63 2.71 
17 Vardenafil 26.4 y = 17.86x + 1.323 0.9995 0.7 – 62.4 0.30 0.67 0.62 3.65 
18 Desethylvardenafil 25.6 y = 25.05x – 0.879 0.9992 0.5 – 59.2 0.20 0.48 0.64 2.20 
19 Pseudovardenafil 42.3 y = 26.45x + 3.971 0.9993 0.4 – 56.4 0.15 0.39 0.80 2.34 
 
a) y = peak area; x = concentration of respective analyte (µg/ml) 
b) R.S.D. (%) = (S.D./mean) × 100 
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Table 3.3 Repeatabilities and recoveries of sildenafil, hydroxyhomosildenafil, 
hydroxythiohomosildenafil and aminotadalafil in 4 commercial products 
(n = 3). 
 





(mean ± S.D., %) 
1 LFW Hydroxyhomosildenafil 2.53 99.5 ± 4.4 
2 Maxidus Hydroxythiohomosildenafil 10.21 104.3 ± 2.0 
3 Cockstar Aminotadalafil 3.30 97.2 ± 3.9 
4 Mojo sensation Sildenafil 4.13 96.8 ± 2.1 
 
a) Recovery (%) = 100 × (amount found – original amount)/amount spiked 
 
3.1.5 Conclusion 
A HPLC-DAD method was successfully developed and used for the 
simultaneous determination of 19 PDE-5 inhibitor and their analogues in this study. 
This method had been validated for linearity, sensitivity, precision and accuracy. This 
method can be applied to screen the adulteration of PDE-5 inhibitors and/or their 
analogues by comparing UV spectra and retention times. 
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3.2 Targeted adulterant screening in botanical health products used for 
sexual performance enhancement and slimming bought on-line 
 
3.2.1 Introduction 
There has been increasing use of botanical health products worldwide in view of 
the public’s growing interest in complementary and alternative medicines. With the 
advancement in technology, purchase of these supplements can be easily done through 
the internet. However, many of these products are offered on-line without sufficient 
relevant information and advice for consumers to make informed decisions about their 
safe and appropriate use. In view of cases of adulteration of botanical health products, 
this study aims to assess the prevalence of adulteration and safety of botanical health 
products available on-line. In this study, total of two hundred and seventy-one 
commercial botanical health products were purchased on-line and screened for 
adulteration with undeclared drugs and unapproved analogues of these drugs. 
 
3.2.2 Objectives 
The objectives of this study are to screen for synthetic adulterant in commercial 
botanical health products used for sexual performance enhancement and slimming 
purchased on-line and to evaluate the prevalence of adulteration and safety of on-line 




Methanol (HPLC grade) was supplied by J. T. Baker (Phillipsburg, NJ, USA). 
Acetonitrile (HPLC grade) was supplied by Tedia (Fairfield, OH, USA). 0.45 µm nylon 
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membrane filters were purchased from Whatman International Ltd. (Maidstone, UK). 
Milli-Q water was obtained using a Synergy purification system (Molsheim, France). 
Sodium dihydrogenphosphate-2-hydrate (NaH2PO4·2H2O) was supplied by Merck 
(Darmstadt, Germany). 
 
3.2.3.2 Botanical health product samples 
The sourcing of products was carried out using the search engine Google and 
keywords such as sexual enhancement, men's health, men's vitality, slimming, weight 
loss, herbal supplement, dietary supplement, botanical supplement, health products and 
combinations of the words. The range of products was also acquired from on-line shops 
and on-line whole salers. Inclusion and exclusion criteria for the selection of botanical 
health products used for sexual performance enhancement and slimming are shown in 
Table 3.4 and Table 3.5, respectively. 
On-line purchases were carried out. Two hundred and seventy-one botanical 
health products were purchased on-line and screened for adulteration with undeclared 
drugs and unapproved analogues of these drugs. Of these two hundred and seventy-one 
products, one hundred and ninety-eight samples were sexual performance enhancement 
products and seventy-three samples were slimming products. For each botanical health 
product, information for sample documentation was collated from the product insert, 
packaging as well as product on-line website. Details such as indications, ingredients 
and their quantity, dosage, dosage forms, appearance and weight of each dosage form 
unit, manufacturer, batch/lot number, manufacture and expiry dates were noted. The 
dosage forms and purchasing websites of these two hundred and seventy-one products 




Table 3.4 Inclusion and exclusion criteria for the procurement of botanical health 




1. Available from Internet 
2. Oral dosage form or topical dosage form (such as cream) 
3. Contain at least one natural product of botanical or animal origin 
4. Claims (any of the following): 
 
For male: 
1) cure/for erectile dysfunction 
2) sex booster 
3) sexual enhancement 
4) sexual stimulant 
5) increase the size (length or width) of penis 
6) increase the number of ejaculatory contractions 
7) increase ejaculate production 
8) improve sexual performance 
9) create firmer, fuller-feeling erections 
10) aphrodisiac 
11) increase libido 
 
For female: 
1) increase female sexual desire levels 
2) increase libido 
3) sex booster 
4) sexual enhancement 
5) sexual stimulant 
6) improve sexual performance 
 
Optional (one or more of the following items): 
1) no side effects reported 
2) completely safe 
3) 100% all natural 
4) no interaction with other drugs 
5) effects lasting up to days after single administration 
 
Exclusion Criteria 
1. Does not satisfy the inclusion criteria 




Table 3.5 Inclusion and exclusion criteria for the procurement of botanical health 




1. Available from Internet 
2. Oral dosage form or topical dosage form 
3. Contain at least one natural product of botanical or animal origin 
4. Claims (any of the following): 
1) Contain ingredients which make people feel full more quickly/eat less 
2) Decreases food cravings 
3) Suppresses the appetite 
4) Loss of fat tissue within days 
5) Reduce absorption of sugar/fat 
6) Quick and great amount of weight loss 
7) Prevent the abnormal accumulation of fat in the liver 
 
Optional (one or more of the following items): 
1) No side effects 
2) Completely safe 
3) Clinically proven to work 
4) Secret formula 
5) Stimulant free 
6) 100% all natural 
7) No interaction with other drugs 
Exclusion Criteria 
1. Does not satisfy the inclusion criteria 
2. Product is not shipped to Singapore 
 
3.2.3.3 Sample preparation 
Samples analyzed were presented in capsules, soft-gel capsules, tablets and 
powders.  Three to five units of the dosage forms were taken randomly. For capsules, 
contents were emptied and mixed thoroughly. For soft-gel capsules, contents were 
squeezed out and mixed thoroughly. Tablets were pounded using mortar and pestle and 
mixed thoroughly. 10 ml of methanol was added to 1 g of finely ground and 
homogenously-mixed samples. These mixtures were then ultra-sonicated for 30 minutes. 
The supernatant liquid was filtered by 0.45 µm nylon membrane filter and transferred 
into 2-ml vials for instrumental analysis. Dilution was done as appropriate. 
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3.2.3.4 HPLC preliminary screening tests and quantitative analyses 
An Agilent 1100 series HPLC chromatograph with diode-array detector (Palo 
Alto, CA, USA) was used for preliminary screening analyses and quantitative analyses. 
System control, data acquisition, processing and auto-library search were performed 
using HP ChemStation software (Palo Alto, CA, USA). An Agilent ZORBAX Eclipse 
Plus C18 column (250 mm × 4.6 mm i.d., 5 µm) was used. The method developed in 
Section 3.1 was applied. 
Preliminary compound identification in the samples was carried out by library 
search using an in-house library. The in-house library (coded as “PHARM”), which was 
jointly built by Pharmaceutical Division, Health Sciences Authority (HSA) of 
Singapore and NUS, was compiled by running the standards of 547 common synthetic 
compounds or drugs with the same chromatographic conditions (Liu et al., 2001). The 
compounds in commercial botanical health product samples were identified by 
matching their retention times and UV spectra against those in the library. Library 
matches of UV spectra were automatically calculated for each peak and a score of 1000 
represents a perfect match. 
 
3.2.3.5 GC-MS confirmatory tests 
Agilent 5973 and Agilent 5975 GC-MSD (Palo Alto, CA, USA) systems were 
used for the analysis. The samples were analyzed using a HP5 MS capillary column (30 
m × 250 µm i.d., 0.25 µm 5 % phenyl – 95% methyl siloxane) with helium as the 
carrier gas at 1 ml/min. An injection volume of 1 µl was used in the splitless mode. 
Data acquisition was controlled by MS ChemStation software. The initial oven 
temperature was set at 80 °C. It was then increased to 300 °C at 15 °C/min. The final 
temperature of 300 °C was held for 10 min. The injector and detector temperature were 
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set at 250 °C (splitless) and 280 °C respectively. The total running time was 32 min. 
The Wiley7 (John Wiley & Sons Pte Ltd., United States) and Nist05 (National Institute 
of Standards and Technology, United States) standard chemical MS libraries, the in-
house “PharmL” standard drug library of HSA and spectra of reference standards were 
used in the identification of compounds. 
 
3.2.3.6 LC-MS confirmatory tests 
A Shimadzu LC-DAD-MS 2010A (Shimadzu Corporation, Kyoto, Japan) 
system was used. Data acquisition and processing were performed using LC-MS 
Solution software. Thermo Bio Basic 18 column (150 mm × 2.1 mm i.d., particle size: 5 
µm) was used for chromatographic separation. An ESI interface with positive and 
negative mode was employed. The mobile phases were (A) 0.1 % formic acid in water 
and (B) 0.1 % formic acid in acetonitrile. Step gradient was from 20 % to 100 % of (B) 
over 15 min, then immediately to 20 % of (B) and maintained for another 10 min. Total 
chromatography duration was 35 min. Injection volume was 5 µL. The MS spectrum 
and molecular weight, as well as UV profiles of the samples were matched with the 
standards. 
 
3.2.4 Results and discussion 
A total of two hundred and seventy-one botanical health products (Appendix 1 
and 2) were purchased on-line, of which one hundred and ninety-eight were claimed to 
be used for sexual performance enhancement and seventy-three were claimed to be used 
for weight loss. One hundred and thirty out of these two hundred and seventy-one 




3.2.4.1 Sexual performance enhancement products 
Out of the one hundred and ninety-eight sexual performance enhancement 
products, one hundred and four (52.5%) were found to be adulterated. The adulterants 
detected in sexual performance enhancement botanical health products are yohimbine, 
PDE-5 inhibitors, PDE-5 inhibitor analogues and other compounds. The number of 
times such components were detected in the one hundred and ninety-eight sexual 
performance enhancement products is summarized in Fig. 3.4. 
 
Figure 3.4 The number of times whereby PDE-5 inhibitors, PDE-5 inhibitor analogues, 
yohimbine and other synthetic compounds in 198 sexual performance 
enhancement botanical health products were detected. 
 
In the one hundred and four adulterated products, twenty-one products (10.6%) 
were found to be adulterated with at least one of the PDE-5 inhibitors or their analogues. 
In these twenty-one products, eight products were adulterated with one or more of the 4 
approved PDE-5 inhibitors (Table 3.6). With sildenafil being the most common 
adulterant, it was detected in seven products, while vardenafil was detected in one 
product.  
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Table 3.6 List of sexual performance enhancement botanical health products and 
compounds detected. 
 
No. Product Name Compounds detected 
1 72 Hours The Ultimate Male Enhancement Formula caffeine, hydroxythiohomosildenafil 
2 8 Hour Sex caffeine, yohimbine 
3 AlcoholX caffeine 
4 Arginmax for Women nicotinamide 
5 AriZe hydroxyhomosildenafil, thiosildenafil, methoxsalen, caffeine, usnic acid 
6 Aziffa sildenafil, thiohomosildenafil 
7 Bali Mojo hydroxythiohomosildenafil 
8 Ball Refill nicotinic acid 
9 Better Man (Light brown) caffeine, methoxalen 
10 Blue Up caffeine 
11 BlueRise yohimbine 
12 Climaxol Female Sexuality Enhancement caffeine 
13 Cobra caffeine, yohimbine 
14 Cockstar aminotadalafil 
15 Cravex caffeine, theobromine 
16 Depth Charge caffeine, hydroxythiohomosildenafil 
17 Desire phentolamine, mesylate 
18 Ejaculoid Semen Volumizer yohimbine 
19 Elexia Plus yohimbine 
20 E-Long-Ate yohimbine 
21 Enhance-9 nicotinamide 
22 Erotica Plus yohimbine 
23 Erox caffeine, yohimbine, propylparaben 
24 Expand capsules yohimbine, nicotinic acid 
25 Extenze yohimbine 
26 ExtenZe New & Improved dehydroepiandrosterone, yohimbine, pregnenolone 
27 Extenzol yohimbine 
28 FertilAid caffeine 
29 Herbal V yohimbine 
30 Herbal virility caffeine, nicotinamide 
31 Herbal Vivid Male Enhancement yohimbine, caffeine, nicotinic acid 
32 H-Force benzoic acid 
33 Horny Goat Weed Tea caffeine 
34 Hot Rod hydoxyhomosildenafil, hydroxythiohomosildenafil 
35 Ikawe caffeine 
36 In Control caffeine 
37 JO System Penis Enlargement yohimbine, caffeine, nicotinic acid 
38 Julian's Rock Hard Cream methylparaben 
39 King Cobra nicotinic acid, safrole 
40 Lean Tabs caffeine 
41 LFW hydroxythiohomosildenafil, hydroxyhomosildenafil
42 Libido & Drive yohimbine 
43 Libidus acetildenafil, acetil-acid 
44 Lyse XL benzoic Acid, methylparaben, propylparaben 
45 Manhood Max yohimbine 
46 Man's Favorite prasterone, dehydroepiandrosterone 
47 Max International Testosterone Herbal nicotinamide, caffeine 
48 Max Stamina yohimbine 
49 Max Vitality Rx caffeine, yohimbine 
  
  63
50 Maxidus hydroxythiohomosildenafil, hydroxyhomosildenafil
51 MOJO Sensation sildenafil 
52 Mr Energy caffeine, yohimbine 
53 NSI Male Enhancement yohimbine 
54 Orexis yohimbine 
55 Oyama-Rectic methylparaben, butylparaben, caffeine 
56 Performax Ultra All Natual Male Performance Enhancer nicotinamide 
57 Pleasure Pills yohimbine, caffeine 
58 Pro Plus Pills caffeine 
59 Provestra nicotinamide, caffeine, triacetin, theobromine 
60 Provestra X caffeine, nicotinamide 
61 Provigrax nicotinamide 
62 Reveal caffeine, nicotinamide, theobromine 
63 Rigid for Men caffeine, acetil-acid, hydroxyhomosildenafil 
64 Rize-2 thiohomosildenafil 
65 Rx Erect yohimbine 
66 SAS LABS - Sexual Health Package yohimbine 
67 Semenax phenolphthalein 
68 Sex Cycle yohimbine 
69 Sex Pill caffeine, theobromine 
70 Sexy Lady sildenafil 
71 Sida Cordifoloia caffeine 
72 Sizepro Ultra nicotinamide 
73 Slevotra vardenafil, piperidenafil 
74 Source Naturals, Tongkat Ali caffeine 
75 Spermamax Male Virility theobromine, caffeine 
76 StamaLong sildenafil 
77 Stamazide nicotinic acid 
78 Stamina-Rx For Men caffeine, methoxalen, yohimbine, triacetin 
79 Stamitrol nicotinic acid, caffeine, yohimbine 
80 Stimuloid yohimbine, nicotinic acid, caffeine 
81 Stinger Rx caffeine 
82 Super Citrimax nicotinamide 
83 Sustanol nicotinamide 
84 SutraMax theobromine, caffeine 
85 Tigra Men caffeine, nicotinamide 
86 Vaxitrol yohimbine 
87 Vialafil yohimbine 
88 Vicerex sildenafil, thiosildenafil 
89 Vigor-Ex caffeine, yohimbine 
90 Vigralis sildenafil 
91 Viraloid caffeine, yohimbine 
92 Virilar caffeine 
93 Virile 1 prasterone 
94 Virility Pills nicotinamide 
95 Viverex for Men caffeine, yohimbine 
96 Vivid Virility nicotinic acid, caffeine, yohimbine 
97 Volume Pills prasterone, dehydroepiandrosterone 
98 Women RA sildenafil 
99 Xiadafil hydroxyhomosildenafil 
100 Yang Pro caffeine 
101 YERBA - DIET benzoic acid, caffeine 
102 Zencore aminotadalafil 
103 Zencore Plus methoxsalen, yohimbine 
104 Zenerx caffeine, nicotinamide 
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In addition, increasing structural analogues of PDE-5 inhibitors have been 
detected in botanical health products. Adding structurally modified PDE-5 inhibitor 
analogues into botanical health products is an apparent attempt to escape the normal 
PDE-5 inhibitors screening by health regulatory authorities. In this study, a total of 
sixteen botanical health products were found to be adulterated with PDE-5 inhibitor 
analogues. All of these analogues are not approved drugs with limited information on 
activity and toxicity. In order to further explore the presented amount, the adulterated 
PDE-5 inhibitors and their analogues in five commercial products (Table 3.6: No. 14, 
41, 50, 51 and 102) were quantified using the method developed and validated in the 
previous section. The five samples were found to be adulterated with sildenafil, 
hydroxyhomosildenafil, hydroxythiohomosildenafil and aminotadalafil. Typical HPLC-
DAD chromatograms of the extracts of these five samples were shown in Fig. 3.5. 
The quantification results are shown in Table 3.7 with the mean values of three 
replicate injections. It is obvious that the adulterated concentrations in these five 
products are extremely high. For example, around 10 mg of sildenafil per capsule was 
found in sample “MOJO sensation”. The recommended serving dosage of this botanical 
health product is 3 capsules everytime before sexual activity. This translates to a dose of 
30 mg of sildenafil which is larger than the recommended starting dosage of Viagra® 
(Sildenafil citrate) (25 mg). In addition, high concentration of PDE-5 inhibitor 
analogues was found in samples 41, 50 and 102. This is extremely dangerous because 
no clinical pharmacological and toxicological data of these analogues has been reported.  
Furthermore, sample 41 and 50, namely LFW and Maxidus respectively, were 
bought from the same on-line shop (BioGulf store). According to the information on 





Figure 3.5 Typical HPLC-DAD chromatograms of extracts of commercial health 
supplements at the UV detection wavelength of 254 nm: (5) AriZe and (14) 
Cockstar. The numbering is consistent with Table 3.6. Abbreviations: AMT: 
aminotadalafil; HHS: hydroxyhomosildenafil, THI: thiosildenafil; SIL: 
sildenafil; HTH: hydroxythiohomosildenafil. 
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Table 3.7 The concentrations of PDE-5 inhibitor and their analogues detected in 5 
botanical health products. 
 
Samplea) Commercial name Compounds detected 
Concentration 
detected 





14 Cockstar aminotadalafil 11.29 ± 0.35 5.87 ± 0.18 
hydroxyhomosildenafil 8.38 ± 0.37 2.93 ± 0.13 41 LFW 
hydroxythiohomosildenafil 65.39 ± 3.55 22.89 ± 1.24 
hydroxyhomosildenafil 8.54 ± 0.42 2.99 ± 0.15 
50 Maxidus 
hydroxythiohomosildenafil 65.58 ± 3.87 22.95 ± 1.35 
51 MOJO sensation sildenafil 13.36 ± 0.03 10.02 ± 0.02 
102 Zencore aminotadalafil 24.98 ± 0.13 20.98 ± 0.11 
 
a) The numbering is consistent with Table 3.6 
b) n = 3 
 
The packagings of these two products were also different. However, the HPLC 
chromatograms of the methanol extract of these two samples were identical as shown in 
Fig. 3.5. Two PDE-5 inhibitor analogues, namely hydroxyhomosildenafil and 
hydroxythiohomosildenafil, were detected in both samples and the concentrations of 
each PDE-5 inhibitor analogue detected per capsule were almost the same between 
these two samples (Table 3.7). Hence, it was speculated that LFW and Maxidus actually 
contained the same raw materials. Hydroxythiohomosildenafil was identified as a new 
sildenafil analogue which was detected for the first time as an adulterant in a 
commercial botanical health product. The isolation, purification and structural 
elucidation of hydroxythiohomosildenafil will be presented in chapter 4. 
Finally, tadalafil was not detected in any of the 198 sexual performance 
enhancement products. It could be either because there is indeed no tadalafil adulterated 
products among these 198 products or because tadalafil was not extracted out by using 




3.2.4.2 Slimming products 
The components detected in slimming botanical health products are presented in 
Table 3.8. Out of seventy-three such products, twenty-six (35.6%) were found to 
contain components such as caffeine, sibutramine, etc. The most commonly detected 
compound was caffeine, a central nervous system stimulant. It is also found in many 
plant species, such as coffee, tea and cocoa beans (Nehlig et al., 1992). Sibutramine, a 
appetite suppressant, was detected in two products. The presence of sibutramine in 
these products is dangerous due to its reported effect of increasing risk of heart attack 
and stroke (Eroglu et al., 2009). 
 
Table 3.8 List of slimming botanical health products and the compounds detected. 
 
No. Product Name Compounds detected 
1 7 DAY FAT BURNER X-TREME (7-DFBX) caffeine, nicotinic acid 
2 AmbiSlimPM caffeine, theobromine 
3 Caudalie caffeine 
4 Cheat Tabs caffeine 
5 Curvelle caffeine 
6 Easiness beauty sibutramine, phenolphthalein 
7 Femme Slender Couture Curves caffeine 
8 Hoodia 1000 caffeine 
9 Lipo 6 Ephedra Free yohimbine, caffeine 
10 Lipotrexate caffeine 
11 Merit Natural Body Slimming caffeine 
12 Metabosafe caffeine 
13 Mustika Ratu Slimming Tea caffeine 
14 NOXYCUT caffeine 
15 Nutridrine caffeine 
16 Oxotrim caffeine 
17 Pai You Su glibenclamide, sibutramine 
18 Phase 2 Carb blocker caffeine 
19 Pure Amazon Acai Slim A to X caffeine 
20 SLIM-1 Metabo Plus caffeine 
21 Slimming I caffeine 
22 Slimming Special Tea caffeine 
23 SlimQuick Hoodia caffeine, theobromine 
24 Super Slimming Herbal Tea caffeine 
25 Xanthadrene caffeine 
26 Zotrim caffeine 
  68 
In addition, the product, Pai You Su, was found to contain both sibutramine and 
glibenclamide. The reported adverse reaction due to glibenclamide (Health Sciences 
Authority of Singapore, 2008b; 2008c) and the side effects of sibutramine make this 
product extremely dangerous for consumers. 
In summary, the presence of adulteration coupled with the increasing usage of 
botanical health products warrant further steps to be implemented by different countries 
to regulate health supplements, especially in the manufacture and accurate labelling of 
products. Consumers and health professionals should be alerted to the potential toxicity 
and drug interactions due to adulteration of supplements with undeclared drugs and 
unapproved analytes. In addition, the general public ought to consult a physician or 
pharmacist before deciding on taking health supplements and to monitor the use. 
 
3.2.5 Conclusion 
In this study, screening of two hundred and seventy-one products purchased on-
line was carried out. One hundred and ninety-eight of these products were sexual 
performance enhancement products, while seventy-three were slimming products. 
Screening and identification were done using HPLC-DAD, GC-MS and LC-MS. One 
hundred and thirty out of two hundred and seventy-one on-line purchased products 
(48.0%) were found to be adulterated. Out of the one hundred and ninety-eight sexual 
performance enhancement products, one hundred and four (52.5%) were found to 
contain unapproved or undeclared components, in which 21 samples were detected to 
contain PDE-5 inhibitors and their analogues (10.6%). Out of the seventy-three 
slimming products, twenty-six (35.6%) were found to contain components, such as 
caffeine, sibutramine and glibenclamide. Health professionals, regulators and the 
general public should be alerted to the high prevalence and the potential danger of 
adulteration of internet health products. 
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Chapter 4 Isolation, purification and structural elucidation of 
new adulterants from botanical health products used for 
sexual performance enhancement 
 
In this chapter, three new synthetic adulterants (compounds X, Y and Z) 
detected in botanical health products used for sexual performance enhancement were 
isolated, purified and structurally elucidated for the first time. These three adulterants 
were identified as hydroxythiohomosildenafil, descarbonsildenafil and dapoxetine, 
respectively. Hydroxythiohomosildenafil and descarbonsildenafil are both sildenafil 
analogues, while dapoxetine is a selective serotonin reuptake inhibitor (SSRI) used for 
premature ejaculation. 
 
4.1 Isolation and identification of compound X 
4.1.1 Introduction 
As introduced in Chapter 3, PDE-5 inhibitors, including sildenafil, tadalafil, 
vardenafil and udenafil, are licensed synthetic drugs used for the treatment of erectile 
dysfunction. The popularity of these synthetic drugs has directly stimulated the growth 
of global market for sexual performance enhancement botanical health products. 
Various types of botanical health products claimed for male sexual performance 
enhancement have appeared in the commercial market about ten years age. Unlike 
synthetic drugs, botanical health products do not need clinical pharmacological and 
toxicological studies before it can be approved for sale and should only be taken as 
supplementary products. However, driven by the huge profit behind, some 
manufacturers may have illegally added one or more PDE-5 inhibitors and their 
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analogues into botanical health products to make them more effective. In Section 3.2, a 
new sildenafil analogue (compound X) was detected in a botanical health product 
bought from an on-line store. The detailed isolation of compound X and its structural 
elucidation using UV, IR, MS and NMR are presented in Section 4.1. 
 
4.1.2 Objective 
The objective of this study is to isolate and purify a new sildenafil analogue 
(compound X) from a commercial botanical health product and to elucidate its chemical 
structure using UV, IR , MS and NMR. 
 
4.1.3 Experimental 
4.1.3.1 Samples and chemicals 
Thiohomosildenafil was isolated and purified from another botanical health 
product and used as a laboratory standard. Its structure was confirmed by comparing its 
1H NMR and 13C NMR spectra with reported data (Zou et al., 2008a). The company 
TLC PharmaChem was commissioned by HSA of Singapore to synthesize compound X 
to be used for structural confirmation. The botanical health product, namely LFW, was 
bought on-line (BioGulf Store®, 2008). It was presented as brown powder in transparent 
capsules. Silica gel 60 (40–63 µm) for normal phase column chromatography was 
supplied by Alfa Aesar (Heysham, Lancs). Methanol (AR grade) and chloroform (AR 
grade) were supplied by Merck (Singapore). Methanol (HPLC grade) was supplied by 
Tedia (OH, USA). Acetonitrile was supplied by Fisher Scientific (New Jersey, USA). 
0.45 µm nylon membrane filters were supplied by Whatman International Ltd. 
(Maidstone, UK). Milli-Q water was obtained using a Synergy Purification System 
(Molsheim, France). CDCl3-d used for NMR analysis and potassium bromide (KBr) 
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powder used for IR analysis were purchased from Sigma-Aldrich (Steinheim, Germany). 
Sodium dihydrogenphosphate-2-hydrate (NaH2PO4·2H2O) was supplied by Merck 
(Darmstadt, Germany). 
 
4.1.3.2 Extraction and purification 
The contents (3.13 g) of ten capsules of LFW sample were ultrasonically 
extracted twice in 60 ml methanol, each time for 30 minutes. The extract was filtered 
and the solvent was evaporated under vacuo. The residue was subjected to column 
chromatography (Silica gel, chloroform : methanol = 60 : 1, v/v). Fractions of 50 ml 
were collected and analyzed by TLC (the Rf of compound X is about 0.4) using 
chloroform and methanol (30:1, v/v). All of the fractions containing compound X were 
pooled and the solvent was evaporated to give purified compound X. 
 
4.1.3.3 Melting point 
The melting point (uncorrected) of compound X was measured on a Gallenkamp 
melting point apparatus (Loughborough, UK). 
 
4.1.3.4 HPLC-DAD analysis 
An Agilent 1100 series HPLC chromatography with diode-array detector (Palo 
Alto, CA, USA) was employed. An Agilent ZORBAX Eclipse Plus C18 column (250 
mm × 4.6 mm i.d., 5 µm) was used. The mobile phase was 25 mM NaH2PO4·H2O (pH 
3.2 ± 0.1) and acetonitrile. The gradient elution profile was as follows: 0–30 minutes, 
acetonitrile rose from 10% to 70% (v/v) and maintained for 5 minutes. The flow rate of 
mobile phase was 1 ml/min. The injection volume was 10 µL. The UV spectra from 200 
to 400 nm were recorded on-line during the chromatographic run. 
  72 
4.1.3.5 ESI-MS/MS and high-resolution MS analysis 
The purified compound X and thiohomosildenafil were dissolved in methanol at 
a concentration of 1 µg/ml, respectively. Samples were injected using an Agilent 1100 
series HPLC chromatography with diode-array detector (Palo Alto, CA, USA). An 
Agilent ZORBAX RX-C18 column (150 mm × 2.1 mm i.d., 5 µm) was used. The 
mobile phase was 0.1% formic acid in water and 0.1% formic acid in acetonitrile. The 
gradient elution profile was as follows: 0–6.5 minutes, 0.1% formic acid in acetonitrile 
rose from 10% to 90% (v/v) and maintained for 3 minutes. The flow rate of the mobile 
phase was 300 µL/min. The injection volume was 5 µL. 
ESI-MS and MS/MS analysis were performed on an API 2000 mass 
spectrometer from Applied Biosystems (Foster City, CA, US). The [M + H]+ was 
selected as a precursor ion and the ESI-MS/MS spectra were acquired. Collision energy 
(CE) was set at 45 V. Data acquisition and processing were performed using Analyst 
software (Version 1.4.1) from Applied Biosystems (Foster City, CA, US). The high-
resolution MS spectrum was acquired in positive mode on a Finnigan MAT 95XL-T 
mass spectrometer (Bremen, Germany) coupled with an electrospray ionization source. 
 
4.1.3.6 NMR and IR analysis 
The purified compound X and thiohomosildenafil were dissolved in CDCl3-d 
separately for NMR analysis. DEPT spectra were recorded on a Bruker AVANCE300 
spectrometer (1H 300 MHz; 13C 75 MHz) (Billerica, MA, USA). 1H, 13C, COSY, 
HMQC and HMBC spectra were recorded on a Bruker DRX500 spectrometer (1H 500 
MHz; 13C 125 MHz) (Billerica, MA, USA). IR spectra were recorded on a Perkin Elmer 
Precisely Spectrum 100 FTIR spectrometer and recorded over the spectral range 4000–
400 cm-1 in KBr disks. 
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4.1.4 Results and discussion 
4.1.4.1 Botanical health products bought on-line 
Libidus was the product offered for sale on the website: 
http://www.biogulfstore.com/. During the on-line purchase, the product name was 
observed to have been changed to “Women Herbal Enhancer” (product code: RP010W) 
on the payment page. However, LFW was delivered. It is labeled as a “herbal dietary 
supplement” and contains seven herbal ingredients. They are Flos carthami, Herba 
epimedium, Herba Cistanches, Astragalus membranaceus, Ginkgo biloba, Rhizoma 
cucurmae longae and Labisia pumila. Of the seven herbs, Herba epimedium has been 
traditionally used as a kidney tonic and aphrodisiac (Wespes et al., 2002). Labisia 
pumila is traditionally used as a post-partum medication to assist contraction of the 
birth channel and is also used to delay fertility and to regain body strength (Shahrim et 
al., 2006). It is also traditionally used for the treatment of flatulence, dysentery, 
dysmenorrhoea, gonorrhea and “sickness in the bones” (Jamia et al., 2003). 
 
4.1.4.2 Structural elucidation of compound X 
Approximately 50 mg of light yellow amorphous powder (compound X) 
(melting point 193.5 – 194.5 oC, uncorrected) was isolated from 3.13 g of contents of 
the capsules of LFW. High-resolution MS spectrum of compound X revealed [M+H]+ at 
m/z 521.1986, suggesting a molecular formula of C23H32N6O4S2. The error between 
observed mass and theoretical mass of [M+H]+ is -2.52 ppm. Compared to 
thiohomosildenafil (C23H32N6O3S2), compound X contains one more oxygen atom. At 
the same time, the UV spectrum of compound X is similar to that of thiohomosildenafil, 




Figure 4.1 Overlaid UV spectra of compound X and thiohomosildenafil. 
 
The HPLC chromatogram of compound X and thiohomosildenafil is shown in 
Fig. 4.2. Compound X is more polar than thiohomosildenafil and the retention time is 
shorter than that of thiohomosildenafil. 
 
Figure 4.2 HPLC chromatogram of compound X and thiohomosildenafil at the UV 
detection wavelength 220 nm. 
 
As shown in Fig. 4.3 (A) and (B), the protonated thiohomosildenafil and the 
protonated compound X showed similar fragmentation pattern in enhanced product ion 






Figure 4.3 ESI enhanced product ion spectra of (A) thiohomosildenafil and (B) compound X. 
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The assignments of the NMR signals for thiohomosildenafil and compound X 
are tabulated in Table 4.1. It is obvious that the 1H and 13C signals of compound X are 
quite similar to those of thiohomosildenafil except for the signals of H-29, H-30, C-29 
and C-30. A triplet at δ 3.60 ppm integrating for two protons and a triplet at δ 2.59 ppm 
integrating for two protons were observed in the 1H spectrum of compound X. These 
signals were not found in the 1H spectrum of thiohomosildenafil. The signal at δ 3.60 
ppm was attributed to the methylene protons at position 30 while the signal at δ 2.59 
ppm was attributed to other methylene protons at position 29. The 13C and DEPT 
spectra of compound X revealed two different secondary carbon signals at δ 59.23 ppm 
and δ 57.55 ppm. They were assigned to the carbon atoms at positions 29 and 30, 
respectively. Hence, it is deduced that compound X is an analogue of 
thiohomosildenafil and the ethyl group at the position 26 is replaced with a 
hydroxyethyl group (Fig. 4.4). This deduction is also supported by the 2D NMR results. 
  




Table 4.1 NMR data of thiohomosildenafil and compound X. 
Thiohomosildenafil Compound X 
Carbon no. δ1H δ13C δ1H δ13C DEPTa COSY HMQC HMBC 
3 - 146.26 - 146.09 0 - - H-11, H-12 
5 - 146.71 - 146.54 0 - - H-15, H-18 
6 12.38 (1H, s) - 12.38 (1H, s) - - - - - 
7 - 172.02 - 171.89 0 - - H-10 
8 - 132.53 - 132.39 0 - - H-10 
9 - 134.13 - 133.93 0 - - H-11 
10 4.50 (3H, s) 39.58 4.51 (3H, s) 39.40 3 - H-10 - 
11 2.91 (2H, t, J = 7.5, 7.2) 27.77 2.93 (2H, t, J = 7.5) 27.58 2 H-11/H-12 H-11 H-12, H-13 
12 1.82 (2H, m, J = 7.5, 7.2) 22.37 1.84 (2H, m, J = 7.4, 6.9) 22.18 2 H-12/H-11, H-13 H-12 H-11, H-13 
13 1.00 (3H, t, J = 7.2) 14.20 1.00 (3H, t, J = 7.4) 14.00 3 H-13/H-12 H-13 H-11, H-12 
14 - 120.10 - 120.15 0 - - H-18 
15 8.81 (1H, s) 131.06 8.83 (1H, s) 130.86 1 H-15/H-17 H-15 H-17 
16 - 129.21 - 129.05 0 - - H-18 
17 7.82 (1H, d, J = 8.3) 132.22 7.84 (1H, d, J = 8.8) 131.92 1 H-17/H-15, H-18 H-17 H-15 
18 7.14 (1H, d, J = 8.7) 113.30 7.18 (1H, d, J = 8.8) 113.21 1 H-18/H-17 H-18 - 
19 - 159.66 - 159.61 0 - - H-15, H-18, H-20 
20 4.37 (2H, q, J = 7.2, 6.8) 66.61 4.39 (2H, q, J = 7.0) 66.44 2 H-20/H-21 H-20 H-21 
21 1.69 (3H, t, J = 7.2, 6.8) 14.87 1.71 (3H, t, J = 7.0) 14.68 3 H-21/H-20 H-21 H-20 
24, 28 3.11 (4H, br.s) 46.05 3.14 (4H, br.s) 45.71 2 H-24, 28/H-25, 27 H-24, 28 - 
25, 27 2.56 (4H, br.s) 51.90 2.69 (4H, br.s) 52.13 2 H-25, 27/H-24, 28 H-25, 27 H-29 
29 2.43 (2H, q, J = 7.5, 7.2) 52.12 2.60 (2H, t, J = 6.0) 59.23 2 H-29/H-30 H-29 H-30 
30 1.00 (3H, t, J = 7.2, 6.8) 11.90 3.60 (2H, t, J = 5.1) 57.55 2 H-30/H-29 H-30 H-29 
OH - - 1.23 (1H, s) - - - - - 
 
δ ppm in CDCl3, J in Hz;  
a Number in DEPT is the number of attached protons. 
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The tentative structure of this compound was finally confirmed by comparing 
the 1H NMR spectra of synthetic standard with the purified compound X. The company 
TLC PharmaChem was commissioned by HSA of Singapore to synthesize compound X 
to serve as a standard. The chemical name of the compound is 5-(2-ethoxy-5-(4-(2-
hydroxyethyl)piperazin-1-ylsulfonyl)phenyl)-1-methyl-3-propyl-1H-pyrazolo[4,3-
d]pyrimidine-7(6H)-thione. It was thus identified as hydroxythiohomosildenafil because 
of the presence of the hydroxyl group in position 30. All the other proton and carbon 
signals of hydroxythiohomosildenafil are assigned by comparing with those of 
thiohomosildenafil. This compound was first synthesized and patented by the Korea 
Institute of Science and Technology (Kim et al., 2002). 
In addition, during the screening analysis presented in the previous chapter, 
another botanical health product, namely Maxidus, which was purchased from the same 
on-line store as LFW, was tested to also contain hydroxythiohomosildenafil. The 
quantified concentration of hydroxythiohomosildenafil in both of these two products is 
around 23 mg per capsule. Take the recommended dosages of 2 capsules every time of 
these two products into consideration, consumers will receive upto 46 mg of 
hydroxythiohomosildenafil which is much higher than the recommended starting 
dosage of sildenafil (25 mg). Potential risk of using these two products is huge. 
 
4.1.4.3 IR spectrum of hydroxythiohomosildenafil 
The IR spectrum of hydroxythiohomosildenafil shows characteristic absorption 
bands of amine (νN-H 3268 cm-1), hydroxyl group (νO-H 3401 cm-1), aromatic ring (νC=C 
1601, 1565, 1514, 1463 cm-1), thione (νC=S 1144 cm-1 ), sulfonamide (νO=S=O 1351, 1258 





An analogue of sildenafil, hydroxythiohomosildenafil, has been isolated and 
identified in a sexual performance enhancement botanical health product. The structure 
of the analogue is elucidated using UV, IR, high-resolution MS, ESI-MS/MS and NMR. 
The adulteration of botanical health products with PDE-5 inhibitors and their analogues 
is very dangerous for consumers because of the unknown efficacy and toxic effects. The 




4.2 Isolation and structural elucidation of compound Y 
4.2.1 Introduction 
Functional foods claimed to have sexual performance enhancement effects have 
increasingly appeared. Some functional foods used for sexual performance 
enhancement are also labeled to have “male tonic effects” because of their “natural 
ingredients” and were “totally safe without having any side effects”. Similar to 
botanical health products, some functional foods used for sexual performance 
enhancement had been found to be adulterated with synthetic PDE-5 inhibitor 
analogues. A sildenafil analogue, acetildenafil, was previously reported to be present in 
a commercial herbal drink (Shin et al., 2004). The US FDA reported a case of 
adulteration of a functional coffee product with a PDE-5 inhibitor analogue (US FDA, 
2010b). The instant coffee product, namely Magic Power Coffee, was marketed as a 
dietary supplement for sexual enhancement. It was detected to contain hydroxy-
thiohomosildenafil which is a new PDE-5 inhibitor analogue as reported in the previous 
section. Consumers using this product are exposed to unpredictable risks. 
In this section, another new sildenafil analogue (compound Y) was found to be 
presented in a functional coffee labeled to have male sexual performance enhancement 
effect. The unknown compound Y was purified and isolated using flash chromatography 
and preparative HPLC. Its structure was elucidated using UV, IR, high resolution MS, 
MS/MS and NMR. 
 
4.2.2 Objective 
The objective of this study is to isolate, purify and elucidate an unknown 





4.2.3.1 Sample and chemicals 
The functional coffee sample was submitted to HSA of Singapore for analysis. It 
is in powder form and brown in color with some white particles. TLC PharmaChem 
(Concord Ontario, Canada) was commissioned to synthesize compound Y to be used for 
structural confirmation. Sildenafil citrate was supplied by Pfizer (New York, NY, USA). 
Methanol (AR grade) was supplied by Merck (Singapore). Methanol (HPLC grade) was 
supplied by J. T. Baker (Phillipsburg, NJ, USA). Acetonitrile and dichloromethane were 
supplied by LAB-SCAN Analytical Sciences (Patumwan, Bangkok, Thailand). 0.45 µm 
nylon membrane filters were supplied by Whatman International Ltd. (Maidstone, UK). 
Milli-Q water was obtained using a Synergy Purification System (Molsheim, France). 
Methanol-d4 used for NMR analysis was purchased from Sigma-Aldrich (Steinheim, 
Germany). Potassium bromide (KBr) powder used for IR analysis was purchased from 
VWR International Ltd. (Poole, England). Sodium dihydrogenphosphate-2-hydrate 
(NaH2PO4·2H2O) was supplied by Merck (Darmstadt, Germany). 
 
4.2.3.2 Sample preparation 
About 10 g of the coffee contents were ultrasonically extracted twice in 50 ml 
methanol (AR grade), each time for 30 minutes. The extract was combined, filtered 
through normal filter paper under vacuo and stored at 4 oC environment for 20 minutes. 
The extract was then filtered through normal filter paper under vacuo again and the 
solvent was evaporated using rotary evaporator. After solvent removal, the residue was 
subjected to flash chromatography for preliminary purification. 
 
4.2.3.3 Flash chromatography 
A Combiflash® Rf automated flash chromatography from Teledyne Isco Inc. 
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(Lincoln, NE, USA) was employed for preliminary purification. A RediSep® Rf 40 
gram silica normal phase flash column from Teledyne Isco Inc. (Lincoln, NE, USA) 
was used for sample separation. The sample residue was loaded onto the sample 
cartridge by solid loading method. Methanol (AR grade) and dichloromethane were 
used as the eluting solvents. The total elution time was 30 minutes. A gradient elution 
method was applied for sample separation. The gradient elution profile was: 0-15 
minutes, 10% (v/v) methanol; 15-25 minutes, methanol rose from 10% to 30%; 25-30 
minutes, 30% methanol. The flow rate of the eluting solvents was 40 ml/min. The UV 
detection wavelength was 254 nm. Fractions were automatically collected based on the 
detection wavelength. Fractions containing target compound were combined and 
evaporated using rotary evaporator. The residue was reconstituted with 4 ml methanol 
(HPLC grade) and filtered through the 0.45 µm nylon membrane filter. The filtrate was 
injected into a preparative HPLC system for further purification. 
 
4.2.3.4 Preparative HPLC 
A Shimadzu HPLC system with binary preparative pumps (LC-8A, Kyoto, 
Japan) and an automatic fraction collector (FRC-10A, Kyoto, Japan) were employed. 
An Agilent ZORBAX SB-C18 reversed phase semi-preparative column (250 × 9.4 mm 
i.d., 5 µm) was used. The mobile phases were (A) 0.1% formic acid in Milli-Q water 
and (B) 0.1% formic acid in acetonitrile. The gradient elution profile was as follows: 0-
6 minutes, (B) increased from 10% to 30% (v/v); 6-14 minutes, (B) increased from 30% 
to 90%; 14-17 minutes, (B) maintained at 90%; 17-19 minutes, (B) decreased from 90% 
to 10%. The flow rate of the mobile phase was 4 ml/min and injection volume was 100 
µl. The UV and visible spectra from 200–800 nm were recorded on-line during the 
chromatographic run. Fractions containing the target compound were collected by the 
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automatic fraction collector based on the UV detection wavelength of 260 nm. The 
solvents were removed using a rotary evaporator, giving purified compound Y. 
 
4.2.3.5 HPLC-DAD analysis 
An Agilent 1100 series HPLC chromatography with diode-array detector (Palo 
Alto, CA, USA) was employed. The same HPLC-DAD method as described in Section 
4.1.3.4 was applied for sample analysis. The UV spectra from 200 to 400 nm were 
recorded on-line during the chromatographic run. The chromatograms of the original 
methanol extract of the functional coffee sample, the purified compound Y and 
sildenafil citrate standard were recorded at the UV detection wavelength 254 nm. 
 
4.2.3.6 High-resolution MS analysis 
An Agilent 1200 series HPLC chromatography coupled with an Agilent 6210 
Accurate-Mass Time-of-Flight (TOF) MS (Santa Clara, CA, USA) was employed. The 
high-resolution MS spectrum was acquired in positive ionization mode. The fragmentor 
was set to 225 V. Nebulizer pressure was set to 60 PSI. Drying gas flow and 
temperature were set to 5 L/min and 325 oC respectively. Scan range was m/z 100–1000. 
The system was tuned using MMI-L low concentration tuning mix from Agilent 
Technologies (New Castle, Delaware, USA). Purine (accurate mass: 121.050873) and 
hexakis(1H, 2H, 3H-tetrafluoropropoxy)phosphazine (accurate mass: 922.009798) were 
used as the reference masses. Data acquisition was performed on the MassHunter 
workstation software (Version A.02.02) from Agilent Technologies (Santa Clara, CA, 
USA). 
 
4.2.3.7 ESI-MS/MS analysis 
The isolated and purified compound Y and sildenafil citrate were dissolved in 
methanol (HPLC grade) at a concentration of 1 µg/ml each. An Agilent 1200 series 
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HPLC chromatography with diode-array detector (Palo Alto, CA, USA) was employed. 
A Dionex® Acclaim C18 column (150 mm × 2.1 mm i.d., 3 µm) was used. The mobile 
phase was (A) 0.1% formic acid in water and (B) acetonitrile. The gradient elution 
profile was as follows: 0–5 minutes, (B) rose from 20% to 95% (v/v); 5–7 minutes, (B) 
maintained at 95%. The flow rate of the mobile phase was 200 µL/min. The injection 
volume was 5 µL. The temperature of the column oven was 30 oC. ESI-MS and MS/MS 
analysis were performed on an API 4000 mass spectrometer from Applied Biosystems 
(Foster City, CA, USA). The [M + H]+ was selected as a precursor ion and the ESI-
MS/MS spectra were acquired. Collision energy (CE) was set at 50 V. Data acquisition 
and processing were performed using the Analyst software (Version 1.4.2) from Applied 
Biosystems (Foster City, CA, USA). 
 
4.2.3.8 NMR analysis 
Sildenafil citrate, the purified compound Y and the synthetic standard of 
compound Y were dissolved in methanol-d4 separately for NMR analysis. DEPT90 and 
DEPT135 spectra were recorded on a Bruker DPX300 spectrometer (1H 300 MHz; 13C 
75 MHz) (Billerica, MA, USA). 1H, 13C, COSY and HMBC spectra were recorded on a 
Bruker DRX500 spectrometer (1H 500 MHz; 13C 125 MHz) (Billerica, MA, USA). 
Chemical shifts were reported in ppm. Coupling constants (J) were measured in Hertz 
(Hz). 
 
4.2.3.9 IR analysis 
IR spectra were recorded on a Nicolet 6700 FT-IR spectrometer from Thermo 
Fisher Scientific (Runcorn, Cheshire, UK) and recorded over the spectral range 4000–
400 cm-1 in KBr disks. 
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4.2.4 Results and discussion 
4.2.4.1 Extraction of compound Y 
Compound Y from coffee contents was extracted ultrasonically. Methanol (AR 
grade) and Milli-Q water were tested as the extraction solvent. Methanol (AR grade) 
was chosen as the extract solvent because mono- and poly-saccharides contained in the 
coffee sample dissolved well in water. The methanol extract also contains small amount 
of mono- and poly-saccharides after 30 minutes of ultrasonication. To reduce 
interference of mono- and poly-saccharides, the extract was cooled to a relatively low 
temperature of 4 oC after ultrasonication. The mono- and poly-saccharides in the 
methanol extract precipitated out and was then filtered off. The filtrate was evaporated 
and subjected for purification. 
 
4.2.4.2 Purification of compound Y 
Methanol (AR grade) and dichloromethane were selected as the eluting solvents 
for the flash chromatography system. One problem encountered with the flash 
chromatography system was that bubbles were easily formed because of the high flow 
rate. The formation of bubbles could significantly affect the separation results. To solve 
this problem, 100% dichloromethane was used to flush and stabilize the system for 2 
minutes before the gradient elution was carried out. A total of three fractions were 
collected during the flash chromatographic run. Further purification was carried out 
using preparative HPLC. Finally, approximately 10 mg of off-white amorphous powder 
was isolated from 10 g of coffee contents. 
 
4.2.4.3 HPLC-DAD analysis 
Fig. 4.5 (A) and (B) showed the HPLC chromatograms of the methanol extract 
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of the coffee sample and the purified compound Y at the UV detection wavelength 254 
nm. The retention times of compound Y in both the methanol extract of the coffee 
sample and the purified sample were 15.5 minutes while the retention time for sildenafil 





Figure 4.5 HPLC chromatograms of (A) the original methanol extract of  Maccino 
coffee sample, (B) purified compound Y and (C) sildenafil citrate at the UV 
detection wavelength 254 nm, the retention time of compound Y in the 
HPLC chromatograms of both original methanol extract and purified 




4.2.4.4 High-resolution mass and UV spectrum of compound Y 
High-resolution MS spectrum of compound Y revealed [M+H]+ at m/z 463.2142, 
suggesting a molecular formula of C21H30N6O4S. The error between the observed mass 
and theoretical mass of [M+H]+ was 0.75 ppm. Compared to sildenafil (C22H30N6O4S), 
compound Y had one carbon atom less. The UV spectrum of compound Y was shown in 
Fig. 4.6. The high similarity of the UV spectra between compound Y and sildenafil 
suggested that compound Y was likely to be an analogue of sildenafil. The tentative 




Figure 4.6 UV spectrum of compound Y, range from 200 nm to 400 nm, with 
maximum absorbance at 209 nm and 291 nm. 
 
 
Figure 4.7 Chemical structures of (A) sildenafil and (B) compound Y. 
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4.2.4.5 ESI-MS/MS analysis 
The protonated sildenafil and the protonated compound Y showed similar 
fragmentation pattern in MS2 spectra as shown in Fig. 4.8 (A) and (B). Both of these 
two spectra showed fragments with m/z 58, 255, 283, 299 and 311, among which 
fragment with m/z 311 was likely to be caused by the cleavage of the bond between C-
16 atom and the sulphur atom. The fragment with m/z 283 was likely to be caused by 
the cleavage of the bond between C-20 atom and the oxygen atom based on fragment 




Figure 4.8 ESI-MS/MS spectra of (A) sildenafil and (B) compound Y, both of these two 





Figure 4.8 (continuted) ESI-MS/MS spectra of (A) sildenafil and (B) compound Y, both 
of these two compounds have fragments: m/z 58, 255, 283, 299 and 311. 
 
  
Figure 4.9 Proposed ESI-MS/MS fragmentation pathway of the protonated molecules 
of compound Y ([M+H]+ m/z 463) and sildenafil. 
(B) 
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4.2.4.6 1D and 2D NMR analysis 
The tentative chemical structure of compound Y was confirmed using 1D and 
2D NMR. The assignments of the 1D and 2D NMR signals for compound Y were 
tabulated in Table 4.2. The 1H and 13C NMR spectra of sildenafil were also acquired 
and listed for comparison. Basically, 1H and 13C NMR spectra of compound Y and 
sildenafil were similar. However, the signals from the piperazine group in sildenafil 
were different from those of compound Y. A singlet at  2.27 ppm integrating for three 
protons and two broad singlets at  2.52 ppm and  3.07 ppm integrating for four 
protons respectively were observed in the 1H spectrum of sildenafil. They were assigned 
to the protons at position 29, 25/27 and 24/28 [Fig. 4.7 (A)], respectively. These signals 
were not found in the 1H spectrum of compound Y. 
On the other hand, one singlet at  2.87 ppm integrating for six protons and 
another broad singlet at  3.21 ppm integrating for four protons were observed in the 1H 
spectrum of compound Y. The singlet at  2.87 ppm was attributed to the protons in two 
equivalent methyl groups. The high chemical shift value of these protons indicated that 
the methyl groups were attached to an electronegative atom (e.g. nitrogen). The broad 
singlet at  3.21 ppm integrating for four protons was likely to be due to the four 
protons in two methylene groups (H-24/H-25) which had same 1H chemical shift but 
different 13C chemical shift. One possible explanation for the same chemical shift of 
these four methylene protons (H-24/H-25) in 1H NMR spectrum was that the nitrogen 
atom at position 26 was protonated during full preparative HPLC purification in which 
0.1% (v/v) formic acid was added into the mobile phases. The protonation of N-26 
caused the similar electron density around H-24 and H-25. The same observation was 
also made in sildenafil while eight methylene protons in the piperazine ring appeared as 




Table 4.2 NMR data of sildenafil and compound Y. 
Sildenafil Compound Y 
No. δ 1H δ 13C No. δ 1H δ 13C DEPT * HMQC HMBC 
3 ─ 147.5 3 ─ 147.4 0 ─ ─ 
5 ─ 149.9 5 ─ 150.0 0 ─ ─ 
7 ─ 155.7 7 ─ 155.6 0 ─ ─ 
8 ─ 126.0 8 ─ 126.0 0 ─ ─ 
9 ─ 139.6 9 ─ 139.4 0 ─ ─ 
10 4.24 (3H, s) 38.4 10 4.23 (3H, s) 38.4 3 C-10 C-8 
11 2.89 (2H, t, J = 7.5, 7.6) 28.4 11 2.88 (2H, t, J = 7.5, 8.5) 28.4 2 C-11 C-3/C-9/C-12/C-13 
12 1.82 (2H, m, J = 7.5, 7.3) 23.4 12 1.81 (2H, m, J = 7.5) 23.5 2 C-12 C-3/C-11/C-13 
13 1.00 (3H, t, J = 7.5) 14.2 13 1.00 (3H, t, J = 7.0, 7.5) 14.2 3 C-13 C-11/C-12 
14 ─ 133.2 14 ─ 132.8 0 ─ ─ 
15 8.17 (1H, s) 129.1 15 8.29 (1H, s) 131.1 1 C-15 C-5/C-17/C-19 
16 ─ 124.3 16 ─ 124.2 0 ─ ─ 
17 7.90 (1H, d, J = 9.0) 131.7 17 8.01 (1H, d, J = 7.0) 132.5 1 C-17 C-15/C-19 
18 7.37 (1H, d, J = 9.0) 114.3 18 7.35 (1H, d, J = 8.5) 114.4 1 C-18 C-14/C-16 
19 ─ 161.6 19 ─ 161.5 0 ─ ─ 
20 4.30 (2H, q, J = 7.0, 6.8) 66.7 20 4.30 (2H, q, J = 7.0) 66.7 2 C-20 C-19/C-21 
21 1.48 (3H, t, J = 7.0) 14.8 21 1.47 (3H, t, J = 6.5, 7.0) 14.8 3 C-21 C-20 
24, 28 3.07 (4H, br.s) 46.9 24 39.3 2 C-24 C-24 
25, 27 2.52 (4H, br.s) 55.1 25 3.21 (4H, br.s) 58.0 2 C-25 C-25/C-27/C-28 
29 2.27 (3H, s) 45.8 27, 28 2.87 (6H, s) 43.8 6 C-27, 28 C-25 
 
δ ppm in methanol-d4, J in Hz. 
* Number in DEPT is the number of attached protons. 
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This was further confirmed by the HMQC spectrum of compound Y, as the 
singlet at  3.21 ppm was found to couple with two secondary carbon atoms giving rise 
to signals at  39.3 ppm and  58.0 ppm (C-24/C-25), simultaneously. Furthermore, the 
protons at position 25 giving rise to a signal at  3.21 ppm were long-range coupled 
with two primary carbons (C-27/C-28) in the HMBC spectrum of compound Y. The 
HMBC spectral data also revealed that the protons at positions 27 and 28 are long-range 
coupled to a secondary carbon (C-25) giving rise to a signal at  58.0 ppm. 
Based on the various chemical analyses, it was confirmed that compound Y was 
an analogue of sildenafil and the piperazine ring in the sildenafil structure was opened 
with the loss of one ring carbon [Fig. 4.7 (A & B)]. The tentative structure of this 
compound was finally confirmed by comparing the 1H NMR spectra of synthetic 
standard with the purified compound Y. The company TLC PharmaChem was 
commissioned by HSA of Singapore to synthesize compound Y to serve as a standard. 
The chemical name of this compound is N-(2-(dimethylamino)ethyl)-4-ethoxy-3-(1-
methyl-7-oxo-3-propyl-6,7-dihydro-1H-pyrazolo[4,3-d]pyrimidin-5-
yl)benzenesulfonamide. It is named as descarbonsildenafil because one carbon was lost 
comparing with sildenafil. 
 
4.2.4.7 IR spectrum of compound Y 
The IR spectrum of compound Y showed characteristic absorption bands of 
amine (νN-H 3462 cm-1), carbonyl group (νC=O 1696 cm-1), aromatic ring (νC=C 1599, 
1584, 1562, 1465 cm-1), sulfonamide (νO=S=O 1333, 1281 cm-1) and other absorption 






In this study, a new sildenafil analogue was isolated from a functional coffee 
sample and its structure was elucidated using UV, IR, high resolution MS, ESI MS/MS 
and NMR. The efficacy and safety profiles of this analogue are unknown. Hence, it is 
potentially dangerous for unknowing consumers to consume this adulterated coffee. 
This is the first report of the detection of descarbonsildenafil in a coffee sample. The 




4.3 Isolation and structural elucidation of compound Z 
4.3.1 Introduction 
According to the WHO, premature ejaculation is persistent or recurrent 
ejaculation with minimal stimulation before, on, or shortly after penetration and before 
the person wishes it, over which the sufferer has little or no voluntary control, causing 
the sufferer and/or partner bother or distress (McMahon et al., 2004). Unlike erectile 
dysfunction, premature ejaculation affects men of all ages and is common among 
adolescents, young adults and men who lack sexual experience and frequency (Vardi et 
al., 2008). 
For the treatment of erectile dysfunction, synthetic PDE-5 inhibitors, such as 
sildenafil, tadalafil and vardenafil, are widely used. Premature ejaculation is usually 
treated by selective serotonin reuptake inhibitors (SSRIs) (Giuliano et al., 2008). 
However, there is currently no FDA-approved therapy for premature ejaculation. 
Dapoxetine is a short-acting SSRI. It was initially investigated as a potential drug for 
the treatment of depression, but it was clinically tested for the treatment of premature 
ejaculation (Shabsigh et al., 2008). Currently it is being considered for approval by 
FDA for the treatment of premature ejaculation in men (Buvat et al., 2009; Kaufman et 
al., 2009; Kendirci et al., 2007). Hence, it is illegal to include dapoxetine in botanical 
health products and unknowingly consuming dapoxetine adulterated products is 
dangerous.  
In this section, a botanical health product submitted to HSA of Singapore was 
found to contain high concentration of an unknown compound Z. The detection and 
isolation of the compound from this sexual performance enhancement botanical health 





The objective of this study is to isolate, purify and elucidate the structure of 
compound Z from a botanical health product used for sexual performance enhancement. 
 
4.3.3 Experimental 
4.3.3.1 Sample and chemicals 
A botanical health product sample, named MHD1, was sent to HSA of 
Singapore for testing. It is a brown bulk powder. The company TLC PharmaChem was 
commissioned by HSA of Singapore to synthesize compound Z to be used for structural 
confirmation. Methanol (AR grade) and acetonitrile (HPLC grade) were supplied by 
Merck (Singapore). Methanol (HPLC grade) was supplied by Tedia (OH, USA). 0.45 
µm nylon membrane filters were supplied by Whatman International Ltd. (Maidstone, 
UK). Milli-Q water was obtained using a Synergy Purification System (Molsheim, 
France). Sodium dihydrogenphosphate-2-hydrate (NaH2PO4·2H2O) was supplied by 
Merck (Darmstadt, Germany). Formic acid, methanol-d4 used for NMR analysis and 
potassium bromide (KBr) powder used for IR analysis were purchased from Sigma-
Aldrich (Steinheim, Germany). 
 
4.3.3.2 Extraction of MHD1 
2 g of MHD1 powder was ultrasonically extracted in 50 ml methanol (AR grade) 
for 30 minutes. The extract was filtered and the solvent was evaporated under vacuo. 
After filtration and solvent removal, the residue was reconstituted with 4 ml methanol 
(HPLC grade) and filtered through the 0.45 µm nylon membrane filter. The sample was 
further purified by preparative HPLC by successive injection of 50 µl of this sample. 
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4.3.3.3 Preparative HPLC 
A Shimadzu HPLC system with two preparative pumps (LC-8A, Kyoto, Japan) 
and an automatic fraction collector (FRC-10A, Kyoto, Japan) was used. An Agilent 
ZORBAX SB-C18 reversed phase semi-preparative column (250 × 9.4 mm i.d., 5 µm) 
was applied for the sample separation. The mobile phases were 0.1% formic acid in 
Milli-Q water and 0.1% formic acid in methanol (HPLC grade). The gradient elution 
profile was as follows: 0.1% formic acid in methanol was increased from 10% to 90% 
(v/v) in 7.5 minutes and maintained for 6 minutes. The flow rate of mobile phase was 4 
ml/min and injection volume was 50 µl. The UV and visible spectra from 200–800 nm 
were recorded on-line during the chromatographic run. Fractions containing the target 
compound were collected by the automatic fraction collector based on the UV detection 
wavelength of 280 nm. The solvents were removed using a rotary evaporator, giving the 
compound Z. 
 
4.3.3.4 Melting point 
The melting point (uncorrected) of the isolated compound Z was measured on a 
Gallenkamp melting point apparatus (Loughborough, UK). 
 
4.3.3.5 HPLC-DAD analysis 
An Agilent 1100 series HPLC chromatograph with diode-array detector (Palo 
Alto, CA, USA) was employed. The same HPLC-DAD method as described in Section 
4.1.3.4 was applied for sample analysis. The UV spectra from 200 to 400 nm were 
recorded on-line during the chromatographic run. The chromatograms of both original 
methanol extract of MHD1 and purified compound Z were recorded at the UV detection 
wavelength 254 nm. 
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4.3.3.6 ESI-MS/MS and high-resolution MS analysis 
The isolated compound Z was dissolved in methanol (HPLC grade) at a 
concentration of 1 µg/ml and was injected using an Agilent 1100 series HPLC 
chromatograph with diode-array detector (Palo Alto, CA, USA). An Agilent ZORBAX 
RX-C18 column (150 mm × 2.1 mm i.d., 5 µm) was used. The mobile phase was 0.1% 
formic acid in water and 0.1% formic acid in acetonitrile (HPLC grade). The gradient 
elution profile was as follows: 0–6.5 minutes, 0.1% formic acid in acetonitrile rose from 
10% to 90% (v/v) and maintained for 3 minutes. The flow rate of the mobile phase was 
300 µL/min. The injection volume was 5 µL. ESI-MS and MS/MS analysis were 
performed on an API 2000 mass spectrometer from Applied Biosystems (Foster City, 
CA, US). The diode-array detector and the ESI-MS detector were operating in series. 
The [M + H]+ was selected as a precursor ion and the ESI-MS/MS spectra were 
acquired. Collision energy (CE) was set at 35 V. Data acquisition and processing were 
performed using Analyst software (Version 1.4.1) from Applied Biosystems (Foster City, 
CA, US). The high-resolution MS spectrum was acquired in positive mode by direct 
infusion on a Finnigan MAT 95 XL-T mass spectrometer (Bremen, Germany) coupled 
with an electrospray ionization source. 
 
4.3.3.7 NMR and IR analysis 
The isolated compound Z was dissolved in MeOD-d4 for NMR analysis. DEPT 
spectra were recorded on a Bruker AVANCE300 spectrometer (1H 300 MHz; 13C 75 
MHz) (Billerica, MA, USA). 1H, 13C, COSY, HMQC and HMBC spectra were recorded 
on a Bruker AMX500 spectrometer (1H 500 MHz; 13C 125 MHz) (Billerica, MA, USA). 
IR spectra were recorded on a Perkin Elmer Precisely Spectrum 100 FTIR spectrometer 
and recorded over the spectral range 4000–400 cm-1 in KBr disks. 
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4.3.4 Results and discussion 
Approximately 15 mg of light grey amorphous powder (melting point 
175─178oC, uncorrected) was isolated from 2 g of MHD1 powder. As shown in Fig. 
4.10, the UV spectrum of isolated compound Z in methanol (HPLC grade) showed 
maximal absorbances at 210 nm, 230 nm and 293 nm, different from the UV spectra of 




Figure 4.10 UV spectrum of compound Z in methanol (HPLC grade). 
 
The HPLC retention times of compound Z of both original extract and purified 
sample were 20.5 min [Fig. 4.11 (A) & (B)]. High-resolution MS spectrum (Fig. 4.12) 
of the compound revealed [M+H]+ at m/z 306.1860 suggesting a molecular formula of 
C21H23NO. The error between observed mass and theoretical mass of [M+H]+ is 2.34 
ppm. This molecular formula was supported by 1H and 13C NMR data which indicated 





Figure 4.11 HPLC chromatograms of compound Z at the UV detection wavelength 280 










Table 4.3 NMR data of compound Z. 
No. 1H (δH) 
13C 
(δC) DEPT
a COSY HMBC 
1 4.67 (1H, dd, J = 4.0, 8.0) 70.0 1 H-2 C-3/C-4/C-5/C-2''/C-6'' 
2 2.72 (1H, m) 2.88 (1H, m) 31.1 2 H-1/H-3 C-1/C-3/C-1'' 
3 4.17 (1H, m) 3.81 (1H, m) 65.4 2 H-2 C-1/C-2/C-1' 
4 2.84 (3H, s) 41.6 3 ─ C-1/C-5 
5 2.84 (3H, s) 41.6 3 ─ C-1/C-4 
1' ─ 155.2 0 ─ ─ 
2' 6.64 (1H, d, J = 7.5) 105.8 1 H-3' C-1'/C-3'/C-4'/C-10' 
3' 7.26 (1H, t, J = 8.0) 126.9 1 H-2'/H-4' C-1'/C-2'/C-9' 
4' 7.38 (1H, d, J = 8.5) 121.6 1 H-3' C-2'/C-5'/C-9'/C-10' 
5' 7.76 (1H, d, J = 7.0) 128.5 1 H-6' C-4'/C-7'/C-9'/C-10' 
6' 7.47 (1H, m) 127.5 1 H-5'/H-7' C-5'/C-8'/C-9' 
7' 7.45 (1H, m) 126.3 1 H-6'/H-8' C-5'/C-8'/C-10' 
8' 8.05 (1H, d, J = 9.0) 122.7 1 H-7' C-1'/C-6'/C-9' 
9' ─ 135.9 0 ─ ─ 
10' ─ 126.6 0 ─ ─ 
1'' ─ 133.0 0 ─ ─ 
2'' 7.48 (1H, d, J = 8.2) 130.6 1 H-3'' C-1/C-1''/C-3''/C-4''/C-6'' 
3'' 7.53 (1H, dd, J = 9.5) 131.8 1 H-2''/H-4'' C-1''/C-2''/C-4''/C-5'' 
4'' 7.43 (1H, dd, J = 8.0) 131.4 1 H-3''/H-5'' C-2''/C-3''/C-5''/C-6'' 
5'' 7.53 (1H, dd, J = 9.5) 131.8 1 H-4''/H-6'' C-1''/C-3''/C-4''/C-6'' 
6'' 7.48 (1H, d, J = 8.2) 130.6 1 H-5'' C-1/C-1''/C-2''/C-4''/C-5'' 
 
δ ppm in MeOD, J in Hz. 
a Number in DEPT is the number of attached protons. 
 
 
One region of the 1H NMR spectrum revealed a sharp singlet at  2.84 ppm and 
two small neighboring multiplets at  2.72 ppm and  2.88 ppm, integrating for a total 
of 8H (Table 4.3). The signals were attributed to six protons from two methyl (H-4/H-5) 
groups and two protons from one methylene (H-2) group at approximately the same 
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chemical shift. The singlet revealed that the atom connected to the methyl groups was 
not attached to a proton. Besides, the chemical shift showed that the two methyl carbon 
atoms (C-4/C-5) were connected with a relatively electronegative atom. The electron 
withdrawing effect of this electronegative atom resulted in the deshielding of the methyl 
protons. Hence, it was speculated that the two methyl groups are connected to the 
nitrogen atom. 
13C NMR and DEPT data showed the signals of two methyl, two methylene, 
thirteen methine and four quaternary carbon atoms. The four quaternary carbon signals 
at  155.2 ppm,  135.9 ppm,  133.0 ppm and  126.6 ppm were likely to be due to the 
carbon atoms in benzene rings. The quaternary carbon at  155.2 ppm was much more 
deshielded compared to the other atoms on the aromatic ring because it was attached to 
the oxygen atom. Hence, it was proposed that the oxygen atom was directly connected 
to benzene ring A. Moreover, the COSY spectral data displayed the correlation between 
the protons of the methylene group with signals at  2.72 ppm /  2.88 ppm (H-2) and 
the proton of methine group with a signal at  4.67 ppm (H-1) as well as protons of 
methylene group with signals at  4.17 ppm /  3.81 ppm (H-3) respectively. Hence, 
these three groups were likely to be connected together. 
In the 13C NMR spectrum, the carbon atom (C-2') giving rise to a signal at  
105.8 ppm was in the ortho position of the carbon atom (C-1') with a signal at  155.2 
ppm because the –OR– group was electron donating and hence the ortho position was 
more shielded. At the same time, the quaternary carbon at position C-10' giving rise to a 
signal at  126.6 ppm was long-range coupled with protons giving rise to signals at  
6.64 ppm (H-2'),  7.38 ppm (H-4'),  7.45 ppm (H-7') and  7.76 ppm (H-5') in the 
HMBC spectrum. 
The HMBC spectral data also revealed that another quaternary carbon giving 
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rise to a signal at  135.9 ppm (C-9') was coupled to the protons giving rise to signals at 
 7.26 ppm (H-3'),  7.38 ppm (H-4'),  7.76 ppm (H-5'),  7.47 ppm (H-6'),  8.05 ppm 
(H-8'). Hence, it was proposed that two benzene rings (A and B) were connected 
together, sharing two quaternary carbons with signals at  126.6 ppm and  135.9 ppm 
to form a naphthalene group.The methine carbon (C-1) giving rise to a signal at  70.0 
ppm was long-ranged coupled to the protons giving rise to signals at  2.84 ppm (H-
4/H-5),  3.81 ppm (H-3),  4.17 ppm (H-3),  7.48 ppm (H-2''/H-6'') in the HMBC 
spectrum, suggesting its connection with the benzene ring C and a dimethylamino 
group. It was confirmed by the methyl carbons with a signal at  41.6 ppm (C-4/C-5) 
and the methine carbon atoms with a signal at  130.6 ppm (C-2''/C-6'') were long-range 
coupled with proton giving rise to a signal at  4.67 ppm (H-1) in the HMBC spectrum.  
Furthermore, the methine carbon giving rise to a signal at  131.4 ppm (C-4'') 
was long-range coupled to the protons giving rise to signals at  7.48 ppm (H-2''/H-6'') 
and  7.53 ppm (H-3''/H-5'') in the HMBC spectrum. The methine carbons giving rise to 
a signal at  130.6 ppm (C-2''/C-6'') were long-range coupled to protons giving rise to a 
signal at  7.43 ppm (H-4'') in the HMBC spectrum. Hence, it was deduced that 
benzene ring C was mono-substituted, with the quaternary carbon giving rise to a signal 
at  133.0 ppm (C-1'') and connecting with the methine carbon giving rise to a signal at 
 70.0 ppm (C-1).  
The tentative structure of this compound was finally confirmed by comparing 
the 1H NMR spectra of synthetic standard with the purified compound Z. The company 
TLC PharmaChem was commissioned by HSA of Singapore to synthesize compound Z 
to serve as a standard. The compound was determined to be N,N-dimethyl-3-
(naphthalene-1-yloxy)-1-phenylpropane-1-amine (Siddiqui et al., 2007), also known as 
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dapoxetine (Fig. 4.13). It was previously clinically tested for the treatment of premature 
ejaculation. This structure was further confirmed by ESI-MS/MS, IR and by comparing 
1H and 13C NMR data with the previous reports (Siddiqui et al., 2007; Torre et al., 
2006).  
  
Figure 4.13 Chemical structure of compound Z (dapoxetine). 
 
The MS2 spectrum revealed several fragments of the parent ion [M+H]+ 306.6 
(Fig. 4.14). As shown in Fig. 4.15, the product ion at m/z 261 (fragmentation 1) was 
derived from the [M+H]+ by the cleavage of the dimethyl amine group. The product ion 
at m/z 157 (fragmentation 2) was formed by the cleavage of the bond between C-2 and 
C-3. The product ion at m/z 129 (fragmentation 3) was produced by the cleavage of the 
bond between the oxygen atom and the aromatic carbon. The product ion at m/z 183 
(fragmentation 4) was formed by cleaving the benzene ring C from the group with m/z 
261. The product ion at m/z 117 (fragmentation 5) was produced by cleaving the C-O 
bond between C-3 and O atom from the group with m/z 261. These fragments were 










Figure 4.15 Proposed ESI-MS/MS fragmentation of the protonated molecules of 
compound Z ([M+H]+ m/z 306), confirmed by Mass FrontierTM 5.0. 
 
(5) m/z 117 
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The IR spectrum of compound Z showed absorption bands of amine (νC-N1267 
cm-1), aromatic ring (νAr-H 3319 cm-1 and νC=C 1594, 1508 cm-1), ether (νC-O-C 1135 cm-1) 
and alkanes (νC-H 2925 cm-1 and δC-H 1391, 1305 cm-1). 
 
4.3.5 Conclusion 
In this section, a synthetic SSRI called dapoxetine, was isolated from a botanical 
health product and its chemical structure was elucidated using UV, IR, high resolution 
MS, ESI MS/MS and NMR. The presence of dapoxetine in the botanical health product 
is very dangerous for consumers because of its unknown safety profile. This is the first 




Chapter 5 Non-targeted metabolomic investigations of 
botanicals using Liquid Chromatography-Linear Ion Trap-
Orbitrap XL hybrid Fourier Transform Mass Spectrometry 
 
In this chapter, a metabolomic platform was developed to investigate the quality 
of commonly used adaptogenic botanicals as well as raw and steamed P. notoginseng 
available in Singapore and China. This metabolomic platform contains two main parts: 
non-targeted metabolite profiling and multivariate data analysis. For the non-targeted 
metabolite profiling, a pressurized liquid extraction (PLE) method for sample extraction 
was developed and optimized using raw P. notoginseng sample. A Liquid 
Chromatography-Linear Ion Trap-Orbitrap XL hybrid Fourier Transform Mass 
Spectrometry (LC-LTQ-Orbitrap XL FT MS) method was developed, validated and 
optimized for chemical analysis (Section 5.1). The method was applied to the analyses 
of 5 adaptogenic botanicals and P. notoginseng with the development of several PLS-
DA models based on their respective chromatographic profiles in Section 5.2. The raw 
and differentially steamed P. notoginseng samples were also investigated. Twelve 
ginsenosides present in these samples were quantified. 
 
5.1 PLE and LC-LTQ-Orbitrap XL FT MS method development 
5.1.1 Introduction 
As introduced in Chapter 1, PLE is an increasingly used sample extraction 
technique and has been used in various research areas. It has the advantages of short 
extraction time, less solvent consumption, high extraction efficiency with good batch-
to-batch repeatability and automatic operating capabilities (Dabrowski et al., 2002; Wan 
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et al., 2006a). PLE has been applied to extract P. notoginseng at a temperature of 150 
oC with 15 min static extraction time (Wan et al., 2005; Wan et al., 2006a; Wan et al., 
2006b; Wan et al., 2007; Wan et al., 2006c). It is worthy to note that although the high 
temperature used in PLE can fasten the extraction procedure, the effects of the high 
temperature on P. notoginseng sample should not be ignored because the extraction 
process at high temperature in the presence of water may be similar to a steaming 
process. Hence, PLE parameters, including extraction temperature, static extraction 
time and static extraction cycle, need to be investigated and optimized. Chemical 
fingerprints based non-targeted metabolite profiling could be used to assess the 
differences and similarities of P. notoginseng samples extracted by different PLE 
procedures. 
In recent years, similar strategies have been applied to analyze the quality of 
botanicals from Panax species. For example, three different Panax species, including P. 
notoginseng, P. ginseng and P. quinquefolium, as well as different parts of P. 
notoginseng have been compared and investigated (Dan et al., 2008; Xie et al., 2008). 
Our group has also reported a metabolomic study of raw and steamed P. notoginseng 
using UHPLC-QTOF-MS (Chan et al., 2007). UHPLC-QTOF-MS was chosen in these 
studies because of its high-speed detection, good resolution and sensitivity (Chan et al., 
2007; Dan et al., 2008). Compared with UHPLC-QTOF-MS, the LC-LTQ-Orbitrap XL 
FT MS system has even higher mass resolution and accuracy (Makarov, 2000). 
Although this instrument is primarily oriented towards proteomics in the life sciences, 
its high mass resolution is useful for botanical metabolite profiling due to the presence 
of several compounds with closely related structures in botanicals and the possibility to 




The first objective of this study is to develop, optimize and validate a LC-LTQ-
Orbitrap XL FT MS method used for the non-targeted metabolite profiling. The second 
objective is to develop and optimize PLE methods for the extraction of P. notoginseng 




5.1.3.1 Chemicals and materials 
Both methanol and acetonitrile used were HPLC grade and were supplied by 
Lab-Scan Analytical Sciences (Patumwan, Bangkok, Thailand). High purity water was 
purchased from Honeywell, Burdick & Jackson® (Muskegon, MI, USA). Formic acid 
was purchased from Sigma-Aldrich (Steinheim, Germany). Notoginsenoside R1, 
ginsenosides Rb1, Rc, Rd and Rg1 were purchased from the National Institute for the 
Control of Pharmaceutical and Biological Products (NICPBP) (Beijing, China). 
Ginsenoside Re was purchased from Indofine Chemical Company (Somerville, NJ, 
USA). Ginsenoside 20S-Rg3 was purchased from Chroma Dex Inc (Irvine, CA, USA). 
Ginsenoside Rh2 was purchased from Delta Information Center for Natural Organic 
Compounds (Anhui, China). Ginsenosides Rk1, Rk3, 20S-Rh1 and 20R-Rh1 were 
isolated and purified from steamed P. notoginseng by Mr Dhaval Patel in our lab and 
used as laboratory standard. Raw P. notoginseng root (in powder form) was purchased 
from Wong Yiu Nam Medical Hall PTE. LTD. (Singapore).  
The caffeine solution (1 mg/ml) and reserpine used for preparing FT MS 
calibration solution were purchased from Sigma-Aldrich (St. Louis, MO, USA). L-
methionyl-arginyl-phenylalanyl-alanine acetate peptide (MRFA) standard used for 
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preparing FT MS calibration solution was ordered from Research Plus, Inc. (Barnegat, 
NJ, USA). Hexakis(1H, 1H, omegaH-perfluoroalkoxy)phosphazeae (Ultramark® 1621) 
used for preparing FT MS calibration solution was purchased from Alfa Aesar® 
(Karlsruhe, Germany). 
 
5.1.3.2 Standard preparation 
Stock solutions of notoginsenoside R1, ginsenosides Rb1, Rc, Rd, Re, Rg1, 
20S-Rg3, 20S/20R-Rh1, Rh2, Rk1 and Rk3 (Fig. 5.1) were prepared at concentration of 
0.04 mg/ml in 80% (v/v) aqueous methanol. Stock solutions were stored at 4 oC. 
Working solutions were diluted from stock solution with 80% (v/v) aqueous methanol 
in different times. 
 
5.1.3.3 PLE method development 
PLE was performed on a Dionex ASE 200 system (Dionex Corp., Sunnyvale, 
CA, USA). PLE methods with different parameters were tabulated in Table 5.1. Four 
different extraction temperatures and different concentrations of methanol were used in 
the extraction of raw P. notoginseng sample. Static extraction time was set at 10 min. 
Different static cycles were also compared. 1 g of raw P. notoginseng was used for each 
extraction. Each PLE method was used to extract six raw P. notoginseng samples 
consecutively. The collected extract was transferred into a 50 ml volumetric flask which 
was made up to volume with the corresponding extraction solvent and filtered through a 
0.45 µm Nylon membrane filter (Whatman®, Maidstone, England). The filtered extract 
was further diluted 100 times using the same extraction solvent before injection into the 




Structure Saponins R1 R2 R3 Formula 
Notoginsenoside R1 -H -O-Glc2-Xyl -Glc C47H80O18 
Ginsenoside Rb1 -Glc2-Glc -H -Glc6-Glc C54H92O23 
Ginsenoside Rc -Glc2-Glc -H -Glc6-Ara(f) C53H90O22 
Ginsenoside Rd -Glc2-Glc -H -Glc C48H82O18 
Ginsenoside Re -H -O-Glc2-Rha -Glc C48H82O18 
Ginsenoside Rg1 -H -O-Glc -Glc C42H72O14 
Ginsenoside Rg3 -Glc2-Glc -H -H C42H72O14 
Ginsenoside Rh1 -H -O-Glc -H C36H62O9 
(A) 
Ginsenoside Rh2 -Glc -H -H C36H62O8 
Ginsenoside Rk1 -Glc2-Glc -OH - C42H70O12 (B) 
Ginsenoside Rk3 -H -O-Glc - C36H60O8 
 
Figure 5.1 Chemical structures of saponins analyzed. The saponins in bold are 
characteristic for steamed P. notoginseng samples. Abbreviations: Ara(f), 





Table 5.1 Different PLE methods investigated for the extraction of raw P. notoginseng. 
Extraction parameters
Solvent No. 
MeOH (%) H2O (%)
Temperature (oC) Static time (min) Static cycle(s)
1 100 0 50 10 1 
2 100 0 50 10 2 
3 100 0 100 10 1 
4 100 0 100 10 2 
5 100 0 150 10 1 
6 100 0 150 10 2 
7 100 0 200 10 1 
8 100 0 200 10 2 
9 80 20 50 10 1 
10 80 20 50 10 2 
11 80 20 100 10 1 
12 80 20 100 10 2 
13 80 20 150 10 1 
14 80 20 150 10 2 
15 80 20 200 10 1 
16 80 20 200 10 2 
17 50 50 50 10 1 
18 50 50 50 10 2 
19 50 50 100 10 1 
20 50 50 100 10 2 
21 50 50 150 10 1 
22 50 50 150 10 2 
23 50 50 200 10 1 
24 50 50 200 10 2 
25 20 80 50 10 1 
26 20 80 50 10 2 
27 20 80 100 10 1 
28 20 80 100 10 2 
29 20 80 150 10 1 
30 20 80 150 10 2 
31 20 80 200 10 1 
32 20 80 200 10 2 
 
5.1.3.4 LC-LTQ-Orbitrap XL FT MS 
LC-LTQ-Orbitrap XL FT MS from Thermo Fisher Scientific (Bremen, Germany) 
was used for the metabolite profiling. Chromatographic separations were carried out 
using an HPLC system (Thermo Scientific Accela; Thermo Fisher Scientific, San Jose, 
CA, USA) equipped with a Hypersil Gold reversed-phase C18 analytical column (150 × 
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2.1 mm i.d., particle size: 3 µm) from Thermo Fisher Scientific (Newington, New 
Hampshire, USA). The temperature of the column oven was maintained at 30 oC. The 
mobile phases used were (A) water with 0.1% (v/v) formic acid and (B) acetonitrile 
with 0.1% (v/v) formic acid. The gradient elution profiles were: 0-8 min, (B) 10-30%; 
8-24 min, (B) 30-50%; 24-28 min, (B) 50-90%; 28-30 min, (B) 90%; 30-31 min, (B) 
90-10%. The total flow rate of the mobile phases was 250 µl/min. The injection volume 
was 3 µl. System control, data acquisition and processing were performed using 
XcaliburTM (Version 2.0.7) from Thermo Fisher Scientific (San Jose, CA, USA). 
Mass spectra were acquired in positive ion mode with electrospray ionization 
(ESI) as the ion source. The mass range was selected as 300-1500 Da. Other parameters 
of FT MS were shown in Table 5.2. The Orbitrap mass analyzer was calibrated weekly 
according to the manufacturer’s directions using FT MS calibration solution containing 
caffeine, reserpine, MRFA peptide and Ultramark® 1621. Mass accuracy was checked 
daily by running a standard mixture containing ginsenosides Rb1, Rc, Rd, Rg1 and 20S-
Rg3 and calculating their mass errors. The maximum acceptable mass error was set as 5 
ppm. Data were centroided during acquisition to ensure mass accuracy and consistence. 
Peak integration was performed using XcaliburTM software (Thermo Fisher Scientific, 
San Jose, CA, USA) by setting baseline window, area noise factor and peak noise factor 
at 50, 7 and 10 respectively. 
 
Table 5.2 FT MS parameters for LC-LTQ-Orbitrap XL FT MS. 
FT MS parameters Value 
Resolution 30000 
Data type centroid 
Spray voltage 3.00 kV 
Sheath gas flow rate 60.00 arbitary units 
Auxiliary gas flow rate 10.00 arbitary units 
Capillary voltage 46.00 V 
Capillary temperature 250.00 oC 
Tube lens 230.00 V 
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5.1.3.5 Method validation 
The mixed standard working solutions at each concentration were injected in 
triplicate. The calibration curves were constructed by plotting the peak areas of the 
reference standards against the corresponding concentration. The LOD and LOQ of 
LTQ-Orbitrap XL FT MS detection were determined and calculated as the analyte 
concentrations with signal/noise ratios of 3 and 10, respectively. The instrument 
precision (repeatability) was obtained by analyzing the peak area variations of nine 
injections of ginsenoside Rg1 standard solutions at three concentration levels (three 
replicates each level). 
The intra-day and inter-day variations (intermediate precision) were evaluated 
by three replicate measurements of the mixed standard solutions of eight studied 
compounds in a single day and on three different days, respectively. The recoveries of 
ginsenosides were determined by the standard addition method. Mixed standard 
solutions of notoginsenoside R1 and ginsenosides Rg1, Rb1, Rd at three different 
concentrations were added into a PLE extract of raw P. notoginseng diluted 100 times 
and was then analyzed in triplicate. The unspiked sample solution was concurrently 
analyzed. 
System suitability tests were carried out daily before and after sample analysis. 
The retention times, peak area and tailing factor were compared between different 
injections of a standard mixture containing ginsenosides Rb1, Rc, Rd, Rg1 and 20S-
Rg3. The retention time shift between tested samples should not be more than 0.3 min. 
The R.S.D. of the peak area should be within ± 10%. The tailing factor is defined as the 
distance from the front slope of the peak to the back slope divided by twice the distance 
from the center line of the peak to the front slope, with all measurements made at 5% of 
the maximum peak height. The maximum acceptable peak tailing factor was set as 2. 
  114 
5.1.3.6 Data pre-processing 
All raw chromatogram data were pre-processed for baseline correction, noise 
elimination and peak alignment using metAlignTM software (http://www.metalign.nl) 
(Lommen, 2009). Fig. 5.2 shows the interface of metAlign software which can be 
divided into three parts: part A is for program configuration, data set selection and 
baseline correction, part B is for scaling and aligning data sets, and part C is for peak 
selection and export to MS software format for visualization. Only parts A and B were 
used for peak alignment in this study. The settings of the parameters for parts A and B 
were optimized according to a total ion chromatogram (TIC) of a raw P. notoginseng 




Figure 5.2 Typical interface of metAlignTM software; Parameters shown in each option 




For baseline correction, maximum amplitude was set at 3 × e6. Peak slope factor 
(× noise), peak threshold factor (× noise), peak threshold (Abs. value) and average peak 
width at half height (scans) were set at 1.0, 2.0, 15 and 8 respectively. For peak 
alignment, maximum retention time shift (Max. Shift) was set at 30 scans for every TIC. 
Iterative mode was chosen for the alignment. The parameter “Min. factor (× Noise)” for 
the first and last iterations, which determine how large a mass peak has to be (× Noise) 
for it to be included in the calculation of the chromatography shift profile, were set at 3 
and 2, respectively. Likewise, “Minimum Number of Masses” is another restriction 
parameter and it determines the minimum number of mass peaks which are to be 
averaged to determine reference points for chromatography shift profile. The first and 
last iterations of “Minimum Number of Masses” were set at 4 and 3, respectively. 
During peak alignment, the peak list of the first data set was taken as an 
arbitrary reference list to which the other peak lists are aligned. All pre-processed data 
were exported to Xcalibur (Thermo Fisher Scientific) format after baseline correction, 
noise elimination and peak-picking steps. All mass peaks per data set were then aligned 
using landmark-dependent alignment algorithms to correct for local chromatographic 
drifts. No specific mass or peak was excluded. A list of the intensities of the peaks 
detected was generated using retention time and mass over charge ratio (m/z) data pairs. 
An arbitrary ID was assigned to each of these data pairs in the order of their elution 
time. Ions of different samples were considered to be the same ion when they 
demonstrated the same retention time (tolerance of 30 mass scans) and m/z value. If a 
peak was not detected in the sample, the ion intensity was documented as zero in the 
final data table. The resulting data table comprising of sample name (observation), 
retention time-m/z data pair number (variable) and ion intensity was exported for the 
following multivariate data analysis by using “Multivariate Compatiable Output” option. 
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5.1.3.7 Multivariate data analysis 
The resulting aligned data set was loaded into the SIMCA P+ software version 
12.0 (Umetrics, Umeå, Sweden) for multivariate data analysis. The data set was mean 
centered (Ctr) and Pareto scaled (Par) before analysis. Principal component analysis 
(PCA) was used to visualize general clustering, trends and outliers among the 
observations. Further classification of the observations was carried out using partial 
least square-discriminant analysis (PLS-DA), which is similar to PCA, but in 
combination with a discriminant analysis. The PLS-DA model was developed by 
leaving 1/7th observations out in each round’s analysis for cross validation. 
 
5.1.4 Results and discussion 
5.1.4.1 LC method development 
The chromatographic conditions of LC-LTQ-Orbitrap XL FT MS were 
optimized using ginsenoside standards and a raw P. notoginseng sample extract. The 
flow rate of every LC-MS system is a key factor affecting sample separation and mass 
resolution. The dilemma in setting flow rate is that higher flow rate could provide better 
separation for LC, while higher flow rate could also cause ion suppression in ion source 
which significantly reduces analytical sensitivity. Considering MS sensitivity, resolution 
and LC separation together, the optimised flow rate of this study was 250 µl/min. 
In addition, because of the high sensitivity of Orbitrap XL FT MS system, 
mobile phase water obtained from normal ultra-pure water system (i.e. Milli-Q water) 
still brought high background noise which was unfavorable for non-targeted total ion 
metabolite profiling. High background noise was alleviated after the commercial high 
purity water from Honeywell, Burdick & Jackson® was used. Different concentrations 
of formic acid (0.05% and 0.1%) in the mobile phases were tested in which similar 
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results were acquired but 0.1% formic acid resulted in slightly greater peak signal. The 
gradient elution profiles were optimized to achieve better chromatographic separation. 
Although almost all the ginsenosides studied here had a retention time beyond 9 min, 
the first 8 min was important for the improvement of separation. Shortening the first 8 
min as well as starting from a higher ratio of organic phase were tested. It affected peak 
separation and reduced the peak resolution. Co-elution of ginsenosides Rg1 and Re was 
a common problem in the separation of P. notoginseng sample. It can be solved by 
extending chromatographic running time. A 80 minute HPLC run method was 
developed by our group previously and it separated ginsenosides Rg1 and Re 
successfully (Lau et al., 2003). Due to the large amount of samples, the 
chromatographic running time was reduced to 31 min, causing the ginsenosides Rg1 
and Re to co-elute at around 10 min. This is acceptable because the molecular masses of 
ginsenosides Rg1 and Re are different and can be extracted out separately using the 
selective ion extraction function. 
 
5.1.4.2 LTQ-Orbitrap XL FT MS optimization 
ESI was used as the ion source. Both positive and negative ion mode were tested. 
Comparing with negative ion mode, positive ion mode provided relatively higher mass 
signal and resolution, which was important for non-targeted metabolite profiling. 
Therefore, the positive ESI mode was employed. LTQ-Orbitrap XL FT MS parameters 
were optimized based on ginsenoside Rg1 standard. Therefore, the optimized MS 
parameters had a relatively good sensitivity for both low and high mass ions. Saponins 
were identified by comparing the retention time and accurate mass of the extracted ion 
peak with those of potential standards. [M + Na]+ was used as the target ion since it 
generally showed greater abundance and constancy comparing to [M + H]+ and [M + 
K]+. The MS and MS2 of 12 studied saponins were shown in Table 5.3. 
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MS2 fragment ions 
(m/z) 
1 Notoginsenoside R1 933.54232 933.53998 1.887 955.52106 971.49042 
915.52954 [M+H-H2O]+, 801.49774 
[M+H-Xyl]+, 753.47656 [M+H-Glc-




2 Ginsenoside Rb1 1109.61081 1109.60901 1.086 1131.58997 1147.55725 
1091.59839 [M+H-H2O]+, 947.5591 
[M+H-Glc]+, 929.54572 [M+H-Glc-
H2O]+, 785.50323 [M+H-GlcGlc]+, 
767.49292 [M+H-GlcGlc-H2O]+, 
749.48218 [M+H-GlcGlc-2H2O]+ 
3 Ginsenoside Rc 1079.60023 1079.59888 0.714 1101.58008 1117.54980 
1061.58875 [M+H-H2O]+, 947.55627 
[M+H-Ara]+, 929.54572 [M+H-Ara-







4 Ginsenoside Rd 947.55792 947.55688 0.540 969.53845 985.50696 
929.54669 [M+H-H2O]+, 767.49347 
[M+H-Glc-H2O]+, 749.48285 [M+H-Glc-





5 Ginsenoside Re 947.55739 947.55634 -1.110 969.53772 985.51135 
929.54608 [M+H-H2O]+, 767.49310 
[M+H-Glc-H2O]+, 749.48242 [M+H-Glc-






6 Ginsenoside Rg1 801.50014 801.49792 1.950 823.47876 839.45251 




3H2O]+, 405.35019 [M+H-GlcGlc-4H2O]+ 
7 Ginsenoside 20S-Rg3 785.50511 785.50311 1.857 807.48474 823.45221 
767.49249 [M+H-H2O]+, 749.48187 
[M+H-2H2O]+, 587.42938 [M+H-Glc-





8 Ginsenosides 20S-Rh1 639.44666 639.44592 -1.157 661.42749 677.40167 
621.43524 [M+H-H20]+, 603.42487 
[M+H-2H20]+, 441.37195 [M+H-Glc-
2H20]+, 423.36157 [M+H-Glc-3H20]+, 
405.35114 [M+H-Glc-4H20]+ 
9 Ginsenosides 20R-Rh1 639.44666 639.44586 -1.251 661.42767 677.40198 
621.43549 [M+H-H20]+, 603.42511 
[M+H-2H20]+, 441.37213 [M+H-Glc-
2H20]+, 423.36176 [M+H-Glc-3H20]+, 
405.35129 [M+H-Glc-4H20]+ 
10 Ginsenoside Rh2 623.45175 623.45197 0.360 645.43298 661.40717 
605.44031 [M+H-H20]+, 587.43018 
[M+H-2H20]+, 443.38803 [M+H-Glc-
H20]+, 425.37729 [M+H-Glc-2H20]+, 
407.36691 [M+H-Glc-3H20]+ 
11 Ginsenoside Rk1 767.49400 767.49341 -0.774 789.47504 805.44836 
749.48260 [M+H-H20]+, 605.44043 
[M+H-Glc]+, 569.41937 [M+H- Glc-
2H20]+, 443.38757 [M+H- GlcGlc]+, 
425.37711 [M+H- GlcGlc-H20]+ 
12 Ginsenoside Rk3 621.43610 621.43451 -2.551 643.41628 659.39069 
603.42401 [M+H-H20]+, 585.41351 
[M+H-2H20]+, 441.37137 [M+H-Glc-





5.1.4.3 LC-LTQ-Orbitrap XL FT MS method validation 
Calibration curves of peak area (y) vs concentration (x) of the twelve saponin 
standards were constructed as shown in Table 5.4. Good linearity (R2 > 0.99) was 
obtained for all calibration curves within the ideal concentration range. The LOD and 
LOQ of each analytes ranged from 8.3 to 30.1 ng/ml and from 23.1 to 100.1 ng/ml, 
respectively (Table 5.4). These values are lower than previously reported values (Dan et 
al., 2009). This may be because of a more concentrated acidic medium used in this 
study which lowered the pH to protonate the analytes and improved ionization. 
The instrument precision was assessed using three consecutive injections of 
ginsenoside Rg1 standard solutions at three concentrations. The resulting R.S.D.s of the 
peak areas were from 0.7% to 1.3%. The intra-day and inter-day variations were 
evaluated using the mixed standard solutions of the eight studied saponins. The results 
were shown in Table 5.4.  
The accuracy of the method was studied by calculating the recoveries of the four 
analyzed ginsenosides after spiking them into P. notoginseng sample. They were chosen 
based their availability. Each analyte’s peak in the total ion chromatogram (TIC) was 
extracted out based on their respective [M + Na]+ before peak integration. The 
recoveries of the four ginsenosides ranged from 96.1 to 105.2% and were shown in 
Table 5.5. The system suitability tests had shown that the R.S.D.s of the peak areas, the 





Table 5.4 Linear regression and precision data for 12 saponins in P. notoginseng. 
Linear regression data Precision R.S.D. (%)b 
No. Saponins Retention  time (min) Calibration curvea R2 Linear range (ng/ml) LOD (ng/ml) LOQ (ng/ml) Intra-day(n = 3) 
Inter-day 
(n = 3) 
1 R1 9.5 y = 912.9x + 10211 0.9990 101.0 – 5050.0 29.5 98.3 0.77 2.32 
2 Rb1 14.8 y = 2627.4x + 20369 0.9995 50.9 – 5087.5 9.1 30.3 1.89 3.04 
3 Rc 15.9 y = 3070.2x + 29007 0.9994 50.5 – 5050.0 6.9 23.1 1.37 2.44 
4 Rd 17.7 y = 1407.1x + 15739 0.9986 100.8 – 5037.5 17.9 59.9 1.03 1.79 
5 Re 10.2 y = 657.9x - 7840.2 0.9997 98.3 – 983.0 30.1 98.3 1.24 1.88 
6 Rg1 10.0 y = 1086.4x + 24446 0.9990 101.2 – 5062.5 20.9 69.5 0.71 1.36 
7 20S-Rg3 26.0 y = 595.5x - 492.46 0.9994 100.0 – 5000.0 28.5 94.9 1.93 2.62 
8 20S-Rh1 15.9 y = 844.0x + 206703 0.9953 13.2 – 13170.0 5.9 13.2 1.55 2.14 
9 20R-Rh1 16.4 y = 1799.3x - 692.05 0.9992 12.5 – 1250.0 7.3 12.5 1.39 2.18 
10 Rh2 29.3 y = 2724.3x + 36948 0.9991 115.5 – 1155.0 5.9 11.6 0.89 1.55 
11 Rk1 28.9 y = 190.7x + 3158.1 0.9992 19.7 – 9830.0 9.8 19.7 1.07 1.73 
12 Rk3 23.5 y = 228.2x - 549.04 0.9995 49.2 – 9830.0 19.7 49.2 1.14 1.82 
 
a y = peak area; x = concentration of respective saponin (ng/ml) 









Recovery (%)a R.S.D.(%)b 
101.0 100.07 ± 1.48 1.48 
202.0 98.10 ± 1.44 1.47 Notoginsenoside R1 
404.0 103.51 ± 2.41 2.33 
101.3 99.62 ± 3.33 3.34 
202.5 101.96 ± 2.44 2.40 Ginsenoside Rg1 
405.0 101.67 ± 1.67 1.64 
101.8 102.60 ± 2.32 2.26 
203.5 101.33 ± 2.74 2.71 Ginsenoside Rb1 
407.0 102.47 ± 2.66 2.60 
100.8 96.71 ± 2.21 2.29 
201.5 101.97 ± 3.38 3.31 Ginsenoside Rd 
403.0 98.41 ± 2.34 2.38 
 
a All values are mean ± S.D. obtained by triplicate analyses 
b R.S.D. (%) = (S.D./mean) × 100% 
 
5.1.4.4 Data pre-processing 
Raw data from LTQ-Orbitrap XL FT MS system were applied to metAlign 
software. MetAlign performs data smoothing, local noise calculation, baseline 
correction, data reduction (binning) and subsequently alignment of large size LC-MS 
raw data sets (Keurentjes et al., 2006). The aligned data, which is a matrix of peak 
intensity data derived from a chromatographic peak of a component commonly 
observed among the samples (eluted at similar retention times with identical mass 
values), could be exported as “.csv” files and applied for further multivariate data 
analysis. Fig. 5.3 showed an example of the metAlign pre-processed TIC (B) compared 




Figure 5.3 Typical (A) original and (B) pre-processed TICs of the extract of P. 
notoginseng sample. Note the reduced noise and increased resolution in 





5.1.4.5 PLE condition development 
In a PLE procedure, extraction conditions, including extraction solvent, 
temperature, time and static cycle, are important parameters controlling extraction yield. 
The ideal PLE method should have highest extraction efficiency and yield, while at the 
same time, should not affect the chemical constituents being extracted. In order to 
develop and optimize a PLE method for the extraction of P. notoginseng samples as 
well as samples of adaptogenic botanicals in the following study, different parameters 
of PLE, including extraction solvents, extraction temperature and static extraction time, 
were compared using both univariate and multivariate data analysis approaches. In the 
univariate data analyses, relative extraction ratio of notoginsenoside R1, ginsenosides 
Rb1 and Rd were used as extraction performance indicators because these three 
saponins are the main components of raw P. notoginseng. In the multivariate data 
analysis, PCA and PLS-DA would be carried out to further prove differences caused by 
high PLE extraction temperature and help to select the suitable PLE method for the 
following study. 
A Dionex ASE 200 system (Dionex Corp., Sunnyvale, CA, USA) was used for 
PLE in this study. One problem encountered with the ASE 200 system was that the P. 
notoginseng samples had a tendency to absorb water during the extraction process. 
When less than 20% (v/v) aqueous methanol was used as the extraction solvent, 
blockage of the ASE 200 system occurred. As a result, the lowest concentration of 
aqueous methanol used is 20% (v/v). Four solvents containing different ratios of 
methanol and water were compared. Since the extraction temperature is known to 
strongly affect the extraction efficiency, four temperatures, from relatively low (50 oC) 
to high (200 oC), were used for comparison. Although different solvent system and 
different static cycles had been used to evaluate the effects of extraction temperature, a 
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fixed PLE extraction condition was chosen for comparing the effects of temperature. In 
this study, 80% (v/v) aqueous methanol as the extraction solvent, 10 min of static 
extraction time and one static cycle were selected. Six replicates were carried out at 
each temperature level and each extract was processed according to the procedure 
introduced in Section 5.1.3.3. Non-targeted metabolite profiling was then carried out by 
injecting each extract into the LC-LTQ-Orbitrap XL FT MS system. The average peak 
areas of the six replicated extracts of each extraction temperature were recorded from 
respective TICs and used for comparing the extraction yields. The average peak area of 
the samples extracted at 50 oC was set as 1 and the average peak areas of the samples 
extracted at the other three temperatures were calculated accordingly. The resulting 
relative extraction ratios of notoginsenoside R1, ginsenosides Rb1 and Rd at different 
temperatures were shown in Fig. 5.4.  
 
Figure 5.4 Effects of extraction temperature on extraction yields of three saponins 
(notoginsenoside R1, ginsenosides Rb1 and Rd). 
 
The extraction yields of these three saponins were highest when the extraction 
temperature was 100 oC and decreased when the extraction temperature was increased 
to 150 oC, but remained constant when the extraction temperature was further increased 
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to 200 oC. The decrease of the extraction yields was possibly due to the degradation of 
the three saponins at temperatures more than 100 oC. When the temperature was further 
increased from 150 oC to 200 oC, it may be possible that most of these ginsenosides 
have been denatured and hence the extraction yield appeared to plateau. 
The extraction yields of ginsensoides in raw P. notoginseng sample were also 
affected by extraction solvents. Four extraction solvents containing different ratio of 
aqueous methanol (20%, 50%, 80%, 100% methanol, v/v) were compared with the 
following ASE conditions: 100 oC of extraction temperature, 10 min static extraction 
time with one static cycle. Six replicates were carried out for each extraction solvent 
and each extract was processed according to the procedure stated in Section 5.1.3.3. The 
average peak areas of six replicated extracts of each extraction solvent were recorded 
from respective TICs and used for comparing the extraction yields. The average peak 
area of the samples extracted with 100% methanol was set as 1 and the average peak 
area of the samples extracted with the other three concentrations of methanol was 
calculated accordingly. The resulting relative extraction ratios of notoginsenoside R1, 
ginsenosides Rb1 and Rd were shown in Fig. 5.5.  
 
Figure 5.5 Effects of extraction solvent (different ratio of aqueous methanol) on the 
extraction efficiency of three saponins (R1, Rb1 and Rd). 
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The extraction yields of these three saponins increased with increasing methanol 
concentration to 80% (v/v) in the solvent system. When the methanol concentration was 
further increased to 100%, the extraction yields decreased. 
In addition, the effect of extraction time was determined by comparing different 
static extraction cycles (specifically, 1 and 2) when the other ASE conditions were the 
same. 80% aqueous methanol as the extraction solvent, 100 oC as the extraction 
temperature and 10 min as one static extraction cycle were selected for the comparison. 
Six replicates were carried out for each static extraction cycle(s). The average 
concentration (peak area) extracted out by one static extraction cycle was set as 100%. 
The average concentration extracted out by two static extraction cycles was calculated 
accordingly. As shown in Table 5.6, comparing with one static extraction cycle, one 
more static extraction cycle would slightly increase the extraction amount of 
ginsenosides inside P. notoginseng. However, with higher extraction efficiency, one 
static extraction cycle was recommended when the static time was set as 10 min. The 
repeatability of the extraction procedure was also determined. The standard deviations 
of the concentrations extracted out by both one and two static extraction cycles were 
within 2.1%. 
 
Table 5.6 Effect of number of static extraction cycle(s) on extraction efficiencies of 
notoginsenoside R1, ginsenosides Rb1 and Rd in P. notoginseng. 
 
Extraction efficiencies (%)* Static extraction cycle 
Notoginsenoside R1 Ginsenoside Rb1 Ginsenoside Rd
1 100 ± 1.86 100 ± 1.10 100 ± 1.56 
2 106.64 ± 2.07 108.33 ± 0.78 114.65 ± 1.18 
 
*: The average concentration extracted out by one static extraction cycle was set as 





5.1.4.6 Multivariate data analysis 
Visual inspection of the TICs of raw P. notoginseng extracted with different 
extraction temperatures revealed that several new chemical components formed at high 
extraction temperature. An example was shown in Fig. 5.6 in which four raw P. 
notoginseng samples were extracted with 50% (v/v) aqueous methanol and with 50, 100, 
150 and 200 oC as the extraction temperature respectively. 
 
 
Figure 5.6 Typical TICs of raw P. notoginseng samples extracted using a Dionex ASE 
200 system at (A) 50 oC, (B) 100 oC, (C) 150 oC and (D) 200 oC. 
  130 
PCA, an unsupervised method for pattern recognition, was performed for 
preliminary inspection of general clustering, trends and outliers among raw datas of the 
P. notoginseng samples extracted under different temperatures. After Pareto scaling (Par) 
with mean-centering, a two component PCA model was built. The PCA score scatter 
plot could be divided into three clusters: P. notoginseng extracted at 50 and 100 oC, P. 
notoginseng extracted at 150 oC and P. notoginseng extracted at 200 oC. However, this 
model was not robust enough because it only cumulatively accounted for 23.5% of 
variation among raw P. notoginseng samples. This is largely because of the background 
noise information. In order to build a more robust model, PLS-DA was applied to the 
same data set using Pareto scaling and mean-centering. A two component PLS-DA 









As shown in Fig. 5.7, the score plot of the PLS-DA model could now be readily 
divided into four clusters. It indicated that raw P. notoginseng samples extracted at 
different extraction temperatures varied between each other. Raw P. notoginseng 
extracted at 150 oC and the other three temperatures were clearly separated by the 
principal component 2 (PC2). Raw P. notoginseng extracted at 200 oC was distributed in 
the third quadrant. It can be separated with raw P. notoginseng extracted at 50 and 100 
oC by principal component 1 (PC1). It is reasonable that the samples extracted at 50 oC 
and 100 oC located near to each other in the score plot because of the relative short 
extraction time. Future research need to clarify whether the difference between these 
two temperature groups will be enlarged when the static extraction time is longer and 
also whether there is difference between the samples extracted at 50 oC and room 
temperature. 
 
5.1.4.7 Tentative marker ions identification 
The identification of the variables which caused differences among groups is 
important for marker ions discovery. A list of potential marker ions was obtained by 
analyzing the combination of score and loading plot of the developed PLS-DA model. 
The accurate mass in terms of [M + Na]+, mass accuracy, double bond equivalent (DBE) 
and empirical formula of these potential marker ions were generated using Xcalibur 
software. In total, fifteen saponins were identified from raw P. notoginseng sample 
extracted at 200 oC (Fig. 5.8). This result was consistent with our group’s previous 
report about the marker ions identified from steamed P. notoginseng sample (Chan et al., 
2007). Thus, the temperature of the PLE procedure was critical for the extraction of P. 
notoginseng. The extraction temperature not only affected the amount of saponins 




Figure 5.8 A typical TIC of a P. notoginseng sample extracted at 200 oC with 50% aqueous methanol as the extraction solvent and 10 min static 
extraction time. Fifteen ions were identified as labelled. 
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When the extraction temperature was set to 150 oC or even higher, the PLE 
extraction process could also be deemed as a steaming process which caused the 
formation of new ginsenosides, such as Rk1, Rk3, Rh4, 20S/20R-Rg3 and Rg5 and the 
degradation of some ginsenosides, such as Rg1, Rb1 and Rd. Further studies need to be 
carried out to correlate the changes of these chemical constituents with the bioactivities 
of these samples. The extraction conditions of 80% (v/v) aqueous methanol, 10 min 
static extraction time and 100 oC were recommended for the extraction of raw P. 
notoginseng using PLE. 
 
5.1.5 Conclusion 
A LC-LTQ-Orbitrap XL FT MS method was developed, optimized and validated 
in this study. The optimal PLE conditions were found to be 80% aqueous methanol as 
the extraction solvent, 100 oC as the extraction temperature and with 10 min static 
extraction time. This study provided a platform for metabolomic investigations of 
botanicals using Orbitrap XL FT MS. 
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5.2 Application of LC-LTQ-Orbitrap XL FT MS for non-targeted 
metabolomic investigation of selected herbs 
5.2.1 Introduction 
As introduced in Section 1.3.1, botanicals that enhance physical performance, 
promotes vitality and increases resistance to stress and ageing are considered to be 
adaptogenic. Adaptogenic botanicals, including P. ginseng, P. quinquefolium, E. 
senticosus, G. pentaphyllum and R. rosea, are well-known botanical medicine and are 
increasingly used globally. For example, G. pentaphyllum is sold in both Asia and 
Europe in the form of herbal tea which is “advantageous to one’s health and beauty” 
(Cui et al., 1999) and is frequently used as substitute for P. ginseng because of its 
relatively cheap price and easy availability. However, in order to earn more profit, some 
manufacturers intentionally use raw botanical materials with poor quality or even with 
wrong raw materials. The quality control of these botanicals as well as their derived 
commercial products is of great importance. 
Metabolomic investigations using chromatographic fingerprinting coupled with 
multivariate data analysis could serve as a suitable and reliable analytical platform for 
the quality assessment of these adaptogenic botanicals. In Section 5.1, a LC-LTQ-
Orbitrap XL FT MS method was developed to analyze raw P. notoginseng samples 
extracted under different PLE conditions through both univariate and multiviate data 
analysis approaches. In this section, the developed PLE method was used for the 
extraction of selected herbs. Chromatographic fingerprinting using LC-LTQ-Orbitrap 
XL FT MS coupled with multivariate data analysis was then applied for the quality 
assessment of these selected herbal samples bought from traditional medical shops in 
Singapore and China. The PLS-DA model developed in this study was cross-validated 
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and successfully used to predict commercial botanical products. In addition, twelve 
marker saponins presented in raw and steamed P. notoginseng were quantified. 
 
5.2.2 Objective 
The objective of this study is to assess the quality of five commonly used 
adaptogenic botanicals as well as raw and steamed P. notoginseng using metabolomic 
analysis platform developed. 
 
5.2.3 Experimental 
5.2.3.1 Chemicals and materials 
Methanol (HPLC grade) and acetonitrile were supplied by Lab-Scan Analytical 
Sciences (Patumwan, Bangkok, Thailand). High purity water was purchased from 
Honeywell, Burdick & Jackson® (Muskegon, MI, USA). Formic acid was purchased 
from Sigma-Aldrich (Steinheim, Germany). The caffeine solution (1 mg/ml) and 
reserpine used for preparing FT MS calibration solution were ordered from Sigma-
Aldrich (St. Louis, MO, USA). L-methionyl-arginyl-phenylalanyl-alanine acetate 
peptide (MRFA) solvent used for preparing FT ms calibration solution was ordered 
from Research Plus, Inc. (Barnegat, NJ, USA). Hexakis(1H, 1H, omegaH-
perfluoroalkoxy)phosphazeae (Ultramark® 1621) used for preparing FT MS calibration 
solution was purchased from Alfa Aesar® (Karlsruhe, Germany). 
Ginsenosides Rg1, Rb1, Rc and Rd were purchased from NICPBP (Beijing, 
China). Ginsenoside Re was purchased from Indofine Chemical Company (Somerville, 
NJ, USA). Ginsenoside Rg3 was purchased from Chroma Dex Inc (Irvine, CA, USA). 
Ginsenoside Rh2 was purchased from Delta Information Center for Natural Organic 
Compounds (Anhui, China). Ginsenosides Rk1, Rk3, 20S-Rh1 and 20R-Rh1 were 
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isolated and purified from steamed P. notoginseng by Mr Dhaval Patel and used as 
laboratory standard. 
The steamed P. notoginseng was obtained by steaming the raw P. notoginseng 
powder at 120 oC using an autoclave (Hirayama, Japan) for different time periods. The 
first batch (batch 1) of the P. notoginseng powder was steamed for 1h, 2h, 4h, 6h, 9h, 
12h, 15h and 24h while the second batch (batch 2) was steamed for 2h, 9h and 24h. The 
steaming practice was carried out by Dr Toh Ding Fung. The steamed P. notoginseng 
was then dried in a vacuum oven at about 80 oC until constant weight. Raw botanical 
materials of P. notoginseng, P. ginseng (including Chinese ginseng, Chinese red ginseng 
and Korean ginseng), P. quinquefolium, E. senticosus, G. pentaphyllum and R. rosea 
were purchased from medical shops in Singapore and China (Table 5.7, refer to 
Appendix 3 for their Chinese names). The voucher specimens of these raw botanicals 
were kept in Department of Pharmacy, National University of Singapore. 
Table 5.7 Sources of raw botanical materials investigated in this study. 
Raw botanical materials Source * 
Panax notoginseng NICPBP, WYN,WS, EYS, SC 
Chinese white ginseng NICPBP, WYN, BB, MT, SC 
Chinese red ginseng WYN, JL, SC, TYS, MT Panax ginseng 
Korean ginseng WYN, EYS, BB, TS 
Panax quinquefolium NICPBP, WYN, SC, TYS 
Eleutherococcus senticosus WYN 
Gynostemma pentaphyllum WYN 
Rhodiola rosea WYN 
 
*:  BB : Bee’s Brand birds nest & health products Pte Ltd. (64-66 Smith Street, 
Singapore); 
EYS : Eu Yan Sang Pte Ltd. (21 Ubi Road I, Singapore); 
JL : Jilin province (China); 
MT : Ming Tai medical shop (Blk 34, Upper Cross Street, #01-150, 
Singapore); 
NICPBP : National Institute for the Control of Pharmaceutical and Biological 
Product (Beijing, China); 
SC : Sinchong Traditional Chinese Medicine (50 Temple Street, Singapore); 
TS : Thye Shan Medical Hall Pte Ltd. (201 New Bridge Road, Singapore); 
TYS : Teck Soon Medical Hall Pte Ltd. (No. 281 South Bridge Road, 
Singapore); 
WS : Wenshan (Yunnan province, China); 
WYN : Wong Yiu Nam Medical Hall Pte Ltd. (51 Temple Street, Singapore). 
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Commercial raw and steamed P. notoginseng products were purchased locally. 
Commercial Korean ginseng products were purchased in Korea. The detailed 
information for the investigated commercial products was shown in Table 5.8. The 
authentic samples of raw P. notoginseng, P. ginseng, Chinese red ginseng and P. 
quinquefolium obtained from NICPBP (Beijing, China) were used as the reference 
botanicals. 
 
Table 5.8 The detailed information of commercial botanical derived products 
investigated in this study. 
 
Code Product name Brand Dosage form Labeled ingredients Manufacturer 




Co., LTD (Yuxi, Yunan, 
China) 




Co., LTD (Yuxi, Yunan, 
China) 




Co., LTD (Yuxi, Yunan, 
China) 
2S Tienchi Tablets (Steamed) Camelia Tablet 
Radix Notoginseng 
Preparata 0.5 g 
Weihe Pharmaceutical 
Co., LTD (Yuxi, Yunan, 
China) 




Co., LTD (Yuxi, Yunan, 
China) 




Co., LTD (Yuxi, Yunan, 
China) 
4R Tienchi Tablets (Raw) Yunfeng Tablet 
Radix Notoginseng 
0.5 g 
Yunnan Baiyao Group 
Co., Ltd (Yunnan, China)




Yunnan Baiyao Group 








ginseng roots  
250 mg 
Korea ginseng MFG. 
CO. LTD. (Seoul, Korea)
6 Korean red ginseng capsule HST Capsule
100% pure Korean 






5.2.3.2 Standard preparation 
Stock solutions of notoginsenoside R1, ginsenosides Rb1, Rc, Rd, Re, Rg1, 
20S-Rg3, 20S/20R-Rh1, Rh2, Rk1 and Rk3 were prepared as described in Section 
5.1.3.2. Stock solutions were stored at 4 oC. Working solutions were diluted from stock 
solution with 80% (v/v) aqueous methanol in different times. 
 
5.2.3.3 Sample extraction and preparation 
Sample extraction for LC-LTQ-Orbitrap XL FT MS analysis was carried out 
using PLE with the condition stated in Section 5.1.4.5. Six individual extractions were 
performed on each raw botanical material. The extracts of all samples were then 
prepared using the same procedure as reported in Section 5.1.3.3 before injection into 
LC-LTQ-Orbitrap XL FT MS system. 
 
5.2.3.4 LC-LTQ-Orbitrap XL FT MS 
All samples were analyzed using a LC-LTQ-Orbitrap XL FT MS system from 
Thermo Fisher Scientific (Bremen, Germany). The optimized and validated method in 
Section 5.1 was used for the non-targeted metabolite profiling. 
 
5.2.3.5 System suitability tests 
System suitability tests were carried out daily before and after sample analysis. 
The retention times, peak area and tailing factor were compared between different 
injections of a standard mixture containing ginsenosides Rb1, Rd, Rg1, 20S-Rh1, 20R-





5.2.3.6 Data pre-processing 
All raw chromatographic data were pre-processed for baseline correction, noise 
elimination and peak alignment using metAlignTM software (http://www.metalign.nl) 
(Lommen, 2009). The parameters for baseline correction and peak alignment were the 
same as described in Section 5.1.3.6. The resulting data set comprising of sample name 
(observation), retention time-m/z data pair number (variable) and ion intensity was 
exported for the following multivariate data analysis. 
 
5.2.3.7 Multivariate data analyses 
The resulting aligned data set was loaded into the SIMCA P+ software version 
12.0 (Umetrics, Umeå, Sweden) for multivariate data analysis. The data set was mean 
centered and pareto scaled before analysis. PCA was used to visualize general 
clustering, trends and outliers among the observations. Further classification of the 
observations was carried out using PLS-DA.  
 
5.2.3.8 PLS-DA model cross-validation 
 The developed PLS-DA models were cross-validated to evaluate the robustness 
and reliability by evaluating similar samples (cross-validation set) in the PLS-DA score 
plot. The extraction and metabolite profiling processes for cross-validation set were the 
same as the model set and were described in Sections 5.1. The pre-processed data of the 
cross-validation set was incorporated into the PLS-DA model and shown in the score 
plot with additional vectors. The clustering of the cross-validation set with the model 
set in the PLS-DA score plot was used to indicate the cross-validation results.  
Specifically, the PLS-DA model used to cluster raw and steamed P. notoginseng 
was cross-validated using raw (Eu Yan Sang and Wenshan), 2h, 9h and 24h steamed 
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(Wong Yiu Nam, batch 2) P. notoginseng. The PLS-DA model used to cluster different 
Panax species was cross-validated using 2h steamed P. notoginseng (batch 2), P. 
quinquefolium (purchased from Sinchong) and Chinese white ginseng (purchased from 
Bee’s Brand). 
 
5.2.3.9 Commercial sample analysis 
Ten commercial P. notoginseng and Korean ginseng products were analyzed 
using the developed metabolomic platform. All of these ten samples were extracted 
using PLE with the condition stated in Section 5.1.4.5. Three individual extractions 
were performed on each sample. The extracts of all samples were then prepared using 
the same procedure as reported in Section 5.1.3.3. All samples were then analyzed using 
the LC-LTQ-Orbitrap XL FT MS method developed in Section 5.1. 
 
5.2.4 Results and discussion 
5.2.4.1 Raw and steamed P. notoginseng analyses 
Raw and steamed P. notoginseng samples were identified using the metabolite 
profiling coupled with multivariate data analysis approach. Fig. 5.9 shows the 
chromatograms of raw and steamed P. notoginseng extracted samples. It was clear that 
with the increase of steaming time, there was a reduction in the concentrations of 
ginsenosides in raw P. notoginseng sample while some additional ginsenosides 






Figure 5.9 Typical TICs of raw (Wong Yiu Nam) and steamed P. notoginseng extracted 
samples (1h, 2h, 4h, 6h, 9h, 12h, 15h and 24h: batch 1) obtained from LC-










Figure 5.9 (Continued) Typical TICs of raw (Wong Yiu Nam) and steamed P. 
notoginseng extracted samples (1h, 2h, 4h, 6h, 9h, 12h, 15h and 24h: 
batch 1) obtained from LC-LTQ-Orbitrap XL FT MS. 
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5.2.4.1.1 Multivariate data analysis 
The raw P. notoginseng sample purchased from Wong Yiu Nam was used to 
prepare the steamed samples. The raw P. notoginseng sample (Wong Yiu Nam) and 
differentially steamed P. notoginseng samples (batch 1) were used to build the PLS-DA 
model. The raw P. notoginseng sample purchased from NICPBP was used as the 
reference material. A six-component PLS-DA model (R2X = 0.486, R2Y = 0.737, Q2 = 
0.508) was built. The score plot of this model demonstrated three distinct clusters of the 
raw, 1h to 6h steamed and 9h to 24h steamed P. notoginseng samples (Fig. 5.10). Each 
vector represents a sample. The raw P. notoginseng samples were distributed in 
quadrant IV, the 1h to 6h steamed P. notoginseng samples were distributed in quadrant I, 
and the 9h to 24h steamed P. notoginseng samples were distributed in quadrant II and 
III. This phenomenon indicated that the metabolite profiles of raw and differentially 
steamed P. notoginseng were different. 
In addition, the vectors of the raw and steamed P. notoginseng samples shown in 
the score plot were located in a clear anticlockwise trajectory pattern with the increase 
of steaming time. This indicated that greater differences of the steamed P. notoginseng 
sample to the raw P. notoginseng sample could be caused by increasing steaming time. 
The 9h to 24h steamed P. notoginseng samples were clearly separated from the other 
samples by PC1, where the 9h to 24h steamed P. notoginseng samples were located on 
the left of the score plot, the other samples were located on the right of the score plot. 
At the same time, the 1h to 6h steamed P. notoginseng samples could be separated from 
the raw P. notoginseng samples by PC2. All of these results were consistent with the 
previous reports based on UHPLC-TOF-MS analysis and multivariate data analysis 





Figure 5.10 PLS-DA score plot of raw and steamed (1h, 2h, 4h 6h, 9h, 12h, 15h and 24h: batch 1) P. notoginseng samples. A clear classification 
of the samples into three different clusters is shown. 
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This PLS-DA model was cross-validated using the pre-processed data of 
steamed P. notoginseng samples (batch 2) together with raw P. notoginseng samples 
purchased from Eu Yan Sang and Wenshan. The PLS-DA cross-validation plot is 
shown in Fig. 5.11. To aid visualization of the cross-validation result, observations 
belonging to the model set were shown using the same legend as Fig. 5.10, while the 
cross-validation set was shown in black triangles. It was evident that the samples 
belonging to the different groups of the cross-validation set, namely the raw, 2h, 9h and 
24h steamed P. notoginseng samples, were accurately clustered near their 
corresponding groups in the model set (Fig. 5.11). The raw P. notoginseng samples 
purchased from Eu Yan Sang and Wenshan were clustered with the raw P. notoginseng 
samples in the model set. Although the exact origin of the two raw P. notoginseng 
materials was not known, the similarility between the model set and the cross-validation 
set indicated that the developed PLS-DA model can be used to help to identify 
unknown commercial P. notoginseng products. The duration of steaming could also be 
estimated. Hence, it was applied to analyze eight commercial raw and steamed P. 
notoginseng products. These eight commercial products were sold as four paired raw 
and steamed P. notoginseng products (product code: 1R, 1S to 4R, 4S). Products 1R to 
3R and 1S to 3S were manufactured by the same factory with different packaging or 
dosage forms. Products 4R and 4S were manufactured by another pharmaceutical 
company. The detailed information of these four paired commercial P. notoginseng 
products was shown in Table 5.8. By comparing the TICs of each paired commercial 
raw and steamed P. notoginseng products (Fig. 5.12), it was easy to recognize that the 
four steamed P. notoginseng samples were very similar to their respective raw products 





Figure 5.11 PLS-DA score plot of raw and steamed (1h, 2h, 4h 6h, 9h, 12h, 15h and 24h: batch 1) P. notoginseng samples with incorporated raw 
and steamed P. notoginseng samples for cross-validation. The raw P. notoginseng samples used for PLS-DA model cross-validation 
were purchased from Eu Yan Sang and Wenshan; the steamed (2h, 9h and 24h: batch 2) P. notoginseng samples used for PLS-DA 




Figure 5.12 Typical TICs of the eight commercial paired raw and steamed P. 
notoginseng products 1R to 4R and 1S to 4S. The 24 to 31 min retention 
time period was enlarged and shown in the inserts. Ginsenosides 20S-




Figure 5.12 (continued) Typical TICs of the eight commercial paired raw and steamed 
P. notoginseng products 1R to 4R and 1S to 4S. The 24 to 31 min retention 
time period was enlarged and shown in the inserts. Ginsenosides 20S-Rg3, 
Rk1 and Rg5 were identified in the steamed commercial samples. 
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Therefore, it was speculated that the conditions used in the processing of these 
commercial steamed P. notoginseng samples were mild compared to the conditions in 
our experimental steaming process. This was further explored using a PLS-DA model. 
Considering the metabolite profiles of the 9h to 24h steamed P. notoginseng samples 
were very different to those of the commercial products investigated in this study, it was 
excluded from the original developed PLS-DA model set to create a new PLS-DA 
model (A = 5, R2X = 0.419, R2Y = 0.991, Q2 = 0.709). This new PLS-DA model, which 
only contains the raw and 1h to 6h steamed P. notoginseng samples data set, could 
magnify the clustering result between raw and steamed P. notoginseng samples. 
The score plot of the new PLS-DA model is shown in Fig. 5.13. In this score 
plot, the raw P. notoginseng samples were still distributed in quadrant IV and located at 
the far right side. At the same time, instead of being distributed in quadrant I of the 
original PLS-DA model, the 1h to 6h steamed P. notoginseng samples group was 
mainly distributed in quadrant II and III except for the 1h steamed sample. The pre-
processed LC-LTQ-Orbitrap XL FT MS data sets of all these eight commercial P. 
notoginseng products were incorporated into the new PLS-DA model.  
Fig. 5.14 shows the prediction result for the eight commercial P. notoginseng 
products. The commercial samples were represented by black triangles. As expected, all 
of the eight commercial samples were distributed in quadrant IV and nearer to the raw P. 
notoginseng sample in the model set. Compared with the steamed samples, the raw 
samples in the four paired commercial products were clustered near to the raw P. 
notoginseng sample in the model set. This preliminary result reinforced our speculation 
that the four commercial steamed P. notoginseng products investigated in this study 














Figure 5.14 PLS-DA prediction plot of raw and steamed (1h, 2h, 4h and 6h: batch 1) P. notoginseng samples with commercial P. notoginseng 
products. Note that both raw and steamed commercial P. notoginseng samples were located in quadrant IV and near to the raw P. 
notoginseng sample group in the model set. Compared to the steamed commercial P. notoginseng samples, the raw commercial P. 
notoginseng samples located nearer to the raw P. notoginseng sample group in the model set. 
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Lau et al. had previously reported similar finding whereby two commercial 
steamed P. notoginseng products were found to have HPLC-DAD chromatograms 
resembling raw samples by pattern matching analysis (Lau et al., 2004). This implied 
that these paired samples were similar, although they were labelled as “raw” and 
“steamed”, suggesting a mild or insufficient steaming process of the “steamed” samples. 
 
5.2.4.1.2 Quantification of ginsenosides 
During the steaming process, the concentrations of some ginsenosides (Rg1, 
Rb1, Rc, Rd, Re and notoginsenoside R1) were reduced while the concentrations of 
some other ginsenosides (Rg3, 20S/20R-Rh1, Rh2, Rk1 and Rk3) were increased. 
Ginsenosides Rg1, Rb1, Rc, Rd, Re and notoginsenoside R1 are the major components 
present in raw P. notoginseng and ginsenosides Rg3, 20S/20R-Rh1, Rh2, Rk1 and Rk3 
are the major ginsenosides present in the steamed P. notoginseng. Ginsenosides 20S-
Rg3 and Rh2 were also reported to have anticancer activity (Kim et al., 2010b; Oh et al., 
1999). The structures of these ginsenosides have been previously shown in Fig. 5.1. 
These ginsenosides had been detected in either the raw or the steamed P. notoginseng 
sample and confirmed by comparing their retention time and accurate mass with 
respective standards. The assignment of ginsenosides Rb1, Rc, Rd, Re, Rg1, Rg3, 
20S/20R-Rh1, Rh2, Rk1, Rk3 and notoginsenoside R1 in a TIC of the 6h steamed P. 
notoginseng sample is shown in Fig. 5.15. The concentrations of ginsenosides Rb1, Rc, 
Rd, Re, Rg1, 20S-Rg3, 20S/20R-Rh1, Rh2, Rk1, Rk3 and notoginsenoside R1 present 
in raw and steamed P. notoginseng samples were quantified using the developed LC-
LTQ-Orbitrap XL FT MS method. This method had been validated for linearity, 




Figure 5.15 The assignment of 12 ginsenosides investigated in this study using a 
typical TIC of the 6h steamed P. notoginseng sample. Ginsenoside Rh2 
was identified by ion extraction and shown in insert of the chromatogram. 
 
The concentrations of these 12 saponins in each 1 g raw and different (1h, 2h, 4h, 
6h, 9h, 12h, 15h and 24h) steamed P. notoginseng sample were calculated according to 
their respective calibration curves as previously present in Table 5.4. The results were 
shown in Table 5.9. In addition, the concentrations of the 12 investigated saponins in 
raw and differentially steamed P. notoginseng samples were shown in Fig. 5.16. In 
general, the concentrations of saponins mainly present in raw P. notoginseng sample, 
namely ginsenosides Rb1, Rc, Rd, Re, Rg1 and notoginsenoside R1, were significantly 
reduced when the steaming duration was increased to 9 hours. This phenomenon is 
consistent with the multivariate data analysis result, in which the raw and differentially 
steamed P. notoginseng samples were grouped into three clusters: raw, 1h to 6h steamed 
and 9h to 24h steamed samples. When the steaming duration was further increased to 12 




Table 5.9 The concentrations of 12 saponins detected in the raw and differentially steamed P. notoginseng samples. 
Saponins investigated (mean ± S.D., mg/g of powder)* 
Sample 
R1 Rg1 Re Rb1 Rc Rd 20S-Rh1 20R-Rh1 Rh2 20S-Rg3 Rk1 Rk3 














































































































































































* n = 6 






Figure 5.16 Concentrations of the 12 investigated saponins in raw and differentially steamed P. notoginseng samples. 
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On the other hand, the concentrations of ginsenosides 20S-Rg3, 20S-Rh1, 20R-
Rh1, Rh2, Rk1 and Rk3 were increased during the steaming process and were the main 
components in steamed P. notoginseng according to chromatographic profiles of 
steamed P. notoginseng. Ginsenoside Rk1 was not detected in raw P. notoginseng 
sample and ginsenosides Rh2 was not detected in both raw and 1h to 4h steamed P. 
notoginseng samples. The result suggests that these two ginsenosides were formed 
through the steaming process. In addition, as shown in Fig. 5.16, the concentrations of 
ginsenosides 20S-Rg3, 20S-Rh1, 20R-Rh1, Rh2, Rk1 and Rk3 of the 12h or 15h 
steamed P. notoginseng samples were the highest. When the steaming duration was 
further increased to 24 hours, the concentrations of ginsenosides 20S-Rg3, 20S-Rh1, 
20R-Rh1, Rh2, Rk1 and Rk3 were decreased. This information could be used for 
developing steaming method of P. notoginseng in future research to optimize the 
production of selected ginsenosides. 
 
5.2.4.2 Different adaptogenic botanicals and P. notoginseng identification 
5.2.4.2.1 Non-targeted metabolite profiling 
P. ginseng, P. quinquefolium, E. senticosus, G. pentaphyllum and R. rosea are 
well-known adaptogenic botanicals. Table 5.10 shows the families and genera of these 
adaptogenic botanicals together with P. notoginseng. P. ginseng, P. quinquefolium and E. 
senticosus belong to the same family, Araliaceae. Although G. pentaphyllum and R. 
rosea belong to two other families, they were proved to have some extent of similar 
adaptogenic activities with botanicals from Araliaceae family (Kelly, 2001;  Hu et al., 
2010). G. pentaphyllum was even used as a cheap substitute of P. ginseng as mentioned 
in Section 5.2.1. With the consideration of structural similarities of the active 
components (mainly saponins) between P. notoginseng and the adaptogenic botanicals, 
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metabolomic approach, which combined non-targeted metabolite profiling with 
multivariate data analysis, was carried out to analyze the quality of the raw adaptogenic 
botanical materials as well as their derived products in Singapore and China. The 
detailed source information of these samples had been previously presented in Section 
5.2.3.1. The voucher specimens of these raw botanicals were kept in Department of 
Pharmacy, National University of Singapore. 
 
 
Table 5.10 List of herbs analyzed in this study. 
 
Family Genus Botanical name and common name in bracket
P. ginseng (Chinese white ginseng, Chinese red 
ginseng, Korean ginseng) 
P. notoginseng (Sanqi, Tianqi) 
Panax 
P. quinquefolium (American ginseng) 
Araliaceae 
Eleutherococcus E. senticosus (Siberian ginseng, Ci Wu Jia) 
Crassulaceae Rhodiola R. rosea (Hong Jin Tian) 
Cucurbitaceae Gynostemma G. pentaphyllum (Jiao Gu Lan) 
 
 
The non-targeted metabolite profiles of these samples were acquired using LC-
LTQ-Orbitrap XL FT MS with the method developed in Section 5.1. Typical TICs of P. 
ginseng (including: Chinese white ginseng, Chinese red ginseng and Korean ginseng), P. 
quinquefolium, E. senticosus, G. pentaphyllum, R. rosea, raw and 24h steamed P. 
notoginseng samples were shown in Fig. 5.17. The assignment of important 
components (mainly saponins) in each sample was based on the comparison of the 
retention time and accurate mass with their reference standards and previous reports 
(Apers et al., 2005; Avula et al., 2009; Christensen et al., 2006; Kao et al., 2008; Kite et 





Figure 5.17 Typical TICs of raw P. notoginseng, 24h steamed P. notoginseng, Chinese 
white ginseng, Chinese red ginseng, Korean ginseng, P. quinquefolium, E. 









Figure 5.17 (Continued) Typical TICs of raw P. notoginseng, 24h steamed P. 
notoginseng, Chinese white ginseng, Chinese red ginseng, Korean 
ginseng, P. quinquefolium, E. senticosus, G. pentaphyllum and R. rosea 




Figure 5.17 (Continued) Typical TICs of raw P. notoginseng, 24h steamed P. 
notoginseng, Chinese white ginseng, Chinese red ginseng, Korean 
ginseng, P. quinquefolium, E. senticosus, G. pentaphyllum and R. rosea 
with tentative assignments of marker compounds. 
 
Within the Araliaceae family, G. pentaphyllum was identified to contain 
gypenosides III, IV, VIII, XII and malonyl gypenosides III and VIII which are identical 
to ginsenosides Rb1, Rb3, Rd, F2 and malonyl ginsenosides Rb1 and Rd respectively 
(Cui et al., 1999). However, the concentrations of these ginsenosides varied with 
botanicals from Panax species. In addition, the chromatographic fingerprints of Chinese 
white ginseng and P. quinquefolium were similar to each other, while Chinese red 
ginseng had the similar chromatographic fingerprints as Korean ginseng. Chinese red 
ginseng and Korean ginseng are commonly processed with steaming procedure. 
Ginsenosides 20S-Rg3, 20R-Rg3, Rk1, Rg5 and Rh4, which are formed during the 
steaming process, can be identified from the chromatograms of these samples by ion 
extraction function (Fig. 5.18). Characteristic constituents of E. senticosus are the 
eleutherosides, in which the major compounds eleutheroside B and E usually serve as 
marker compounds in the identification and analysis of E. senticosus. While for R. 
rosea, it was believed that a variety of phytochemical constituents (such as the 
phenylpropanoids [e.g. rosavins]) may be responsible for its unique pharmacological 
activity. The distinct chemical constituents of these two botanicals make it relatively 





Figure 5.18 Typical examples of chromatograms of (A) Chinese red ginseng and (B) 
Korean ginseng with ginsenosides 20S/20R-Rg3, Rh4, Rk1 and Rg5 
identifed by ion extraction function as labelled. 
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5.2.4.2.2 Multivariate data analysis 
In order to further investigate these five adpatogenic botanicals together with 
raw and steamed P. notoginseng, multivariate data analysis was applied to cluster and 
differentiate these samples. In this study, these different PLS-DA models have been 
built and cross-validated. PLS-DA model (A) and (B) were built using the pre-
processed data of a typical sample of each investigated botanicals. The PLS-DA model 
(B) was cross-validated and used to predict ten commercial products. The PLS-DA 
model (C) was built using botanical samples bought from different medical shops in 
Singapore. This model is used to explore the quality of the investigated adaptogenic 
botanicals and P. notoginseng in Singapore. 
 
PLS-DA model (A) 
Samples of raw P. notoginseng, Chinese white ginseng and P. quinquefolium 
from NICPBP, 1h and 9h steamed P. notoginseng processed using raw P. notoginseng 
purchased from Wong Yiu Nam and Chinese red ginseng, Korean ginseng, E. senticosus, 
G. pentaphyllum, R. rosea purchased from Wong Yiu Nam were used to build the PLS-
DA model (A). Fig. 5.19 shows the six-component PLS-DA score plot (R2X = 0.334, 
R2Y = 0.662, Q2 = 0.517), demonstrating three distinct clusters of the samples. The 1h 
and 9h steamed P. notoginseng samples were distributed in quadrant III. The raw P. 
notoginseng, Chinese white ginseng, Chinese red ginseng, Korean ginseng and P. 
quinquefolium samples were clustered together and distributed on the right side of the 
plot (quadrant I and IV). The E. senticosus, G. pentaphyllum and R. rosea samples were 
mainly distributed in quadrant II. This phenomenon is consistent with the observation of 






Figure 5.19 PLS-DA model (A) score plot of adaptogenic botanicals together with raw and steamed P. notoginseng samples. A clear 
classification of the samples into three different clusters is shown. 
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Although also from Araliaceae family, G. pentaphyllum was not clustered with 
Panax botanicals in the score plot. The result showed that despite some common 
saponins, the chromatographic profiles of G. pentaphyllum and Panax species were 
quite different. Hence, this model can be used to distinguish E. senticosus, G. 
pentaphyllum and R. rosea from other adaptogenic botanicals as well as raw and 
steamed P. notoginseng. However, it cannot be used to differentiate botanicals within 
the Panax species. In order to explore whether PLS-DA method was able to distinguish 
between the Panax species, the data of E. senticosus, G. pentaphyllum and R. rosea was 
excluded from the original model set to create another PLS-DA model [model (B)]. 
 
PLS-DA model (B) 
PLS-DA model (B) (A = 6, R2X = 0.503, R2Y = 0.993, Q2 = 0.904) was created 
to investigate the differences among botanicals from Panax species. The score plot of 
this model was shown in Fig. 5.20. Compared with model (A), botanicals from Panax 
species were much more clearly separated in this model. The raw, 1h steamed and 9h 
steamed P. notoginseng samples were distributed on the right side of the score plot. The 
distance between the 1h steamed and 9h steamed P. notoginseng samples were also 
larger compared with the score plot of model (A). P. ginseng including Chinese white 
ginseng, Chinese red ginseng and Korean ginseng, as well as P. quinquefolium were 
located at the left side of the score plot with relatively closer clustering. In addition, 
among samples of P. ginseng, P. notoginseng and P. quinquefolium, Chinese white 
ginseng was more likely to cluster with P. quinquefolium and Chinese red ginseng was 
almost clustered in one group with Korean ginseng. This result is partially inconsistent 
with a previous report in which Chinese white ginseng was clustered nearer to P. 







Figure 5.20 PLS-DA model (B) score plot of botanicals from Panax species. The raw, 1h steamed and 9h steamed P. notoginseng samples were 
distributed on the right side of the score plot. Chinese white ginseng, Chinese red ginseng and Korean ginseng, as well as P. 
quinquefolium were located at the left side of the score plot with relatively closer clustering. 
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This could possibly be caused by concentration variations of ginsenoside Rf and 
notoginsenoside R1 in P. quinquefolium and P. notoginseng samples used to build the 
models because these two saponins are characteristic components to differentiate P. 
quinquefolium and P. notoginseng from P. ginseng.  
In addition, the relatively large distance between raw and steamed P. 
notoginseng to P. ginseng and P. quinquefolium can be explained by their relatively 
larger differences of chemical constituents. For example, raw P. notoginseng is known 
to contain unique saponins such as notoginsenoside R1, which can be used to 
differentiate P. notoginseng from other Panax botanicals. The steaming process for P. 
notoginseng could accentuate these differences by forming several new ginsenosides 
such as Rk1, Rk3, Rh1, Rh2 and Rg5. Although Chinese red ginseng and Korean 
ginseng were also supposed to be steamed products, the steaming process for these two 
samples was either with shorter time or with milder conditions (such as lower steaming 
temperature) compared with the steaming conditions for P. notoginseng in this study. 
Hence, Chinese red ginseng and Korean ginseng were still closely clustered to Chinese 
white ginseng.  
 
Cross-validation of PLS-DA model (B) 
This PLS-DA model was cross-validated using 2h steamed P. notoginseng 
(batch 2), P. quinquefolium (Sinchong), Chinese white ginseng (Bee’s Brand) and a 
mixture of Chinese white ginseng (Wong Yiu Nam) and raw P. notoginseng (Wong Yiu 
Nam) (1 : 1). The pre-processed data set of these three samples was incorporated into 
the PLS-DA model and plotted in the same score plot as shown in Fig. 5.21. The blue 
triangles shown in this plot represented the model set and kept the same position with 
vectors shown in Fig. 5.20. The red squares shown in the plot represented the cross-






Figure 5.21 The cross-validation score plot of PLS-DA model (B). The blue triangles represent the model set and the red squares represent the 
cross-validation set. The position of each vector in the model set is the same as shown in Fig. 5.20. Abbreviations: MS, model set; 
CVS, cross-validation set; PN, P. notoginseng; PQ, P. quinquefolim; CWG, Chinese white ginseng; CRG, Chinese red ginseng; KG, 
Korean ginseng; S1h, 1h steamed; S2h, 2h steamed; S9h, 9h steamed. 
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The 2h steamed P. notoginseng sample (batch 2) and P. quinquefolium sample 
(Sinchong) were distributed to positions close to the 1h steamed P. notoginseng and P. 
quinquefolium samples from the model set respectively. Based on the findings of the 
previous section, differentially steamed P. notoginseng can be separated into two 
groups: 1h to 6h steamed and 9h to 24h steamed. Hence, the 2h steamed P. notoginseng 
located next to 1h steamed P. notoginseng indicated that this PLS-DA model at least 
can be used to predict steamed P. notoginseng with these two steaming duration ranges. 
In addition, the three extracts of the 1:1 mixed Chinese white ginseng and raw P. 
notoginseng sample were distributed in the area between Chinese white ginseng group 
and P. notoginseng group in the model set (Fig. 5.21). The results demonstrated the 
reliability of the PLS-DA model.  
However, the “Chinese white ginseng” sample (Bee’s Brand) used for cross-
validation was found to be more similar to P. quinquefolium sample group in the model 
set, instead of the Chinese white ginseng sample group (Fig. 5.21). This anomaly was 
further investigated by comparing the chromatographic profiles of these three samples. 
As shown in Fig. 5.22, the chromatographic profile of the “Chinese white ginseng” 
sample (Bee’s Brand) was more similar to the authentic P. quinquefolium sample (from 
NICPBP) rather than the authentic Chinese white ginseng sample (from NICPBP). 
There may be possible mis-labeling for this sample, i.e. it was wrongly labeled as 
Chinese white ginseng as analysis shows that it resembles P. quinquefolium. Hence, it 
was reasonable that the so-called “Chinese white ginseng” was clustered near to the P. 
quinquefolium group in the model set. The results suggested that choosing this sample 
for the cross-validation of the PLS-DA model may not be very appropriate. However, 
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Figure 5.22 Typical TICs of (A) Chinese white ginseng reference sample from NICPBP; (B) P. quinquefolium reference sample from NICPBP 















PLS-DA model (C) 
As introduced previously in Section 1.3, the content of the chemical constituents 
of botanicals varies among different species, geographical sources and time of 
collection. Hence, it is valuable to investigate the quality of the botanicals from 
different geographic sources or different time of collection, etc. However, due to the 
unavailability of such samples, botanicals investigated during this study were not 
collected in these ways. Instead, the same raw botanical material from different medical 
shops was obtained to simulate these conditions. The PLS-DA model (C) was created to 
evaluate the quality of 5 Panax botanicals (Chinese white ginseng, Chinese red ginseng, 
Korean ginseng, P. notoginseng and P. quinquefolium) purchased from medical shops in 
Singapore and China. The samples are listed in Table 5.7. The Chinese white ginseng, P. 
notoginseng and P. quinquefolium purchased from NICPBP were included to serve as 
the reference materials. Each source of the botanical sample was extracted twice using 
ASE. The diluted extracts were then profiled using LC-LTQ-Orbitrap XL FT MS. The 
pre-processed data was subjected to multivariate data analysis using SIMCA P+ 
software.  
A six-component PLS-DA model (R2X = 0.272, R2Y = 0.99, Q2 = 0.721) was 
finally built. The score plot of the developed PLS-DA model was shown in Fig. 5.23. It 
is evident that the 5 investigated botanicals are clustered into three groups. The raw P. 
notoginseng samples obtained from different sources clustered together with the 
authentic sample from NICPBP in quadrant IV of the score plot. Samples of Chinese 
white ginseng and P. quinquefolium with different sources were distributed in quadrant I. 
They are clearly separated from raw P. notoginseng by latent variable 2. The relatively 
large distribution area of Chinese white ginseng indicated that the quality of Chinese 






Figure 5.23 The score plot of PLS-DA model (C). Three clear clusters can be seen: P. notoginseng; P. quinquefolium and Chinese white ginseng; 
Korean ginseng and Chinese red ginseng. P. notoginseng samples are clustered in quadrant IV; P. quinquefolium and Chinese white 
ginseng samples are clustered in quadrant I; Korean ginseng and Chinese red ginseng samples are clustered in quadrant II and III. 
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This is partly reflected by the large variations of their prices in different medical 
shops. In addition, similar to PLS-DA model (B), samples of Chinese red ginseng and 
Korean ginseng with different sources were clustered near to each other on the left side 
of the score plot (quadrant II and III). They can be separated from raw P. notoginseng, 
Chinese white ginseng and P. quinquefolium group by latent variable 1 in the score plot. 
Although this PLS-DA model successfully clustered the 5 botanicals of Panax species 
into three groups and differentiated raw P. notoginseng from the other samples, this 
model has limitations. As shown in the score plot (Fig. 5.23), the Chinese white ginseng 
group is still cluster with P. quinquefolium group, and the Chinese red ginseng group is 
still cluster with Korean ginseng group. This is most likely to be caused by the similar 
raw materials and processing methods of these two botanicals. On the other hand, the 
result also showed the quality of each of the 5 Panax botanicals available in medical 
shops were of reasonable and consistent quality. 
 
5.2.4.2.3 Evaluation of ten commercial products 
The PLS-DA model (B) was further applied to evaluate the quality of ten 
commercial products, including four paired raw and steamed P. notoginseng products 
and two commercial Korean ginseng products. The four paired raw and steamed P. 
notoginseng products were previously investigated using the raw and steamed P. 
notoginseng PLS-DA model developed in Section 5.2.4.1. The prediction set was 
incorporated and plotted into the PLS-DA model (B). The resulted prediction plot was 
shown in Fig. 5.24. Same as the cross-validation plot (Fig. 5.20), the model set was 
represented with blue triangles with the position of each vector keeping the same with 







Figure 5.24 The prediction plot of 10 commercial products using PLS-DA model (B). The blue triangles are model set and the red squares are 
prediction set. The position of each vector in the model set is the same as shown in Fig. 5.20. Abbreviations: MS, model set; PS, 
prediction set; PN, P. notoginseng; PQ, P. quinquefolim; CWG, Chinese white ginseng; CRG, Chinese red ginseng; CKG, 
commercial Korean ginseng, CRPN, commercial raw P. notoginseng; CSPN, commercial steamed P. notoginseng; KG, Korean 
ginseng; S1h, 1h steamed; S9h, 9h steamed. Commercial Korean ginseng (1) and (2) are HST Korean red ginseng capsule and 
Heaven 1 Korean ginseng extract capsule Gold as introduced previously in Section 5.2.3.1. 
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As shown in Fig. 5.24, the four paired commercial raw and steamed P. 
notoginseng samples were clearly separated into two groups in quadrant I, in which the 
raw samples were trended to cluster with the raw P. notoginseng in the model set. At 
the same time, all of the commercial steamed P. notoginseng samples which formed 
another group were distributed to the area between the raw and 1h steamed P. 
notoginseng samples in the model set. The results suggested that the commercial 
steamed P. notoginseng samples were either processed with less than 1 hour steaming 
duration or with lower steaming temperature. This observation is consistent with the 
previous findings described in Section 5.2.4.1.  
Furthermore, two commercial Korean ginseng products, (1) HST Korean red 
ginseng capsule and (2) Heaven 1 Korean ginseng extract capsule Gold, were predicted 
using this PLS-DA model. HST Korean red ginseng capsule (commercial Korean 
ginseng 1) was accurately distributed to the Korean ginseng group in the model set. The 
second commercial Korean ginseng product (Heaven 1 Korean ginseng extract capsule 
Gold) was distributed relatively far to the Korean ginseng group in the model set (Fig. 
5.24). Hence, it is speculated that Heaven 1 Korean ginseng extract capsule Gold is 
either the white form of P. ginseng or processed under milder condition compared to 
HST Korean red ginseng capsule.  
In order to confirm the PLS-DA prediction results, the chromatographic profiles 
of these two products were investigated. The chromatograms of these two commercial 
Korean ginseng products, including TICs, m/z 785 and 789 extracted chromatograms, 
were shown in Fig. 5.25. It is evident that HST Korean red ginseng capsule contained 
higher concentrations of ginsenosides 20S/20R-Rg3, Rk1 and Rg5 compared to Heaven 
1 Korean ginseng extract capsule Gold. This observation is consistent with the PLS-DA 






Figure 5.25 The chromatograms of (A) HST Korean red ginseng capsule and (B) 
Heaven 1 Korean ginseng extract capsule Gold with ginsenosides 
20S/20R-Rg3, Rk1 and Rg5 identifed by ion extraction function as 
labelled. 
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The lack of quality control and standardizations of these steamed products is an 
important issue to address. Currently, there is no standardization of the processing 
conditions used to steam the samples. Such information is also not available and is kept 
confidential by the manufacturers. The general lack of quality control and 
standardization of the processing methods may be responsible for the wide variations of 
results for different pairs of P. notoginseng and Korean ginseng samples. 
In summary, non-targeted metabolite profiling is used to evaluate the quality of 
botanicals in this study. The adventage of this preliminary non-targeted metabolite 
profiling study is to holistically analyze the quality of botanicals based on their 
metabolite fingerprints rather than only depending on one or several marker compounds. 
Through metabolomic investigation, the detectable chemical constituent signals in 
metabolite fingerprinting are simultaneously and comprehensively processed by 
multivariate data analysis. Hence, the correlation between chemical constituents in 
botanicals and their quality can be visualized from statistical results. The PLS-DA 
model developed in this study could serve as a suitable tool to help to evaluate the 
quality of botanicals. 
 
5.2.5 Conclusion 
In this study, a PLE extraction method and a non-targeted metabolite profiling 
method using LC-LTQ-Orbitrap XL FT MS coupled with multivariate data analysis 
were successfully developed for the analysis of five adaptogenic botanicals together 
with raw and steamed P. notoginseng. 
For the analysis of raw and differentially steamed P. notoginseng samples, a 
PLS-DA model was developed. This model was cross-validated using steamed P. 
notoginseng sample prepared in another batch. Four pairs of commercial raw and 
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steamed P. notoginseng samples were predicted using this model. The prediction results 
suggested that the steaming conditions for the steamed samples were either less than 1 
hour or with milder condition, i.e. temperature less then 120 oC. In addition, using the 
validated LC-LTQ-Orbitrap XL FT MS method, twelve saponins present in raw and 
differentially steamed P. notoginseng samples were quantified and compared. 
For the analysis of five adaptogenic botanicals together with raw and steamed P. 
notoginseng, three PLS-DA models had been built. PLS-DA model (A) was developed 
and used to differentiate E. senticosus, G. pentaphyllum and R. rosea from other 
adaptogenic botanical from Panax species and from raw and steamed P. notoginseng. 
PLS-DA model (B) was developed and cross-validated to differentiate the rest of the 
Panax species. The “Chinese white ginseng” sample (Bee’s Brand) used for cross-
validation was identified as P. quinquefolium. This is caused by mis-labeling or in-
correct identification. The cross-validation results showed that the PLS-DA model (B) 
was robust for identifying and predicting the quality of commercial botanical products. 
The PLS-DA model (C) was developed to investigate the qualities of the 5 most 
commonly used botanicals in the genus Panax in Singapore and China. The result 
suggested that Chinese white ginseng has relatively larger quality variations, whereas 
the other four Panax species, namely Chinese red ginseng, Korean ginseng, P. 
notoginseng and P. quinquefolium are of reasonable and consistent quality among 
different sources. Further more, using the PLS-DA model (B), the quality of ten 
commercial products were evaluated. The prediction results were confirmed by 
exploring their respective chromatographic profiles. Finally, the metabolomic 
investigation platform has been demonstrated to be a useful tool for the quality 
evaluation of adaptogenic botanicals and P. notoginseng. 
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Chapter 6 Conclusion and Future work 
 
6.1 Conclusions 
The quality of botanicals is of paramount importance because it can affect the 
safety and efficacy of botanicals and botanical health products. The work presented in 
this thesis aims to develop analytical methods and apply them for the quality control of 
commonly used botanicals as well as botanical health products used for sexual 
performance enhancement and slimming. 
Chapter 1 gives a general overview of quality issues concerning botanicals and 
botanical health products. Factors affecting the quality of botanical materials and 
different techniques used for the quality control of botanicals and botanical health 
products are introduced. The adulteration of undeclared drugs and illegal compounds in 
health products is a major quality concern. Targeted adulterant screening for the quality 
control of botanical health products is reviewed. The reported adulteration cases of 
botanical health products used for sexual performance enhancement and for slimming 
are collected. The potential risk to consumers who use those adulterated products makes 
it necessary to investigate the quality of botanical health products. In addition, the 
metabolomic analytical methods used to assess the quality of botanicals are reviewed. 
Investigated botanical samples, sample preparation techniques, metabolite profiling 
techniques, data pre-processing softwares and multivariate data analysis methods are 
described. The hypotheses and objectives of the work are presented in Chapter 2. 
In Chapter 3, a simple and useful HPLC-DAD method is developed and 
optimized for the simultaneous detection and determination of 19 PDE-5 inhibitors and 
their analogues in botanical health products used for sexual performance enhancement. 
This method has been validated for linearity, precision and accuracy. It can be used for 
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the preliminary screening of PDE-5 inhibitors and their analogues based on the 
comparison of the retention times and UV spectra with their respective standards. This 
is the first report of using HPLC-DAD to simultaneously detect 19 PDE-5 inhibitors 
and their analogues. This method could be used as a preliminary screening method.  
In addition, in the second section of Chapter 3, a total of two hundred and 
seventy-one botanical health products used for sexual performance enhancement and 
slimming were purchased on-line and were screened for the presence of synthetic 
components using HPLC-DAD, GC-MS and LC-MS. Using these techniques, one 
hundred and thirty out of two hundred and seventy-one products (48.0%) were found to 
be adulterated with illicit components. Out of the one hundred and ninety-eight sexual 
performance enhancement products, one hundred and four (52.5%) were found to be 
adulterated with unapproved or undeclared components, in which 21 samples (10.6%) 
were detected to contain PDE-5 inhibitors and their analogues. Out of the seventy-three 
slimming products, twenty-six (35.6%) were found to contain compounds such as 
caffeine, sibutramine and glibenclamide. Five products which were adulterated with 
PDE-5 inhibitors and their analogues were subjected to further investigations. The 
concentrations of their respective adulterants were quantified using the HPLC-DAD 
method developed in Section 3.1. The high concentrations of the adulterants in these 
five samples showed that consumers are exposed to adulterated products from the 
internet and this is worrying. The presence of adulteration coupled with increasing 
usage of botanical health products warrant additional control measures to ensure 
patients’ safety. 
In Chapter 4, three new synthetic adulterants, namely hydroxythiohomo-
sildenafil (compound X), descarbonsildenafil (compound Y) and dapoxetine (compound 
Z), were isolated and purified from botanical health product samples. Hydroxythio-
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homosildenafil and descarbonsildeanfil are sildenafil analogues. Hydroxythiohomo-
sildenafil was first detected in a botanical health product bought from an on-line store 
(Appendix 2). The product is claimed to be “100% natural” and “without any synthetic 
ingredients”. Besides the detection of hydroxythiohomosildenafil present in high 
concentration in the product, another sildenafil analogue, hydroxyhomosildenafil, was 
also detected in smaller concentration. Descarbonsildenafil was detected in a functional 
coffee sample which claimed to have male tonic effects. In addition, dapoxetine, which 
belongs to SSRI and is still under clinical trials for the treatment of premature 
ejaculation, was detected in a botanical health product called MHD1. The structures of 
these three compounds were elucidated using UV, IR, high-resolution MS, LC-MS/MS 
and NMR techniques. It is the first report of the detection and determination of these 
three adulterants in botanical health products. All of these adulterants are synthetic 
compounds and are not approved drugs. Their safety and toxicity are still largely 
unknown. Hence, the adulteration of these compounds with high concentration in 
botanical health products is extremely dangerous for consumers. These three new 
adulterants should be included as target compounds during adulterant screening. Their 
structural information could be used to elucidate new PDE-5 inhibitor analogues in 
future. 
In Chapter 5, metabolomic investigation approaches were developed and used to 
evaluate the quality of five adaptogenic botanicals together with raw and steamed P. 
notoginseng purchased in Singapore and China. The metabolomic investigation consists 
of two parts: non-targeted metabolite fingerprinting and multivariate data analysis. 
Firstly, a new LC-LTQ-Orbitrap XL FT MS method was developed and optimized for 
the non-targeted metabolite fingerprinting. This method had been validated for linearity, 
precision and accuracy. This is the first reported LC-LTQ-Orbitrap XL FT MS method 
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which is optimized for the analysis of P. notoginseng and adaptogenic botanicals. A 
PLE method was also developed and optimized for the extraction of botanical samples. 
Raw P. notoginseng was used as the sample for the development of the PLE extraction 
conditions. The extracts of raw P. notoginseng sample under different PLE conditions, 
mainly including different extraction temperatures and solvents, were injected into the 
LC-LTQ-Orbitrap XL FT MS system to compare the amount of typical ginsenosides 
extracted out. The optimal PLE method was finally selected with 80% (v/v) aqueous 
methanol as the extraction solvent, 100 oC as the extraction temperature and with 10 
min static extraction time. This is the first study of the influence of PLE conditions on 
the extraction of P. notoginseng. The PLE method offers improved extraction efficiency 
compared with traditional extraction methods e.g. ultrasonication and soaking and has 
been developed and applied successfully for the extraction of raw and steamed P. 
notoginseng. 
In the second part of Chapter 5, extracts of raw and steamed P. notoginseng and 
adaptogenic botanicals were profiled using the developed PLE and LC-LTQ-Orbitrap 
XL FT MS methods. By comparing the retention time and accurate mass with reference 
standards or reported data, several marker compounds of each botanical sample were 
identified or tentatively characterized. The raw chromatographic data of the extracts of 
botanicals obtained from LC-LTQ-Orbitrap XL FT MS were pre-processed using 
metAlign software for noise elimination, baseline correction and peak alignment. The 
aligned chromatographic data set was then subjected to multivariate data analysis.  
A PLS-DA model (A = 6, R2X = 0.486, R2Y = 0.737, Q2 = 0.508) was developed 
for the clustering of raw and different (1h, 2h, 4h, 6h, 9h, 12h, 15h and 24h: batch 1) 
steamed P. notoginseng samples. This model was cross-validated using steamed P. 
notoginseng samples (batch 2). The differentially steaming duration groups of the cross-
  182 
validation set were accurately distributed near to their respective groups from the model 
set, which indicated the robustness of this PLS-DA model. The score plot of this model 
showed three clear clusters: raw, 1h to 6h and 9h to 24h steamed P. notoginseng 
samples.This is consistent with a previous reported PLS-DA model based on UHPLC-
TOF MS profiling by our group (Toh et al., 2009). Moreover, four paired commercial 
raw and steamed P. notoginseng samples were predicted using the developed PLS-DA 
model. The prediction result suggested that the steaming procedure for the steamed 
samples were either less than 1 hour or with mild condition, such as lower steaming 
temperature. In addition, twelve saponins presented in raw and differentially steamed P. 
notoginseng samples were quantified and compared using the validated LC-LTQ-
Orbitrap XL FT MS method.The quantification results can serve as useful background 
information for future in vitro and in vivo activity studies of these raw and steamed P. 
notoginseng samples. 
Furthermore, three PLS-DA models were built for the analysis of adaptogenic 
botanicals together with raw and steamed P. notoginseng. The PLS-DA model (A) (A = 
6, R2X = 0.334, R2Y = 0.662, Q2 = 0.517) was developed and used to separate E. 
senticosus, G. pentaphyllum and R. rosea from other adaptogenic botanical from Panax 
species and from raw and steamed P. notoginseng. The PLS-DA model (B) (A = 6, R2X 
= 0.503, R2Y = 0.993, Q2 = 0.904) was developed to differentiate the rest of the Panax 
species. It was cross-validated and then applied to the prediction of commercial 
botanical derived products. The cross-validation and prediction results showed that the 
PLS-DA model (B) was robust for identifying and predicting the property of 
commercial botanical products. The PLS-DA model (C) (A = 6, R2X = 0.272, R2Y = 
0.99, Q2 = 0.721) was developed to investigate the quality status of the most commonly 
used Panax botanicals available from commercial markets of Singapore and China. The 
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result suggested that except Chinese white ginseng which was found to have relatively 
larger quality variations, the other four Panax botanicals, namely Chinese red ginseng, 
Korean ginseng, P. notoginseng and P. quinquefolium were of reasonably consistent 
quality among different sources. In summary, the metabolomic investigation platform, 
with different PLS-DA modals developed in this study, has been shown to be a useful 
tool for the quality assessment of adaptogenic botanicals as well as P. notoginseng. 
In conclusion, the work presented in this thesis has provided a new screening 
method for adulterants and a new metabolomic platform for evaluating the quality of 
botanicals and botanical health products. The methodologies developed and applied are 
important to ensure the quality of health products and hence the safety of consumers. 
 
6.2 Future work 
Future work can be divided into two main areas. For the targeted adulterant 
screening of botanical health products, more botanical health product samples from 
local market need to be investigated in order to evaluate the prevalence of adulteration 
of the commercial botanical health products. It is also necessary to develop more 
systematic sample preparation method for adulterants which have low solubility in 
methanol e.g. tadalafil and cannot be extracted by methanol. For the quantitation of 
analogues in adulterated products, the quantification can be carried out on individual 
dosage form samples as the drug contents can vary due to poor quality control in the 
manufacturing process. In addition, studies on comparing the efficacy and toxicity 
profile of the identified PDE-5 inhibitor analogues with their corresponding parent 
compounds can be carried out. 
For the quality evaluation of raw botanical materials, due to the limitation of 
time and sourcing channel, botanicals investigated in this study were collected from 
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commercial markets of Singapore and China. The origin and processing procedure of 
these botanical materials are uncertain. Moreover, the influences of different geographic 
sources, different years of cultivation and different time of harvesting on the quality of 
botanical material have not been considered in this study. These influences should be 
addressed in future studies to provide us a better understanding of the quality of these 
botanicals. At the same time, more substantial metabolite fingerprinting techniques and 
statistical models need to be developed for future quality control process. The methods 
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Appendix 1: List of sexual performance enhancement botanical health products 
purchased, dosage form, quantity per package and websites. 
 
No. Product name Dosage form 
Quantity/ 
Package Website of purchase 
1 Stamina-Rx For Men Tablet 60 http://www.aragonproducts.com/theproducts.cfm?master=5455 
2 Stamazide Tablet 60 http://www.aragonproducts.com/theproducts.cfm?master=6126 
3 Cerniplex Tablet 30 http://www.aragonproducts.com/theproducts.cfm?master=5999 
4 Arginmax for Women Tablet 180 
http://www.aragonproducts.com/theproducts.cf
m?master=476 
5 Kohinoor Gold Capsule 60 http://www.ayurvediccure.com/kohinoor.htm 
6 Maxidus for Men Capsule 20 https://www.biogulfstore.com/orders/Affiliate/products.php 
7 Maxidus for Men (oil) Liquid 60 ml 
https://www.biogulfstore.com/orders/Affiliate/
products.php 
8 LFW Capsule 20 https://www.biogulfstore.com/orders/Affiliate/products.php 
9 Libidus Capsule 20 https://www.biogulfstore.com/orders/Affiliate/products.php 
10 Semenax Capsule 90 http://www.bettersexsupplements.com/ 
11 Provestra Caplet 30 http://www.bettersexsupplements.com/ 
12 Viverex for Men Tablet 10 http://www.erecting-confidence.com/male_sexual_enhancement.html 
13 Veromax Natural Tablet 60 http://www.vitacost.com/VeromaxForMenSexualPerformanceEnhancer 
14 NSI Women's Passion Booster Capsule 120 
http://www.vitacost.com/NSI-Womens-
Passion-Booster-All-Natural-Extracts 




16 NSI Male Enhancement Capsule 60 
http://www.vitacost.com/NSI-Male-
Enhancement-Formula-with-MacaPure 
17 Provigro Capsule 24 http://www.harvesthealth.com/provigro.html 
18 LJ 100 Tongkat Ali Capsule 90 http://www.iherb.com/ProductDetails.aspx?c=1&pid=3666&at=0 
19 LJ 100 Freeze Dried Eurycoma Longifolia Powder 10 g 
http://www.iherb.com/ProductDetails.aspx?c=1
&pid=8307&at=0 
20 Testo Jack Capsule 60 http://www.iherb.com/ProductDetails.aspx?c=1&pid=5026&at=0 
21 Erox Capsule 60 http://www.iherb.com/ProductDetails.aspx?c=1&pid=4609&at=0 
22 Source Naturals, Tongkat Ali Tablet 60 
http://www.iherb.com/ProductDetails.aspx?c=1
&pid=1504&at=0 
23 Women RA Tablet 20 http://www.scillausa.com/womenra-sildenafil.html 
24 Slevotra Tablet 4 http://www.scillausa.com/slevotra-vardenafil.html 
25 Vitro Man Power Plus Capsule 60 
http://www.sexpo.com.sg/onlinestore/index.ph
p?act=viewProd&productId=200 
26 Virilar Capsule 30 http://www.sexpo.com.sg/onlinestore/index.php?act=viewProd&productId=123507 
27 XP Tongkat Ali Capsule 4 http://www.sexpo.com.sg/onlinestore/index.php?act=viewProd&productId=123589 




29 Extenze Capsule 60 http://www.extenze-direct.com/?a=emoshe&t=Google-INTL&c=0 
30 E-Long-Ate Capsule 60 http://www.paramount-supplements.com/e60camaenpi.html 
31 Enhance-9 Tablet 30 http://www.paramount-supplements.com/enhance9.html 
32 Max Vitality Rx Capsule 60 http://www.paramount-supplements.com/maxvirxmaen6.html 
33 Kong Herbal Enhancer Tablet 60 
http://www.paramount-
supplements.com/koasseonhost.html 
34 Liquid Rx Liquid 30 ml http://www.paramount-supplements.com/liplsebo.html 
35 Max Stamina Capsule 30 http://www.paramount-supplements.com/maxst30camas.html 
36 Pleasure Pills Capsule 30 http://www.paramount-supplements.com/plpi30co.html 
37 Pro Plus Pills Tablet 60 http://www.paramount-supplements.com/proplpi60cap.html 
38 Rigid for Men Capsule 10 http://www.paramount-supplements.com/riformen10ca.html 
39 Rize-2 Capsule 12 http://www.paramount-supplements.com/ri212cabo.html 
40 Rx Erect Capsule 30 http://www.paramount-supplements.com/rxerect.html 
41 Stimuloid Capsule 30 http://www.paramount-supplements.com/stimuloid.html 
42 Vialafil Capsule 30 http://www.paramount-supplements.com/vimaenfo.html 
43 Viacil Tablet 30 http://www.paramount-supplements.com/viacil30ct.html 
44 Vigor-Ex Capsule 4 http://whttp://www.vigorexonline.com/ 
45 Ikawe Liquid 50 ml http://www.enaturalremedies.com/ikawe_for_sexual_performance.htm 
46 Thanda Capsule 60 http://www.enaturalremedies.com/thanda_for_passion_libido_boosting.htm 
47 Pro-Solution Pills Tablet 60 http://www.prosolutionpills.com/?a=101858&c=0 
48 VigRx Capsule 60 http://www.vigrx.com/?a=nudei096&c=0 
49 Bali Mojo Capsule 10 http://www.balimojo.com/?gclid=CLPu66urm44CFR3JYAod7xk1TQ 
50 Vitro Man Tongkat Ali 100 Capsule 60 
http://www.vitroman.com/en/index_en.asp?pag
eID=tongkat-ali-100 
51 Erexin Tablet 90 http://www.vitadigest.com/erexin.html 
52 Avela Capsule 30 http://www.vitadigest.com/avela.html 
53 Vivid Virility Tablet 72 http://www.vitadigest.com/vivid-virility-men.html 
54 Virility Ex Pills Tablet 60 http://www.ultraherbal.com/product/overview/Virility_Pills_For_Men/ 
55 Kama Raja Capsule 60 http://www.kamaraja.com/index.htm?aff=google1 
56 Vimax Capsule 30 http://www.pillsexpert.com/penispills/ 
57 Better Man (Light brown) Capsule 40 
http://www.wholesalesupplementstore.com/bett
erman.html 
58 Better Man (Dark brown) Capsule 40 
http://www.wholesalesupplementstore.com/bett
erman.html 
59 Marathon 21 Tablet 60 http://www.lhslive.com/product_info.php?products_id=113 
60 Alpha Male Plus Capsule 60 http://www.lhslive.com/product_info.php?products_id=108 
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61 Zenerx Capsule 60 http://www.zenerx.com/ 
62 H-Force Capsule 60 http://www.vitavips.com/studmax.php 
63 Provigrax Tablet 60 http://www.vitavips.com/provigrax.php 
64 MX MAN Capsule 60 http://www.vitavips.com/mx-man.php 
65 Vaxitrol Capsule 16 http://www.paramount-supplements.com/vaxitrol.html 
66 Stamitrol Tablet 30 http://www.paramount-supplements.com/stamitrol30ct.html 
67 Xiadafil Tablet 8 http://www.paramount-supplements.com/xiadafil.html 
68 XOMAX Capsule 30 http://www.xomax-man.com/ 
69 Erotica Plus Capsule 60 https://www.buyxomax.com/products.php?pg=2 
70 Yang Pro Tablet 60 https://www.buyxomax.com/products.php?cat=1 
71 Sex Pill Capsule 60 https://www.buyxomax.com/products.php?cat=1 
72 Sure-Erect Capsule 60 http://www.mensexpills.net/sureerect.php 
73 SAS LABS - Sexual Health Package Powder 240 g 
http://www.internationalsupplements.com/prod
uct_info.php?products_id=234 
74 ESE LABS - Sexual Health Package Powder 240 g 
http://www.global-supplements.com/Sexual-
Health-Package/ 
75 YERBA - DIET Capsule 30 http://www.vitavips.com/yerbaslim.php 
76 Cravex Capsule 90 http://www.vitadigest.com/natrol-cravex-90.html 
77 Lean Tabs Tablet 90 http://www.vitadigest.com/lean-tabs.html 
78 Oyama-Rectic Capsule 30 http://www.vitadigest.com/dyma-retic-dymatize.html 
79 Super Citrimax Capsule 90 http://www.nutrasanus.com/super-citrimax-product.html 
80 Lyse XL Capsule 90 http://www.vitavips.com/lyse-xl.php 
81 SZM Formula for Men Capsule 10 
http://www.netpharmacy.co.nz/szm-formula-
for-men-1 








84 Avaprex Capsule 60 http://www.avaprex.com/adipex.htm?gclid=COmk4KOB344CFQEgYAodCWILSg 
85 In Control Capsule 60 http://www.wholesalesupplementstore.com/fat-attack-stack.html 
86 Reveal Tablet 60 http://www.wholesalesupplementstore.com/fat-attack-stack.html 
87 TestoraNx Tablet 60 http://allnutri.com/pid38657/testoranx.aspx 
88 Horny Goat Weed Capsule 30 http://www.evitamins.com/product.asp?pid=10424 
89 Rizer XL Capsule 60 http://www.rizerxl.com/ 
90 Tribuloid Capsule 60 http://www.herballoveshop.com/product.asp?PID=14351 
91 Damiana leaves Capsule 100 http://www.herballoveshop.com/product.asp?PID=1564 
92 Moodmax Tablet 60 http://www.herballoveshop.com/product.asp?PID=1007 
93 Natural V for Men Capsule 60 http://wholesalesupplementstore.com/naturalv-formen.html 
94 Viraloid Capsule 60 http://www.herballoveshop.com/product.asp?PID=18367 
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95 Excite Capsule 90 http://www.evitamins.com/product.asp?pid=5654 
96 Aziffa Capsule 2 http://supplementkingdom.com/azzifa.html 
97 Vigralis Capsule 12 http://supplementkingdom.com/v_gralis.html 
98 MacaActive Tablet 100 http://www.natural-male-health.com/order-macaactive.htm 
99 Elexia Plus Tablet 60 http://www.vitadigest.com/elexia-men.html 
100 Tigra Men Tablet 56 http://www.body4real.co.uk/product.php?productid=17948 
101 Blue Up Capsule 60 http://supplementkingdom.com/blue_up.html 
102 Hypertest Capsule 120 http://supplementkingdom.com/hypertest.html 





104 Paravol Male Enhancer Capsule 60 http://www.evitamins.com/product.asp?pid=6289 
105 Sida Cordifoloia Capsule 40 http://www.expresschemist.co.uk/Sida_Cordifolia_by_Reflex.html 




107 Libido & Drive Liquid soft-gel 60 
http://www.iherb.com/ProductDetails.aspx?c=1
&pid=3147&at=0 





109 Horny Goat Weed Extract (Healthy direct) Tablet 90 
http://www.healthydirect.com/product/HNYG
W/d.jsf 
110 Deer Antler Plus Capsule 60 http://www.deerantlerplus.com/ 
111 Maxine's Intima for women Tablet 60 http://www.evitamins.com/product.asp?pid=199 
112 Sexy Lady Capsule 60 http://www.evitamins.com/product.asp?pid=7301 
113 Adios Max Tablet 60 http://www.expresschemist.co.uk/Adios-Max.html 
114 Horny Goat Weed (Epimedium) Tablet 60 http://www.evitamins.com/product.asp?pid=10424 
115 RedHorn Capsule 30 http://www.evitamins.com/product.asp?pid=6438 
116 KONG Black Voodoo Capsule 60 http://www.evitamins.com/product.asp?pid=6437 
117 Male Power Tablet 120 http://www.evitamins.com/product.asp?pid=1374 
118 Semenax Tablet 20 http://www.bettersexmall.com/semenax_review.html?ss=e0585fe84e49c5973a59de11a1e7ce87
119 Cockstar Capsule 14 http://www.vitadigest.com/cockstar.html 
120 24/7 Sure Capsule 60 http://www.strictlyhealth.com/viagra_alternative.php
121 
XP Tongkat Ali for 
Men Supreme 
Capsules 
Capsule 40 http://www.sexpo.com.sg/onlinestore/index.php?act=viewProd&productId=123589 
122 Avlimil Capsule 30 http://www.aragonproducts.com/theproducts.cfm?master=5936&owner=694 
123 Ejaculoid Semen Volumizer Capsule 60 
http://www.aragonproducts.com/theproducts.cfm?cat
=1&master=6830&owner=694&subcat=578 
124 Spermamax Male Virility Capsule 60 
http://www.aragonproducts.com/theproducts.cfm?cat
=1&master=6436&owner=694&subcat=578 


























131 Sustanol Tablet 30 www.aragonproducts.com/theproducts.cfm?master=6258 
132 Orexis Capsule 60 http://www.aragonproducts.com/theproducts.cfm?master=6030 
133 Expand capsules Capsule 60 http://www.expandcapsules.com/ 
134 King Cobra Capsule 40 http://favstore.net/kingcobra/order.php 
135 Roaring tiger Capsule 28 http://www.roaringtiger.com/free_trial_offer.php 
136 ErogenX Capsule 60 http://www.intimatewholesalers.com/a8308-9.html 
137 Vicerex Capsule 10 http://www.aragonproducts.com/theproducts.cfm?cat=0&master=7435&owner=694&subcat=0 
138 Sizepro Ultra Tablet 30 http://www.ordersizepro.com/?hostid=bettersexmall.com&src=bettersexmall.com 
139 




Tablet 60 http://www.wellnessalternatives.com/cart/?product=WAPERMX01 
140 Mxman Capsule 60 http://www.mxman-herbal-penis-enlargement-pills.com/ordernow.php 
141 Virility Pills Capsule 60 http://www.buyvprx.com/?hostid=bettersexmall.com&src=bettersexmall.com 
142 Katana Tablet 60 http://www.bettersexmall.com/katana_review.html 
143 Last longer Tablet 60 http://www.mensexpills.net/lastlonger.php 
144 Gokshura Capsule 60 http://www.ayurvediccure.com/tribulus-terrestris.htm 
145 Virile 1 Tablet 50 http://www.vitasprings.com/virile-one-biotech.html 
146 Stinger Rx Capsule 30 http://www.vitasprings.com/stinger-rx--1-male-enhancement-formula.html 
147 Man's Favorite Capsule 10 http://www.vitasprings.com/man-s-favorite-far-long.html 
148 Herbal virility Tablet 90 http://www.vitasprings.com/herbal-virility-male-performance.html 
149 Herbal V Capsule 10 http://www.vitasprings.com/herbal-v-10-caps-lane-labs.html 
150 AlcoholX Capsule 2 http://www.alcohol-x.com/ 
151 Mr Energy Capsule 4 http://www.mrenergypills.com/order.html 
152 Azikiwe plus Tablet 60 http://www.azikiweplus.com/?hostid=bettersexmall.com&src=bettersexmall.com 
153 Volume Pills Tablet 60 http://www.aragonproducts.com/theproducts.cfm?cat=0&master=6103&owner=694&subcat=0 
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154 Erosyn for women - Nokomis Tablet 30 
http://www.feelgoodnatural.com/catalogue/BE
LL123.html 
155 MOJO Sensation Tablet 30 https://www.herbalsex.com/product.php?productid=16162&cat=0&page= 
156 StamaLong Capsule 3 http://www.herbalsex.com/product.php?productid=16167&cat=318&page=1 
157 Zencore Capsule 10 https://www.herbalsex.com/product.php?productid=16169&cat=0&page= 















Capsule 10 http://www.vitalfoodstore.com/female-libido-product-female-libido-booster-p/700018.htm 
162 Extenzol Capsule 20 http://www.aragonproducts.com/theproducts.cfm?master=9253 
163 Sensuvive Capsule 60 http://www.aragonproducts.com/theproducts.cfm?master=8292&owner=694 
164 Venerx Capsule 60 http://www.aragonproducts.com/theproducts.cfm?master=7429&owner=694 
165 BlueRise Capsule 30 http://nitropoppers.com/bluerisefromthemakersofnasutra.aspx 
166 Arginmax for Women Capsule 180 
http://www.americanlifestyle.com/theproducts.
cfm?master=477 
167 Horny Goat Weed Tea Bag 20 
http://www.vitaminshoppe.com/store/en/browse/sku
_detail.jsp?fromCatId=cat10411&id=TF-7034 




169 Nymphomax Capsule 60 http://www.americanlifestyle.com/theproducts.cfm?master=5551&owner=651 
170 Dr Joel Penis Enlargement Pills Capsule 60 
http://www.vitamaker.com/dr-joel-
enlargement-60.html 
171 Enzyte Tablet 10 http://www.vitamaker.com/enzyte.html 
172 Liquid Rise Liquid 150 ml http://www.vitamaker.com/liquid-rise.html 
173 NSI Muira Puama Capsule 120 http://www.vitacost.com/NSI-Muira-Puama#IngredientFacts 
174 NSI Healthy Libido Capsule 180 http://www.vitacost.com/NSI-Healthy-Libido#IngredientFacts 




176 Maxaman Capsule 60 http://www.aragonproducts.com/theproducts.cfm?master=5557&owner=694 
177 XXLarge Tablet 30 http://www.vitadigest.com/xxlarge.html 
178 Herbal Quiver Tablet 30 http://www.vitadigest.com/herbal-quiver.html 
179 Elexia Plus Tablet 60 http://www.vitadigest.com/elexia-women.html 
180 Female Sexual Tonic Liquid 1 oz http://canadian-drugshop.com/item.php?id=3430 





182 Emperor  Capsule 6 http://www.herbsensation.net/sex-enhancer-emperor-29-p.asp 
183 Fu Bao Capsule Capsule 30 http://www.asianangel.co.uk/_shop/product_info.php?products_id=45 
184 Superdragon Capsule 6 http://www.asianangel.co.uk/_shop/product_info.php?products_id=48 
185 Atlas Pills Capsule 4 http://www.asianangel.co.uk/_shop/product_info.php?products_id=49 
186 Tadalis - SX Tablet 10 http://www.tadalissx.net/ 
187 FertilAid Capsule 30 http://www.shopwars.com/Shop/Control/Product/fp/vpid/7016054/vpcsid/0/SFV/31959 
188 Provestra Tablet 30 http://www.provestra.com/order.html 
189 Desire Capsule 3 http://www.paramount-supplements.com/desire.html 









Tablet 10 http://www.paramount-supplements.com/72-hours-male-enhancement-formula.html 
192 Dr. Boss Penis Rejuvenator Tablet 60 
http://www.paramount-supplements.com/penis-
rejuvenator-virility-pills.html 




194 Herbal Vivid Male Enhancement Tablet 60 
http://www.herbalvivid.com/indexmain.php?W
MID=11407 
195 Julian's Rock Hard Cream Cream - 
http://www.vitamindeal.com/julian-rock-hard-
crm.html 






197 ExtenZe New & Improved Tablet 30 http://www.vitadigest.com/extenze.html 
198 Zencore Plus Capsule 10 https://www.zencore.com/ 
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Appendix 2: List of slimming botanical health products purchased, dosage form, 
quantity per package and websites. 
 
No. Product Name Dosage form 
Quantity/
Package Website of purchase 
1 




Capsule 160 http://www.7-dfbx.com/ 
2 72 Hour Slimming Pill Capsule 60 http://www.72hourslimmingpill.com/ 
3 AmbiSlimPM Capsule 60 http://www.ambislim.com/ 
4 LipoSeduction Capsule 30 http://www.liposeduction.com/ 
5 Easiness beauty Capsule 30 http://www.drug-store-china.com/slim/treasure/ 




7 SLIM 1-2-3 Tablet 90 http://www.cljhealth.com/weight_loss.htm 
8 Slim-Rite Tablet 90 http://www.worldwideshoppingmall.co.uk/body-soul/slim-rite.asp 
9 FITANSLIM Powder 150 g http://www.thinknatural.com/products/114422/Bional-Fitanslim-40s.htm 
10 Slimthru Liquid 7.5 ml http://www.expresschemist.co.uk/slimthru_weight_loss_supplement.html 
11 Slimming drinking tea Bag 10 http://www.9k9.com.cn/ 





Pill 300 http://www.alibaba.com/product-free/101636387/Merit_Slimming_Pills.html 
























19 Unique Hoodia Capsule 90 https://www.uniquehoodia.com/online1.php 
20 Ephedrasil Hardcore Capsule 40 http://www.ephedrasilhardcore.com/ 
21 Fenphedra Capsule 69 http://www.fenphedra.com/ 
22 DecaSlim Slimming Pill Capsule 60 http://decaslim.com/ 
23 7 Day Detox Capsule 14 http://www.7day-detox.com/ 
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24 Apidexin Capsule 60 http://www.apidexin.com/ 
25 Fenterdren Capsule 90 http://www.fenterdren.com/ 
26 Alvitum Powder 6.45 oz http://www.americanlifestyle.com/theproducts.cfm?cat=58&master=8375&owner=651&subcat=2069 
27 Lipotea Capsule 60 http://www.lipotea.com/ 
28 Anoretix Capsule 60 http://www.anoretix.com/ 
29 Healthslim Capsule 90 http://www.americanlifestyle.com/theproducts.cfm?cat=58&master=7624&owner=651&subcat=2069 
30 Lepti-Trim Capsule 60 http://www.paramount-supplements.com/slfawile180c.html 
31 Acai Amazon Burn Capsule 60 
http://www.paramount-supplements.com/acai-amazon-
burn.html 
32 XinYan Slimming Tea Bag 20 
http://www.herbsensation.net/xinyan-slimming-tea-20-
tea-bags--box-15-p.asp 
33 Piao Yi Slimming Tea Bag 20 
http://www.asianangel.co.uk/_shop/product_info.php?pr
oducts_id=30 





Jian Fei Wan 
Slimming 
Pills  
Pill 200 http://www.herbsensation.net/nong-suo-jian-fei-wan-slimming-pills-buy-1-get-1-free-7-p.asp 
36 Zhen You Mei Capsule 40 
http://www.herbsensation.net/zhen-you-mei-weight-loss-
capsules-buy-2-get-1-free-8-p.asp 
37 SoloSlim Capsule 60 http://www.soloslim.com/ 
38 Aminoforce Capsule 100 http://www.newton-everett.com/category.aspx?CID=706
39 Xanthadrene Capsule 90 http://www.newton-everett.com/category.aspx?CID=706
40 Oxotrim Tablet 150 http://www.newton-everett.com/category.aspx?CID=706
41 Isotropin Sachet 30 http://www.biovea.net/product_detail.aspx?PID=1773&CID=0
42 
Cha de Bugre 
(Cordia 
salicifolia) 
Capsule 100 http://www.rain-tree.com/cha-de-bugre-capsules.htm 
43 
Pure Amazon 
Acai Slim A 
to X 
Capsule 60 http://www.amazonslimatox.com/ 






Tablet 90 http://www.natural-alternative-products.co.uk/femme-slender-couture-curves-90-tablets-p-1241.html 
46 Caudalie Bag 30 g http://www.beautyexpert.co.uk/Caudalie-Draining-Organic-Herbal-Teas-30g-PRODCDTA1/ 
47 Cheat Tabs Tablet 30 http://www.paramount-supplements.com/chta90tabyfi.html 
48 Blaze Capsule 60 http://www.paramount-supplements.com/blbysannu.html
49 Slimming I Capsule 30 http://www.naturallydirect.net/thyroid-weight-loss-pill.html 
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50 SLIM-1 Metabo Plus Capsule 30 http://www.naturallydirect.net/weight-loss-herb.html 
51 Slimming II Capsule 30 http://www.naturallydirect.net/weight-loss-detox.html 
52 Pai You Su Pill 50 http://www.alibaba.com/product-gs/325559585/FAN_HOU_QING_PAI_YOU_SU.html 
53 Lean System 7 Capsule 90 http://www.expresschemist.co.uk/product_8222_lean-system7-90-capsules.html 
54 Liposafe Capsule 60 http://www.worldwidebestsupplements.com/supplements_Liposafe_601.html 
55 Dietrine Capsule 60 http://www.worldwidebestsupplements.com/supplements_Dietrine%20Carb%20Blocker_695.html 
56 The body-Kit Eat & Cheat Tablet 90 
http://www.expresschemist.co.uk/product_6620_eat-and-
cheat.html 
57 Hoodia 1000 Capsule 90 http://www.worldwidebestsupplements.com/supplements_Hoodia%201000_582.html 
58 Zotrim Tablet 180 http://www.expresschemist.co.uk/product_3584_zotrim----2-x-90-tablets.html?newcurrency=3 
59 Lipobind Capsule 60 http://www.expresschemist.co.uk/Lipobind-Fat-Binder-x60.html 
60 Metabosafe Capsule 60 http://www.worldwidebestsupplements.com/supplements_MetaboSafe_604.html 
61 Lipotrexate Capsule 60 http://www.worldwidebestsupplements.com/supplements_Lipotrexate_603.html 
62 Fat Stripper Tablet 90 http://www.expresschemist.co.uk/product_6621_fat-stripper.html 
63 Adios Tablet 100 http://www.expresschemist.co.uk/product_3585_adios-100x.html 
64 Helix Slim Tablet 60 http://www.expresschemist.co.uk/product_7621_helix-slim-tincture-tablets-60x.html 
65 Anti Fat Tablet 90 http://www.expresschemist.co.uk/product_6619_anti-fat.html 
66 Lipothin Capsule 60 http://www.worldwidebestsupplements.com/supplements_LipoThin_602.html 




68 SlimQuick Hoodia Capsule 120 http://www.slimquickonline.com/ 
69 Lipo 6 Ephedra Free Capsule 120 http://www.nutrexlipo6.com/lipo-6-ephedra-free.html 
70 Curvelle Capsule 100 http://www.wholesalesupplementstore.com/curvelle.html
71 Phase 2 Carb blocker Capsule 60 
http://www.wholesalesupplementstore.com/phase-2-
carb-blocker.html  
72 NOXYCUT Capsule 75 http://www.noxycut.com/ 




Appendix 3: The English and Chinese names of botanicals purchased from different 
sources. 
 
Source * English name Chinese name 
Chinese white ginseng 中国白参 BB 
Korean ginseng 高丽参 
Chinese white ginseng 中国人参 EYS 
Korean ginseng 高丽参 
JL Chinese red ginseng 吉林参 
Chinese white ginseng 中国白参 MT 
Chinese red ginseng 吉林参 
Panax notoginseng 三七 
Chinese white ginseng 人参 NICPBP 
Panax quinquefolium 西洋参 
Panax notoginseng 三七 
Chinese white ginseng 中国白参 
Chinese red ginseng 石柱参 SC 
Panax quinquefolium 西洋参 
TS Korean ginseng 高丽参 
TYS Chinese red ginseng 吉林参 
 Panax quinquefolium 西洋参 
WS Panax notoginseng 三七 
Panax notoginseng 三七 
Chinese white ginseng 人参 
Chinese red ginseng 吉林参 
Korean ginseng 高丽参 
Eleutherococcus senticosus 刺五加 
Gynostemma pentaphyllum 绞股兰 
WYN 
Rhodiola rosea 红景天 
 
* BB : Bee’s Brand birds nest & health products Pte Ltd. (64-66 Smith Street, 
Singapore); 
EYS : Eu Yan Sang Pte Ltd. (21 Ubi Road I, Singapore); 
JL : Jilin province (China); 
MT : Ming Tai medical shop (Blk 34, Upper Cross Street, #01-150, 
Singapore); 
NICPBP : National Institute for the Control of Pharmaceutical and Biological 
Product (Beijing, China); 
SC : Sinchong Traditional Chinese Medicine (50 Temple Street, Singapore); 
TS : Thye Shan Medical Hall Pte Ltd. (201 New Bridge Road, Singapore); 
TYS : Teck Soon Medical Hall Pte Ltd. (No. 281 South Bridge Road, 
Singapore); 
WS : Wenshan (Yunnan province, China); 
WYN : Wong Yiu Nam Medical Hall Pte Ltd. (51 Temple Street, Singapore). 
 
